##### Table of Contents



U.S. SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-K



|x | Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|- | ------------------------------------------------------------------------------------

For the fiscal year ended August 31, 2008



| ̈ | Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|- | ----------------------------------------------------------------------------------------

For the transition period from
 to

Commission file number:000-21574

DYNACQ HEALTHCARE, INC.

(Exact name of registrant as specified in its charter)



|                                                               |  |                                     
|-------------------------------------------------------------- |  | ------------------------------------
|Nevada                                                         |  | 76-0375477                          
|(State or Other Jurisdiction of Incorporation or Organization) |  | (I.R.S. Employer Identification No.)
|                                                               | 
|10304 Interstate 10 East, Suite 369, Houston, Texas            |  | 77029                               
|(Address of Principal Executive Offices)                       |  | (Zip Code)                          

Registrants telephone number, including area code: (713) 378-2000

Securities registered pursuant to Section 12(b) of the Exchange Act: None

Securities registered pursuant to Section 12(g) of the Exchange Act:



|                               |  |                                          
|------------------------------ |  | -----------------------------------------
|Title of each class            |  | Name of each exchange on which registered
|Common Stock, $0.001 Par Value |  | NASDAQ                                   

Indicate by check mark if the registrant is a well-known seasoned issuer as defined in Rule 405 of
the Securities Act.    Yes   ̈    No  x

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.    Yes   ̈    No  x

Indicate by check mark whether
the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No   ̈

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained
herein, and will not be contained, to the best of registrants knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.   ̈

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated filer, or a smaller reporting company. (Check One):

Large accelerated filer   ̈  Accelerated filer   ̈  Non-accelerated filer   ̈  Smaller reporting company  x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the
Act).    Yes   ̈    No  x

The aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common
equity, as of February 29, 2008 was $34,775,202. As of October 31, 2008, the registrant had 15,555,731 shares of common stock outstanding.



---

##### Table of Contents

TABLE OF CONTENTS



|            |  |                                                                                                               |  |     
|----------- |  | ------------------------------------------------------------------------------------------------------------- |  | ----
|            |  |                                                                                                               |  | Page
|PART I     
|            |  |                                                                                                              
|Item 1.     |  | Business.                                                                                                     |  | 1   
|            |  |                                                                                                              
|Item 1A.    |  | Risk Factors.                                                                                                 |  | 15  
|            |  |                                                                                                              
|Item 1B.    |  | Unresolved Staff Comments                                                                                     |  | 20  
|            |  |                                                                                                              
|Item 2.     |  | Properties.                                                                                                   |  | 20  
|            |  |                                                                                                              
|Item 3.     |  | Legal Proceedings.                                                                                            |  | 21  
|            |  |                                                                                                              
|Item 4.     |  | Submission of Matters to a Vote of Security Holders.                                                          |  | 21  
|           
|PART II    
|            |  |                                                                                                              
|Item 5.     |  | Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity
Securities. |  | 21  
|            |  |                                                                                                              
|Item 6.     |  | Selected Financial Data.                                                                                      |  | 22  
|            |  |                                                                                                              
|Item 7.     |  | Managements Discussion and Analysis of Financial Condition and Results of Operations.                        |  | 22  
|            |  |                                                                                                              
|Item 7A.    |  | Quantitative and Qualitative Disclosures About Market Risk.                                                   |  | 32  
|            |  |                                                                                                              
|Item 8.     |  | Financial Statements and Supplementary Data.                                                                  |  | 32  
|            |  |                                                                                                              
|Item 9.     |  | Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.                         |  | 58  
|            |  |                                                                                                              
|Item 9A(T). |  | Controls and Procedures.                                                                                      |  | 58  
|            |  |                                                                                                              
|Item 9B.    |  | Other Information.                                                                                            |  | 59  
|           
|PART III   
|            |  |                                                                                                              
|Item 10.    |  | Directors, Executive Officers and Corporate Governance                                                        |  | 59  
|            |  |                                                                                                              
|Item 11.    |  | Executive Compensation.                                                                                       |  | 59  
|            |  |                                                                                                              
|Item 12.    |  | Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.               |  | 59  
|            |  |                                                                                                              
|Item 13.    |  | Certain Relationships and Related Transactions and Director Independence                                      |  | 59  
|            |  |                                                                                                              
|Item 14.    |  | Principal Accounting Fees and Services.                                                                       |  | 59  
|           
|PART IV    
|            |  |                                                                                                              
|Item 15.    |  | Exhibits, Financial Statement Schedules.                                                                      |  | 59  



i



---

##### Table of Contents

PART I

This annual report on Form 10-K contains forward-looking statements regarding future events and our future financial performance. Words such as expects, intends, forecasts,
projects, plans, anticipates, believes, estimates, predicts, potential and similar expressions identify forward-looking statements within the meaning of the Private
Securities Litigation Reform Act. All forward-looking statements are based on our current beliefs as well as assumptions made by and information currently available to us. These statements reflect our current views with respect to future events.
Important factors that could cause actual results to materially differ from our current expectations include the risks and uncertainties described in Item 1A. Risk Factors below. Please read the following discussion of the results of our
business and our operations and financial condition and the risk factors along with our consolidated financial statements, including the notes, included in this annual report on Form 10-K.



|Item 1. | Business.
|------- | ---------

General

Dynacq Healthcare, Inc., a Nevada corporation, is a holding company that through its subsidiaries develops and manages general acute care hospitals that
principally provide specialized surgeries. We are composed of two divisions, based on our geographic area of operations  U.S. and China.

U.S. Division

The Companys business strategy is to develop and operate general acute care hospitals designed to
handle specialized surgeries such as bariatric, orthopedic and neuro-spine surgeries. Certain of the Companys facilities also provide plastic surgery, podiatry, gynecology, spine, sleep laboratory and pain management services, as well as minor
emergency treatment services. The Companys hospitals include operating rooms, pre- and post-operative space, intensive care units, nursing units and diagnostic facilities, as well as adjacent medical office buildings that lease space to
physicians and other healthcare providers. These hospitals are the Surgery Specialty Hospitals of America  Southeast Houston Campus (formerly Vista Medical Center Hospital) in Pasadena, Texas, near Houston (the Pasadena facility);
Vista Hospital of Dallas (the Garland facility); and Vista Surgical Hospital of Baton Rouge (the Baton Rouge facility). During the fiscal year ended August 31, 2008 the Company sold the Baton Rouge facility and in 2007
the Company sold its outpatient surgery center, Vista Surgical Center West (the West Houston facility).

Except for emergency
room patients, surgeries at our facilities are typically pre-certified or pre-authorized by the insurance carriers. The bulk of the surgeries are either covered by workers compensation insurance or by commercial insurers on an out-of-network
health plan basis. The Company participates in a small number of managed care contracts.

The Company, through its affiliates, owns or
leases 100% of the real estate for and equipment in its facilities. The Company maintains a majority ownership and controlling interest in all of its operating entities. As of August 31, 2008, the Company owned the following percentages of its
operating entities:



|                  |  |      |  
|----------------- |  | ---- | -
|Pasadena facility |  | 99.9 | %
|Garland facility  |  | 100  | %

China Division

The Company has sought to expand its operations into China not only to achieve geographic diversity but also to allow the Company to improve its
profitability by taking advantage of a high growth market in the provision of healthcare services in that country. Foreign participation in the provision of healthcare services in China is relatively new, and Dynacq believes it is uniquely qualified
to become a significant player in that area. Currently many areas of China lack the level of acute care provided by many hospitals in the U.S. Dynacq believes its experience managing U.S. hospitals will enable it to improve the management of
existing primary care hospitals in China as well as develop specialized facilities offering advanced levels of treatment, while achieving an attractive



1



---

##### Table of Contents

return on its investment.

Many hospitals in
China are government owned, but may be managed by nongovernmental entities with the consent of the local healthcare governmental authority. In a typical management contract, Dynacq would assume responsibility for the operations of the hospital and
receive any profits earned or losses incurred from its operations. Although many local hospitals in China are currently not profitable, the Company believes that its experience in providing quality healthcare management and its ability to implement
internal controls in healthcare administration will enable it to be profitable in its management of hospitals in China. The management arrangement also allows Dynacq to minimize its expenditure of capital to purchase assets, but still have the
potential for an attractive return in its efficient management of the hospital facility.

The Company currently owns 100% of Dynacq Huai
Bei Healthcare, Inc. (Dynacq-Huai Bei), a Chinese corporation formed to provide healthcare management services in China. On May 30, 2008, Dynacq-Huai Bei entered into a Management Agreement with the Rui An City Department of Health
to manage the Rui An Hospital in Rui An, China upon completion of its construction in October 2009. The Company is currently overseeing the construction of this hospital.

For financial information for each of our segments, including information regarding revenues and total assets, see Note 15Industry Segments and Geographic Information contained in the Notes to
Consolidated Financial Statements.

The Company was incorporated in Nevada in February 1992. In November 2003, the Company reincorporated
in Delaware and changed its name from Dynacq International, Inc. to Dynacq Healthcare, Inc. In August, 2007, the Company reincorporated back in Nevada. The terms Company, Dynacq, our or we are used
herein to refer to Dynacq Healthcare, Inc. and its affiliates unless otherwise stated or indicated by context. The term affiliates means direct and indirect subsidiaries of Dynacq Healthcare, Inc. and partnerships and joint ventures in
which subsidiaries are general or limited partners or members.

Recent Developments

Texas Workers Compensation Cases

A significant amount of our net revenue results from Texas
workers compensation claims, which are governed by the rules and regulations of the Texas Department of Workers Compensation (TDWC) and the workers compensation healthcare networks. If one of our hospitals chooses to
participate in a network, the amount of revenue that will be generated from workers compensation claims will be governed by the network contract.

For claims arising prior to the implementation of workers compensation networks and out of network claims, inpatient and outpatient surgical services are either reimbursed pursuant to the Acute Care In-Patient
Hospital Fee Guideline or at a fair and reasonable rate for services in which the fee guideline is not applicable. Starting March 1, 2008, the Texas Workers Compensation 2008 Acute Care Hospital Outpatient and Inpatient
Facility Fee Guidelines (the Guidelines) became effective. Under these Guidelines, the reimbursement amounts are determined by applying the most recently adopted and effective Medicare reimbursement formula and factors; however, if the
maximum allowable reimbursement for the procedure performed cannot be calculated using these Guidelines, then reimbursement is determined on a fair and reasonable basis.

Based on these new Guidelines, the reimbursement due the Company for workers compensation cases is lower than we previously experienced. The Company has continued accepting Texas workers compensation
cases, and has not made any substantial changes in its focus towards such cases. Our net patient service revenue for Texas workers compensation cases as a percentage of gross billings has decreased primarily as a result of lower reimbursement
rates for workers compensation procedures still being performed.

Should our facility disagree with the amount of reimbursement
provided by a third-party payer, we are required to pursue the MDR process at the TDWC to request proper reimbursement for services. The Company has recently been successful in its pursuit of collections regarding the stop-loss cases pending before
the State Office of Administrative Hearings (SOAH), receiving positive rulings in over 90% of its claims presented for administrative



2



---

##### Table of Contents

determination. The 2007 district court decision upholding our interpretation of the statute as applied to the stop-loss claims was recently appealed by
certain insurance carriers, and the Third Court of Appeals determined that in order for a hospital to be reimbursed at 75% of its usual and customary audited charges for an inpatient admission, the hospital must not only bill at least $40,000, but
also show that the admission involved unusually costly and unusually extensive services. Procedurally, the decision means that each case where a carrier raised an issue regarding whether the services provided were unusually costly or unusually
extensive would be remanded to either SOAH or Medical Dispute Resolution (MDR) for a case-by-case determination of whether the services provided meet these standards, once the definitions of those standards are determined. We plan to
appeal the Third Court of Appeals decision and anticipate further, lengthy litigation at the Travis County District Courts and the Texas Courts of Appeals to establish the legal definition for these standards. Because of this lengthy process and the
uncertainty of recovery in these cases, collection of a material amount of funds in these pending stop-loss cases is not anticipated during the 2009 fiscal year.

To date, insurance carriers have voluntarily paid the awards in the decisions and orders issued by SOAH, plus interest, in approximately 180 cases, involving approximately $11 million. In most of these cases, the
carriers have requested refunds of the payments made in the event that the SOAH decisions and orders are reversed on appeal. We believe the Companys ultimate obligation to refund the payments is remote. Our request that the TDWC Commissioner
enforce the awards which have not been voluntarily paid by the carriers has been refused in approximately 130 cases.

Claims regarding
payment for hospital outpatient services remain pending at the TDWC. It is expected that these claims will be adjudicated at SOAH and ultimately in the Texas district and appellate courts. The basis for reimbursement for these services made the
subject of these pending cases is the determination of fair and reasonable charges. In 2007, we received unfavorable rulings from SOAH in all of our appeals of unfavorable decisions related to services provided in 2001 and 2002. The 179
cases which have been appealed to the Travis County district courts challenge the constitutionality of the relevant statutory language. A lead case has been selected and is scheduled to be heard on January 14, 2009. Although we would appeal any
negative ruling handed down in this lead case, such ruling will impact cases in which a fee guideline was not applicable, specifically all pending cases involving ambulatory surgical services provided in 2001 and 2002 as well as all pending cases
involving hospital outpatient services provided prior to March 1, 2008. Successful collection of material amounts in these cases is unlikely.

We are currently pursuing claims against two healthcare agents relating to contracts with certain of our facilities which set out reimbursement guidelines by several workers compensation carriers at a minimum of 70% of the
facilitys charges. Discovery is continuing on these claims to determine which carriers are involved and the amount of reimbursement due to us.

Due to the uncertainties regarding the accounts receivable in the MDR process, the recent Third Court of Appeals opinion and our legal counsels advice that settlements with insurance carriers have
virtually stopped, the Company has fully reserved all accounts receivable related to the MDR process as of August 31, 2008.

Transactions in China

The DeAn Joint Venture (DeAn), which was formed for the purpose of constructing, owning and operating a hospital in
Shanghai, China, had entered into land use agreements with the Chinese government under which it leased, for a term of 50 years, approximately 28.88 acres of government-owned land on which the hospital would be constructed. After protracted
negotiations with the Chinese government for, among other matters, the payment by the government of the amounts due by it under the Joint Venture Agreement which it had not funded, the sale by the government of its interest in DeAn to a third party,
and the extension of the dates for completion of construction of the hospital, the Company agreed to sell its interest in the property owned by DeAn for the construction of the hospital for approximately $4.3 million U.S., net of commissions.
Proceeds of the sale were received on July 14, 2008. The Company expects to dissolve DeAn.

Dynacq-Huai Bei was organized to provide
healthcare management services in China and is a party to the Management Agreement for the Rui An Hospital. It is currently overseeing the construction of the new hospital to open in October 2009. Upon completion of the new hospital, Dynacq-Huai Bei
will manage the facility, and all



3



---

##### Table of Contents

profits, liabilities, operating deficits, and legal disputes of the hospital will be assumed by Dynacq-Huai Bei. Dynacq-Huai Bei has agreed to assume and
discharge within ten years $883,000 of existing liabilities, of which $736,000 has already been paid in fiscal year ended August 31, 2008, and to loan to Rui An $2.1 million for the construction costs of the hospital building and up to $730,000
for equipment purchases. At the expiration of the 15 year term, Dynacq-Huai Bei will be compensated for the increase in value of the hospital assets and for the purchase at fair value of all equipment and medical supplies bought by it costing less
than $7,267 each. As of the date of this filing, Dynacq has funded Dynacq-Huai Bei with approximately $14 million U.S.

The Company has
also organized Sino Bond Inc. Limited, a Hong Kong corporation (Sino Bond), through which it has made approximately $23 million in various investments in Hong Kong. Sino Bond has no operations to date but has entered into a marketing
contract for the provision of healthcare services by Dynacq subsidiaries in China and Southeast Asia.

Sale of Properties

The Company sold its land in The Woodlands, Texas, its Baton Rouge facility and its interest in the property owned by DeAn for the construction of a
hospital in China in the fiscal year ended August 31, 2008.

Industry Background

U.S. Division

The development of
proprietary general acute care hospital networks occurred during the 1970s. During the past 20 years, freestanding outpatient surgery centers were developed to compete with these general hospitals for outpatient procedures. Freestanding
outpatient surgery centers have allowed physicians to perform outpatient procedures in specialized facilities designed to improve efficiency and enhance patient care. The Company believes that its operational model allows physicians to perform
inpatient and outpatient procedures at facilities that provide similar efficiencies as those provided at freestanding outpatient surgery centers.

General acute care hospitals specializing in specific complex surgical procedures are designed with the goal of improving both physician and facility efficiency. The surgeries performed are primarily non-emergency procedures that are
electively scheduled and, therefore, allow for efficiency available through block time/scheduling. Given the opportunity to utilize multiple operating rooms for pre-determined periods of time, the physicians are able to schedule their time more
efficiently and, therefore, increase the number of procedures they can perform within a given amount of time. The facility receives the benefit of consistent staffing patterns and greater facility utilization. In addition, the Company believes that,
due to the relatively small size of its facilities, many physicians prefer to perform procedures in the Companys facilities because their patients prefer the comfort of a more personal atmosphere and the convenience of simplified admission and
discharge procedures.

At August 31, 2008, the Company owned, through its subsidiaries, a 99.9% partnership interest in the Pasadena
facility operating entity. The Pasadena facilitys areas of practice include orthopedic and general surgery, such as spine and bariatric surgeries, various pain management modalities and other services. The Pasadena facility represented
approximately 39% and 38% of the Companys net patient revenues in fiscal years 2008 and 2007, respectively. Through its affiliates, the Company owns 100% of the real estate and owns or leases 100% of the equipment and, in turn, leases the
land, hospital facility and equipment to the hospital operating entity.

As of August 31, 2008, the Company owned, through its
subsidiaries, 100% of the partnership interests in the Garland facility operating entity. The areas of practice performed at this facility are orthopedic surgery, bariatric surgery, general surgery, plastic surgery, podiatry, gynecology, spine and
pain management procedures. The Garland facility represented approximately 61% and 62% of the Companys net patient revenues in fiscal years 2008 and 2007, respectively. Through its affiliates, the Company owns 100% of the real estate and owns
or leases 100% of the equipment and, in turn, leases the land, hospital facility and equipment to the hospital operating entity.

The
facility located in Baton Rouge, Louisiana was 100% owned by the Company until its sale in December 2007. The West Houston facility was sold during the fiscal year 2007.



4



---

##### Table of Contents

China Division

DeAn, which was formed for the purpose of constructing, owning and operating a hospital in Shanghai, China, had entered into land use agreements with the Chinese government under which it leased, for a term of 50
years, approximately 28.88 acres of government-owned land on which the hospital would be constructed. After protracted negotiations with the Chinese government for, among other matters, the payment by the government of the amounts due by it under
the Joint Venture Agreement which it had not funded, the sale by the government of its interest in DeAn to a third party, and the extension of the dates for completion of construction of the hospital, the Company agreed to sell its interest in the
property owned by DeAn for the construction of the hospital for approximately $4.3 million U.S., net of commissions. Proceeds of the sale were received on July 14, 2008, and the Company intends to dissolve DeAn.

On May 30, 2008, Dynacq-Huai Bei entered into a Management Agreement with the Rui An City Department of Health to manage the Rui An Hospital in Rui
An, China upon completion of its construction in October 2009. The Company is currently overseeing the construction of this hospital.

As
of the date of this filing, Dynacq has funded the China Division with approximately $37 million.

Business Growth Strategy

The Company has focused on developing and expanding its surgical services facilities. The Companys business strategy involves:



| |  |  | Creating and maintaining relationships with quality physicians;
| | - |  | ---------------------------------------------------------------



| |  |  | Attracting and retaining key management, marketing and operating personnel;
| | - |  | ---------------------------------------------------------------------------



| |  |  | Further developing and refining its hospital prototype to, among other things, enhance the facility design of its hospitals to provide efficient, effective, and
quality patient care for its current surgical mix as well as additional types of services;
| | - |  | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | Adding new capabilities to its existing hospital campuses; and
| | - |  | --------------------------------------------------------------



| |  |  | Developing the China Division.
| | - |  | ------------------------------

Creating and
Maintaining Relationships with Quality Physicians

Since physicians provide and influence the direction of healthcare, we have
developed our operating model to encourage physicians to affiliate with us and to use our facilities in accordance with their practice needs. Our strategy is to focus on the development of physician partnerships and facilities that will enhance
their practices in order to provide quality healthcare in a friendly environment for the patient. We seek to attract new physicians to our facilities in order to grow or to replace physicians who retire or otherwise depart from time to time, as well
as to expand the surgical case mix. In order to attract new physicians and maintain existing physician relationships, the Company affords them the opportunity to purchase interests in the operating entities of the facilities. By doing so, the
physician becomes more integrally involved in the quality of patient care and the overall efficiency of facility operations.

Attracting and Retaining
Key Personnel

We place the utmost importance on attracting and retaining key personnel to be able to provide quality facilities to
attract and retain qualified physicians. Attracting and retaining the appropriate personnel at all levels within the organization, including senior executives at the corporate level, are also important goals of management and essential in expanding
our operations.



5



---

##### Table of Contents

Further Refining Hospital Design

We believe we attract physicians because we design our facilities and adopt staffing, scheduling and clinical systems and protocols to increase physician productivity and promote their professional success. We focus
attention on providing physicians with quality facilities designed to improve the physicians and their patients satisfaction.

Adding New
Capabilities to Existing Hospitals

Our overall strategy is to develop and operate hospitals designed to handle complex surgeries.
Currently, some of our more complex surgeries include spine and bariatric surgeries for which we have added more surgical equipment. The Company continues to explore the possibility of adding other types of surgical procedures that fit into our
business model.

Developing the China Division

In China, gaining the confidence of the current hospital administrators and members of the local healthcare governing authority will be key to acquiring new management agreements on hospitals. We intend to create and maintain quality
relationships with such personnel to expand our operations in that country. We believe the employee we have hired to head our China Division is uniquely positioned to enter into additional management agreements with local healthcare governing
authorities in China similar to our arrangement with the Rui An Hospital.

Marketing

U.S. Division

Our marketing efforts
are directed primarily at physicians and other healthcare professionals who are principally responsible for referring patients to our facilities. We market our facilities to physicians by emphasizing the high level of patient satisfaction with our
hospitals, the quality and responsiveness of our services and the practice efficiencies provided by our facilities. We believe that providing quality facilities creates a positive environment for patients and physicians. The Company, through its
subsidiaries, also has agreements with outside organizations that offer marketing, pre-authorization and follow up support services to prospective orthopedic and/or bariatric patients in areas serviced by the Pasadena and/or Garland facilities.
These facilities receive orthopedic and bariatric referrals from other sources, and such organizations also refer clients to other area hospitals.

In addition to our arrangements with outside organizations regarding marketing, new bariatric or weight control programs were implemented at the Pasadena facility in the first quarter of fiscal 2006 and at the Garland facility in the second
quarter of fiscal 2006, to replace the former bariatric programs at those facilities and to reduce costs associated with outside vendor programs. Our programs provide or contract for marketing, pre-authorization and follow up support services to
prospective bariatric patients in areas serviced by the Pasadena or Garland facilities. Each of our Pasadena and Garland facilities was designated as a Bariatric Center of Excellence by the American Society for Bariatric Surgery (ASBS) in June 2007
and August 2008, respectively. The ASBS Center of Excellence designation recognizes surgical programs and surgeons who have demonstrated a track record of favorable short and long-term outcomes in bariatric surgery and have the resources to perform
safe bariatric surgeries.

China Division

A three-year management support and marketing agreement was executed effective October 1, 2008 between Sino Bond, Inc. Ltd., the Companys Hong Kong subsidiary and Otto Regent Ltd., a Hong Kong marketing
company to develop strategies to lead the Companys marketing activities in China including but not limited to recruitment of physicians, multi-media advertising and enhancing the reputation of the Companys healthcare services.



6



---

##### Table of Contents

Competition

U.S. Division

Presently, the Company operates in the greater Houston, Texas, and Dallas-Fort Worth, Texas metropolitan
markets. In each market, the Company competes with other providers, including major acute care hospitals. These entities may have various competitive advantages over the Company, including their community position, capital resources, physician
partnerships and proximity to physician office buildings. The Company also encounters competition with other companies for strategic relationships with physicians.

There are several large publicly-held companies, and numerous privately-held companies, that acquire and develop freestanding private hospitals and outpatient surgery centers. Many of these competitors have greater
financial and other resources than the Company. The principal competitive factors that affect the Companys ability and the ability of its competitors to acquire or develop private hospitals are experience, reputation, relationships with
physicians and other medical providers, as well as access to capital. Further, some surgeon groups develop surgical facilities without a corporate partner. The Company can provide no assurance that it will be able to compete successfully in these
markets.

China Division

Most hospitals in China are owned and operated by the local governments subject to the oversight by the central government. The Companys strategy is to minimize its capital investment by entering into long term mutually beneficial
relationships by utilizing space from existing government hospitals and providing specialty medical treatment therapies that the government owned hospitals are lacking and are in high demand. There currently exist joint venture arrangements between
foreign healthcare providers and government owned hospitals, principally in major cities such as Shanghai and Beijing. Some of these competitors have greater financial and other resources than the Company in China. The Company has no prior
experience of operating hospitals and can provide no assurance that it will be able to compete successfully in China.

Government Regulation

U.S. Division

Overview

All participants in the healthcare industry are required to comply with extensive government regulation at the federal, state and local
levels. Under these laws and regulations, hospitals must meet requirements for licensure and qualify to participate in government programs, including Medicare and Medicaid. These requirements relate to the adequacy of medical care, equipment,
personnel, operating policies and procedures, maintenance of adequate records, hospital use, rate-setting, compliance with building codes and environmental protection laws, as well as patient confidentiality requirements. There are also extensive
regulations governing a hospitals participation in government programs and payment for services provided to program beneficiaries. These laws and regulations are extremely complex and, in many instances, the industry does not have the benefit
of significant regulatory or judicial interpretation. Some of the laws applicable to us are subject to limited or evolving interpretations; therefore, a review of our operations by a court or law enforcement or regulatory authority may result in a
determination that could have a material adverse effect on us. Furthermore, the laws applicable to us may be amended or interpreted in a manner that could have a material adverse effect on us.

We believe that our facilities are in substantial compliance with current applicable federal, state and local regulations and standards. In the event of
a determination that we violated applicable laws, rules or regulations or if changes in the regulatory framework occur, we may be subject to criminal penalties and/or civil sanctions and our facilities could lose their licenses and/or their ability
to participate in government programs. In addition, government regulations frequently change, and when regulations change we may be required to make changes in our



7



---

##### Table of Contents

facilities, equipment, personnel and services so that our facilities remain licensed and qualified to participate in these programs. One or more of these
outcomes could be material to our operations.

Texas Workers Compensation Systems

A significant amount of our net revenue results from Texas workers compensation claims. As such, we are subject to the rules and regulations of the
TDWC. See discussion above under Recent Developments.

Licensure, Certification and Accreditation

Our healthcare facilities are subject to state and local licensing regulations ranging from the adequacy of medical care to compliance with
building codes and environmental protection laws. The failure to comply with these regulations could result in the suspension or revocation of a healthcare facilitys license. To assure continued compliance with these regulations, our
facilities are subject to periodic inspection by governmental and other authorities. Moreover, in order to participate in the Medicare and Medicaid programs, each of our hospitals must comply with the applicable regulations of the United States
Department of Health and Human Services (DHHS) relating to, among other things, equipment, personnel and standards of medical care, as well as comply with all applicable state and local laws and regulations. If a hospital fails to
substantially comply with the numerous conditions of participation in the Medicare and Medicaid programs or performs certain prohibited acts, the hospitals participation in the federal or state healthcare programs may be terminated, civil or
criminal penalties may be imposed under certain provisions of the Social Security Act, or both.

We believe that our
hospitals are in substantial compliance with current applicable federal, state and local regulations and standards. However, the requirements for licensure and certification are subject to change. Effective August 2008, the Texas licensing rules for
hospitals underwent significant revisions. Consequently, in order for our hospitals to remain licensed and certified, it may be necessary from time to time for us to make material changes in our facilities, equipment, personnel and/or services.
Additionally, the revisions to the Texas hospital licensing rules may have an impact on any future expansions or renovations to our healthcare facilities in that state.

Professional Licensure

Healthcare professionals at our facilities are required to be individually
and currently licensed or certified under applicable state law and may be subject to numerous Medicare and Medicaid participation and reimbursement regulations. We take steps to ensure that all independent physicians and our employees and agents
have the necessary licenses and certifications with their respective licensing agency. We believe that our employees and agents as well as all independent physicians on staff comply with all applicable state licensure laws.

Corporate Practice of Medicine and Fee-splitting

Some states, such as Texas, have laws that prohibit unlicensed persons or business entities, including corporations, from employing physicians. Some states also have adopted laws that prohibit direct or indirect payments or fee-splitting
arrangements between physicians and unlicensed persons or business entities. Possible sanctions for violations of these restrictions include loss of license, civil and criminal penalties, and rescission of the business arrangements. These laws vary
from state to state, are often vague and in most states have seldom been interpreted by the courts or regulatory agencies. We have structured our arrangements with healthcare providers to avoid the exercise of any responsibility on behalf of the
physicians utilizing our hospitals that could be construed as affecting the practice of medicine and to comply with all such applicable state laws. However, we cannot assure you that governmental officials charged with the responsibility for
enforcing these laws will not assert that we, or the transactions in which we are involved, are in violation of these laws. These laws also may be interpreted by courts in a manner inconsistent with our interpretations. The Texas legislature is
currently holding committee hearings to identify possible changes to the states corporate practice of medicine laws.



8



---

##### Table of Contents

Medicare Reimbursement

On August 22, 2007, the Centers for Medicare and Medicaid Services (CMS) posted its final rule of inpatient hospital payment reforms which excluded payment for several hospital-acquired conditions
(HACs) if any of them occurred during a Medicare beneficiarys inpatient stay. These initial HACs were discussed, revised and ultimately finalized in the August 19, 2008, final rule for the 2009 Inpatient Prospective Payment
System (IPPS) payment year. These exclusions were effective for discharges beginning on October 1, 2008. Under the rule, CMS no longer reimburses hospitals for the treatment of certain conditions that could reasonably have
been prevented. The conditions for which CMS no longer reimburses hospitals for treatment include falls; mediastinitis, an infection that can develop after heart surgery; urinary tract infections that result from improper use of catheters;
pressure ulcers; and vascular infections that result from improper use of catheters. Additionally, the conditions include the following three never events: objects left in the body during surgery, air embolisms and blood incompatibility.
Various insurance companies have also announced plans to stop paying for serious preventable errors. The new CMS and insurance company policies could affect not only reimbursement but evidence in malpractice suits and potential claims
under the False Claims Act. However, given the recent enactment of these changes, it is not possible to accurately assess what effect, if any, they might have on our operations.

Federal Anti-kickback Statute

The Medicaid/Medicare Anti-kickback Statute prohibits providers and
others from soliciting, receiving, offering or paying, directly or indirectly, any remuneration with the intent of generating referrals or orders for services or items covered by a federal healthcare program. Courts have interpreted this statute
broadly. A violation of the Anti-kickback Statute constitutes a felony and may be punished by a criminal fine of up to $25,000 for each violation, imprisonment up to five years, or both, civil money penalties of up to $50,000 per violation and
damages of up to three times the amount of the illegal kickback and/or exclusion from participation in federal healthcare programs, including Medicare and Medicaid.

The Office of Inspector General at the DHHS (the OIG), among other regulatory agencies, is responsible for identifying and eliminating fraud, abuse and waste in federal healthcare programs. The OIG carries
out this mission through a nationwide program of audits, investigations and inspections. The OIG has published final safe harbor regulations that outline categories of activities that are deemed protected from prosecution under the Anti-kickback
Statute. Currently there are statutory exceptions and safe harbors for various activities, including the following: investment interests, space rental, equipment rental, practitioner recruitment, personal services and management contracts, sale of
practice, referral services, warranties, discounts, employees, group purchasing organizations, waiver of beneficiary coinsurance and deductible amounts, managed care arrangements, obstetrical malpractice insurance subsidies, investments in group
practices, freestanding surgery centers and referral agreements for specialty services. Compliance with a safe harbor is not mandatory. The fact that a particular conduct or a business arrangement does not fall within a safe harbor does not
automatically render the conduct or business arrangement illegal under the Anti-kickback Statute. Such conduct and business arrangements, however, may lead to increased scrutiny by government enforcement authorities. The determination as to
compliance with the Anti-kickback statute outside of a safe harbor rests on the particular facts and circumstances and on the parties intent in entering into the transaction or arrangement.

The safe harbor regulations with respect to investment interests establish two instances in which payments to an investor in a venture will not be
treated as a violation of the Anti-kickback Statute. The first safe harbor is for investment interests in public companies that have total assets exceeding $50 million and whose investment securities are registered pursuant to the Securities
Exchange Act of 1934, as amended (the Exchange Act). The second safe harbor or small entity safe harbor is for investments in entities when certain criteria are met. Two significant criteria for this safe harbor are
(1) that no more than 40% of the value of the investment interests of each class of investments may be held in the previous fiscal year or previous twelve-month period by investors who are in a position to make or influence referrals to,
furnish items or services to, or otherwise generate business, for the entity, and (2) that no more than 40% of the gross revenue of the entity in the previous fiscal year or previous twelve-month period may come from referrals or business
otherwise generated from investors. In addition to promulgating safe harbor regulations, to further assist providers, the OIG has established a process to enable healthcare providers to request advisory opinions on whether individual transactions
might violate the Anti-kickback and certain other statutes. The OIG also provides insight into its views on the application of the Anti-kickback



9



---

##### Table of Contents

Statute through various documents including Special Fraud Alerts, Special Advisory Bulletins, Medicare Fraud Alerts and Medicare Advisory Bulletins.

We have a variety of financial relationships with physicians who refer patients to our hospitals. Physicians may own interests in certain
of our hospitals and may also own our stock. We also have medical directorship agreements with some physicians. Although we believe that our arrangements with physicians have been structured to comply with the current law and available
interpretations, we cannot assure you that regulatory authorities will not determine that these arrangements violate the Anti-kickback Statute or other applicable laws. Also, the states in which we operate have adopted anti-kickback laws, some of
which apply more broadly to all payers, not just to federal healthcare programs. Many of these state laws do not have safe harbor regulations comparable to the federal Anti-kickback Statute and have only rarely been interpreted by the courts or
other government agencies. If our arrangements were found to violate any of these anti-kickback laws, we could be subject to criminal and civil penalties and/or possible exclusion from participating in Medicare, Medicaid or other governmental
healthcare programs such as workers compensation programs. Exclusion from these programs could result in significant reductions in revenue and could have a material adverse effect on our business.

Stark Law

The federal physician self-referral
statute is commonly known as the Stark law. This law prohibits physicians from referring Medicare and Medicaid patients who need designated health services (DHS) to entities with which the physician or an immediate family
member has a financial relationship and prohibits the entities from billing Medicare or Medicaid for services ordered pursuant to a prohibited referral. Stark does, however, have a number of exceptions that permit financial relationships between
physicians and entities providing DHS. Sanctions for violating the Stark law include denial of payment, refunding amounts received for services provided pursuant to prohibited referrals, civil monetary penalties of up to $15,000 per prohibited
service provided and exclusion from the Medicare and Medicaid programs. The statute also provides for a penalty of up to $100,000 for a circumvention scheme that has the principal purpose of assuring referrals and that, if directly made, would
violate the Stark law.

On September 5, 2007, CMS completed the third and final installment in its rulemaking process under the Stark
law in an effort to provide the healthcare industry additional interpretation and modification of previously promulgated exceptions to the Stark laws general prohibition on referrals. The new final rule is referred to as Phase III
and addresses the entire Stark law regulatory scheme. The new regulations were effective December 4, 2007. Additionally, effective October 2, 2007, CMS issued a final rule to update the hospital IPPS for fiscal year 2008. Included in the
final rule were two important disclosure provisions that apply to many hospitals. These two disclosure requirements relate to (1) disclosure of physician ownership of hospitals to all patients at the beginning of their hospital stay or
outpatient visit, and (2) whether physicians are on site at the hospital 24 hours a day, 7 days a week. This rule also contains provisions for CMS to require 500 hospitals to furnish information concerning their financial relationships with
their physicians on the Disclosure of Financial Relationship Report. Other provisions of the IPPS rule significantly modify the Stark regulations and some of these modifications will require physicians, hospitals, and other healthcare providers to
unwind or restructure their arrangements. Most of these new Stark regulations are not effective until October 1, 2009, in order to give parties time to unwind or restructure arrangements which are impacted by the changes. There are several
other significant rulemaking proposals, and pending legislation, any and all of which may lead to more changes to the Stark regulations and may have a profound impact on the healthcare industry in general and the operation of our healthcare
facilities in particular.

One of the exceptions utilized to exempt hospital-provided DHS from the ownership proscription is commonly
referred to as the whole hospital exception. This exception permits a physician with an ownership interest in a hospital to make referrals to that hospital provided that: (1) the referring physician is authorized to perform services
at the hospital; and (2) the physicians ownership or investment interest is in the entire hospital and not merely in a distinct part or department of the hospital. We believe we have structured our financial arrangements with physicians
to comply with the whole hospital exception. However, in the recent past, legislation has been introduced that would have essentially eliminated the whole hospital exceptions under the Stark law and would have severely limited the
ability of physicians to have ownership interests in hospitals. While the legislation was unsuccessful this time, we cannot predict whether other similar legislation will ever be adopted or enacted into law and how such legislation, if passed, would
affect our healthcare facilities. However, it is possible that such legislation could require us to restructure our ownership arrangements with physician investors.



10



---

##### Table of Contents

The Stark law may be amended in ways that we cannot predict at this time, including possible changes to
the current physician ownership and compensation exceptions. We cannot predict whether any other law or amendment will be enacted or the effect they might have on us.

State Anti-kickback and Physician Self-Referral Laws

Many states, including those in which we do or
expect to do business, have laws that prohibit payment of kickbacks or other remuneration in return for the referral of patients. Some of these laws apply only to services reimbursable under state Medicaid programs. However, a number of these laws
apply to all healthcare services in the state, regardless of the source of payment for the service. Based on court and administrative interpretations of the federal Anti-kickback Statute, we believe that the Anti-kickback Statute prohibits payments
only if they are intended to induce referrals. However, the laws in most states regarding kickbacks have been subjected to more limited judicial and regulatory interpretation than federal law. Therefore, we can give you no assurances that our
activities will be found to be in compliance with these laws. Noncompliance with these laws could subject us to penalties and sanctions and could have a material adverse effect on us.

A number of states, including those in which we do or expect to do business, have enacted physician self-referral laws that are similar in purpose to the
Stark law but which impose different restrictions. Some states, for example, only prohibit referrals when the physicians financial relationship with a healthcare provider is based upon an investment interest. Other state laws apply only to a
limited number of designated health services. Some states do not prohibit referrals, but require that a patient be informed of the financial relationship before the referral is made. We believe that our operations are in material compliance with the
physician self-referral laws of the states in which our facilities are located.

Other Fraud and Abuse Provisions

The Health Insurance Portability and Accountability Act of 1996 (HIPAA) broadened the scope of certain federal fraud and abuse laws by adding
several criminal provisions for healthcare fraud offenses that apply to all health benefit programs. HIPAA also added a prohibition against incentives intended to influence decisions by Medicare beneficiaries as to the provider from which they will
receive services. In addition, HIPAA created new enforcement mechanisms to combat fraud and abuse, including the Medicare Integrity Program and an incentive program under which individuals can receive up to $1,000 for providing information on
Medicare fraud and abuse that lead to the recovery of at least $100 of Medicare funds. HIPAA was followed by The Balanced Budget Act of 1997, which created additional fraud and abuse provisions, including civil penalties for contracting with an
individual or entity that the provider knows or should know is excluded from a federal healthcare program.

The Social Security Act also
imposes criminal and civil penalties for making false claims and statements to Medicare and Medicaid programs. False claims include, but are not limited to, billing for services not rendered or for misrepresenting actual services rendered in order
to obtain higher reimbursement, billing for unnecessary goods and services, and cost report fraud. Criminal and civil penalties may be imposed for a number of other prohibited activities, including failure to return known overpayments, certain
gainsharing arrangements, and offering remuneration to influence a Medicare or Medicaid beneficiarys selection of a healthcare provider. Like the Anti-kickback Statute, these provisions are very broad. Careful and accurate coding of claims for
reimbursement, as well as accurately preparing cost reports, must be performed to avoid liability.

The Federal False Claims Act and Similar State Laws

A factor affecting the healthcare industry today is the use of the Federal False Claims Act and, in particular, actions brought by
individuals on the governments behalf under the False Claims Acts qui tam, or whistleblower, provisions. Whistleblower provisions allow private individuals to bring actions on behalf of the government alleging that the
defendant has defrauded the federal government.

When a defendant is determined by a court of law to be liable under the False Claims Act,
the defendant may be required to pay three times the actual damages sustained by the government, plus mandatory civil penalties of



11



---

##### Table of Contents

between $5,500 and $11,000 for each false claim submitted. There are many potential bases for liability under the False Claims Act. Liability often arises
when an entity knowingly submits a false claim for reimbursement to the federal government. The False Claims Act defines the term knowingly broadly. Thus, although simple negligence will not give rise to liability under the False Claims
Act, submitting a claim with reckless disregard to its truth or falsity constitutes a knowing submission under the False Claims Act and, therefore, will qualify for liability.

In some cases, whistleblowers and the federal government have taken the position that providers who allegedly have violated other statutes, such as the
Anti-kickback Statute and the Stark law, have thereby submitted false claims under the False Claims Act. Certain states in which we operate have adopted their own false claims provisions as well as their own whistleblower provisions whereby a
private party may file a civil lawsuit in state court. In its 2007 session, the Texas Legislature made numerous revisions to the states laws which make it easier and potentially more profitable for a whistleblower to maintain a qui
tam action.

The regulations governing reimbursement under the Medicare and Medicaid programs are very complex. Third-party payers
may also have complicated requirements that must be adhered to by healthcare providers. These rules are not always clear and may be subject to interpretation. It is necessary to ensure that claims submitted for reimbursement are accurately coded and
completed. Failure to comply with these services and coding requirements can result in denials of payments or the recoupment of payments already received.

Health Information Security and Privacy Practices

The Administrative Simplification provisions of HIPAA require certain
organizations, including us, to implement very significant business and operational systems designed to protect each patients individual healthcare information. Among the standards that the DHHS adopted pursuant to HIPAA are standards for the
following:



| |  |  | electronic transactions and code sets;
| | - |  | --------------------------------------



| |  |  | unique identifiers for providers, employers, health plans and individuals;
| | - |  | --------------------------------------------------------------------------



| |  |  | security and electronic signatures;
| | - |  | -----------------------------------



| |  |  | privacy; and
| | - |  | ------------



| |  |  | enforcement.
| | - |  | ------------

Pursuant to HIPAA, we
are obligated to appoint and have appointed privacy and security officers, analyzed our existing patient record confidentiality system, developed systems to meet the increased confidentiality requirements in the areas of both privacy and security,
drafted and implemented policies and procedures to maintain those systems, trained all relevant personnel in the policies and procedures, monitored the systems on an on-going and continuous basis, notified every new and existing patient of our
confidentiality practices and contracted with certain vendors to assure they adhere to the same strict confidentiality and security standards.

In addition, the transaction standards require us to use standard code sets established by the rule when transmitting health information in connection with some transactions, including health claims and health payment and remittance
invoices. On August 21, 2008, DHHS proposed a rule that would adopt updated versions of the standards for electronic transactions under the authority of HIPAA. The updated standards would replace the current standards. We believe we are in
substantial compliance with the standards that have been implemented to date by DHHS.

The imposition of HIPAA privacy, security and
transactional code set standards on healthcare providers, among others, is a substantial step by the federal government toward requiring that individual health and medical records are developed, maintained and billed for in electronic format. The
rules continue to be amended and, as such, we will continue to modify our systems in order to maintain compliance with the standards.



12



---

##### Table of Contents

A violation of the privacy standards could result in civil money penalties of $100 per incident, up to a
maximum of $25,000 per person per year per standard. The final rule also provides for criminal penalties of up to $50,000 and one year in prison for knowingly and improperly obtaining or disclosing protected health information, up to $100,000 and
five years in prison for obtaining protected health information under false pretenses, and up to $250,000 and ten years in prison for obtaining or disclosing protected health information with the intent to sell, transfer or use such information for
commercial advantage, personal gain or malicious harm. In 2006, the DHHS adopted final rules for the imposition, by the Secretary of Health and Human Services, of civil monetary penalties on entities that violate the administrative simplification
provisions of HIPAA. The final rule amended the existing rules relating to the investigation of noncompliance to make them apply to all of the HIPAA Administrative Simplification rules, rather than exclusively to the privacy standards. It also
amended the existing rules relating to the process for imposition of civil money penalties. Among other matters, the final rule clarified and elaborates upon the investigation process, bases for liability, determination of the penalty amount,
grounds for waiver, conduct of the hearing and the appeal process. The act also provides for criminal penalties for violations. We have established a plan and committed the resources necessary to comply with HIPAA. At this time, we anticipate that
we will be able to maintain compliance with HIPAA regulations that have been issued. Based on the existing regulations and anticipated additions and amendments to the regulation, we believe that the cost of our compliance with HIPAA will not have a
material adverse effect on our results of operations.

Emergency Medical Treatment and Labor Act

All of our hospitals are subject to the Emergency Medical Treatment and Labor Act (EMTALA). This federal law requires any hospital that
participates in the Medicare program to conduct an appropriate medical screening examination of every person who presents to the hospitals dedicated emergency department for treatment and, if the patient is suffering from an emergency medical
condition, either to stabilize that condition or to make an appropriate transfer of the patient to a facility that can stabilize the condition. The obligation to screen and stabilize emergency medical conditions exists regardless of a patients
ability to pay for treatment. CMS has issued final regulations and interpretive guidelines clarifying various requirements under EMTALA. There are severe penalties under EMTALA if a hospital fails to screen or appropriately stabilize or transfer a
patient or if the hospital delays appropriate treatment in order to first inquire about the patients ability to pay. Penalties for violations of EMTALA include civil monetary penalties and exclusion from participation in the Medicare program.
In addition, an injured patient, the patients family or a medical facility that suffers a financial loss as a direct result of another hospitals violation of the law can bring a civil suit against the hospital.

Although we believe that our emergency care practices are in compliance with EMTALA requirements, we cannot assure that CMS or others will not assert
that our facilities are in violation or predict any modifications that CMS will implement in the future. On May 13, 2004, CMS issued revised interpretive guidelines for surveyors investigating EMTALA complaints that require, in addition to
other changes, that hospitals have call coverage that meets the needs of hospital patients. On August 19, 2008, CMS adopted a final rule containing significant changes to EMTALA. These revisions were effective October 1, 2008.
In summary, CMS made the following changes: (1) rather than expand the obligations of hospitals with specialized capability with regard to the transfer on an inpatient with an emergency medical condition, CMS confirmed its 2003 position
regarding inpatients, (2) hospitals may satisfy their on-call coverage obligations by participating in an acceptable formal community/regional call coverage program that meets various requirements. We cannot predict whether we will be in
compliance with any new requirements or interpretive guidelines.

Healthcare Reform

As one of the largest industries in the United States, healthcare continues to attract significant legislative interest and public attention. In recent
years, various legislative proposals have been introduced or proposed in Congress and in some state legislatures that would affect major changes in the healthcare system, either nationally or at the state level. Many states have enacted or are
considering enacting measures designed to reduce their Medicaid expenditures and change private healthcare insurance. Particularly given the recent Presidential and Congressional elections results, we cannot predict the course of future healthcare
legislation or other changes in the administration or interpretation of governmental healthcare programs or the effect that any legislation, interpretation or change may have on us.



13



---

##### Table of Contents

Conversion Legislation

Many states have enacted or are considering enacting laws affecting the conversion or sale of not-for-profit hospitals. These laws, in general, include provisions relating to attorney general approval, advance
notification and community involvement. In addition, state attorneys general in states without specific conversion legislation may exercise authority over these transactions based upon existing law. In many states there has been an increased
interest in the oversight of not-for-profit conversions. We may effect a conversion of a not-for-profit hospital in the future and accordingly, the adoption of conversion legislation and the increased review of not-for-profit hospital conversions
may increase the cost and difficulty or prevent our completion of transactions with not-for-profit organizations in certain states in the future.

Certificate of Need

Some states require state approval for construction and expansion of healthcare facilities, including
findings of need for additional or expanded healthcare facilities or services. Certificates of need, which are issued by governmental agencies with jurisdiction over healthcare facilities, are sometimes required for capital expenditures exceeding a
prescribed amount, changes in bed capacity or services and certain other matters. Currently, we do not operate in any state that requires a certificate of need. Should we desire to expand our operations to any jurisdiction where a certificate of
need will be required, we are unable to predict whether we will be able to obtain any such certificate of need.

Environmental Regulation

Our facilities operations generate medical waste that must be disposed of in compliance with federal, state and local environmental
laws, rules and regulations. These operations also are subject to compliance with various other environmental laws, rules and regulations. We cannot predict whether the cost of such compliance will have a material effect on our future capital
expenditures, earnings or competitive position.

China Division

There are environmental laws, rules and regulations governing hospitals in China including but not limited to medical waste, medical radioactive agents,
and pollution. We cannot predict whether the cost of such compliance will have a material effect on our future earnings, competitiveness, and expansion in China.

Insurance

The Company maintains various insurance policies that cover each of its facilities. Specifically, the Company
has occurrence medical malpractice coverage for its Pasadena and Garland facilities. In addition, all physicians granted privileges at the Companys facilities are required to maintain medical malpractice insurance coverage. The Company also
maintains general liability and property insurance coverage for each facility, including flood coverage. The Company does not currently maintain workers compensation coverage in Texas. In regard to the Employee Health Insurance Plan, the
Company is self insured with specific and aggregate re-insurance with stop-loss levels appropriate for the Companys group size. Coverage is maintained in amounts management deems adequate.

Because hospitals in China are owned by the government, lawsuits against hospitals are generally prohibited. As a result, Dynacq-Huai Bei does not intend
to obtain insurance coverage for its operations in China beyond the minimum required for its operations, if any.

Employees

As of October 25, 2008, the Company employed approximately 199 full-time employees and 73 part-time employees, which represents approximately 231
full-time equivalent employees.



14



---

##### Table of Contents

Available Information

We file proxy statements and annual, quarterly and current reports with the U.S. Securities and Exchange Commission (SEC). You may read and copy any document that we file at the SECs public reference
room located at 100 F Street, N.E., Washington, D.C. 20549. You may also call the SEC at 1-800-SEC-0330 for information on the operation of the public reference room. Our SEC filings are also available to you free of charge at the SECs website
at http://www.sec.gov. We also maintain a website at http://www.dynacq.com that includes links to our SEC filings, including our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and any amendments to those
reports. These reports are available on our website without charge as soon as reasonably practicable after such reports are filed with or furnished to the SEC. Information contained on our website is not part of this report.



|Item 1A. | Risk Factors
|-------- | ------------

The value of an investment in
Dynacq Healthcare, Inc. is subject to significant risks, certain of which are specific to our Company, others are inherent in our business and the industry in which we operate, and still others are market related. If any of the matters described in
the risk factors listed below were to occur, our business and financial results could be materially adversely affected. The Risk Factors described below apply to the current operations and market for the common stock of the Company, and do not
address risks that may arise in the future.

Risks Related to our Business

A significant percentage of our revenues are generated through relatively few physicians.

For the fiscal year ended August 31, 2008, approximately 87% of our gross revenues were generated from 23 surgeons, primarily in our Garland facility. For the fiscal year ended August 31, 2007, approximately 81% of our gross
revenues were generated from 15 surgeons, primarily in our Garland facility. The loss of physicians who provide significant net patient revenues for the Company may adversely affect our results of operations.

Because foreign participation in hospitals in China is relatively new and unproven, our efforts to obtain management contracts in that country may not be
successful, and the management of Rui An Hospital and any other hospitals we may manage may not be profitable.

We have invested a
substantial amount of funds and management resources into the development of our China Division. There is no reliable history of foreign participation in the operation of hospitals in China on which to base our prospects for success. The agreement
under which Dynacq-Huai Bei will manage Rui An Hospital currently provides for substantial investment of funds in capital expenditures for that hospital, the repayment of liabilities, and the loan of certain amounts to Rui An Hospital. Since
May 30, 2008, Dynacq-Huai Bei has incurred, and will continue to incur, substantial costs in managing the construction of the new hospital to be completed in October 2009, before it can begin to realize the profits from the operations of that
hospital. Although management agreements on additional hospitals may vary in their terms, there can be no assurances that additional management agreements will be undertaken.

Our lack of success in obtaining necessary local government participation for the DeAn Joint Venture to construct, own and operate a hospital in Shanghai may be indicative of the difficulties involved in foreign
investment in China.

DeAn was formed for the purpose of constructing, owning and operating a hospital in Shanghai, China and on
May 16, 2005 entered into land use agreements with the Chinese government under which it leased, for a term of 50 years, approximately 28.88 acres of government-owned land on which the hospital would be constructed. The Company was engaged in
protracted negotiations for several years for, among other matters, the payment by the local government of the unfunded amounts due by it under the Joint Venture Agreement, the sale by the local government of its interest in DeAn to a third party,
and the extension of the dates for construction of the hospital, none of which proved successful. As a result, the Company sold its interest in the property owned by DeAn for the construction of the Shanghai hospital. Although management believes
Dynacq Huai-Bei, as a 100% foreign owned domestic corporation, will have certain advantages in operating in China which were not available to DeAn which



15



---

##### Table of Contents

was only 70% owned by Dynacq, there can be no assurances that those advantages will be realized or that Dynacq-Huai Bei will be able to own, operate or
manage additional hospitals in China. Dynacq may only be able to obtain certain hospital management arrangements in China by entering into joint ventures with the local government. As a result, we will not have total control over the joint venture,
and there can be no assurances that the local government will be able to fulfill its commitments to our joint venture arrangements.

Our expansion
into international operations could be harmed by economic, political, regulatory and other risks associated with doing business in foreign countries.

The risks associated with international expansion could adversely affect our ability to expand our business. Expansion of our operations into new markets entails substantial working capital and capital requirements
associated with complying with a variety of foreign laws and regulations, complexities related to obtaining agreements from foreign governments and third parties, foreign taxes, and financial risks, such as those related to foreign currency
fluctuations. International expansion will also be subject to general geopolitical risks, such as political and economic instability and changes in diplomatic relationships. In many market areas, other healthcare facilities and companies already
have significant presence, the effect of which could be to make it more difficult for us to attract patients and recruit qualified physicians. There can be no assurances that we will be able to successfully manage the hospital in Rui An or other
hospitals that we may enter into contracts to manage. The failure to do so, including the failure to attract patients and to recruit qualified physicians to those facilities, could have a material adverse effect on our business, financial condition
and results of operations.

Our credit facility was terminated on October 10, 2008 due to technical defaults in reporting and the Companys
investment in China, so we no longer have access to a credit facility were we to need one.

Our credit facility originally obtained
through Merrill Lynch Capital for up to $10 million was transferred to General Electric Commercial Finance in February 2008. General Electric Commercial Finance informed us in September 2008 of certain technical defaults in the credit facility and
cited them as reasons to terminate that facility. Because the Company has sufficient cash on hand and cash flow from operations, it has no present need for the credit facility. In the event we were to identify a need for cash in excess of that
available to us, however, we may have difficulty arranging a new credit facility on favorable terms in view of the generally tight credit market.

We
are subject to substantial uninsured liabilities for which we have incurred, and may continue to incur, significant expenses.

In
January 2007, Dynacq settled a class action lawsuit filed by shareholders against it, its directors and officers for allegedly publishing materially misleading financial statements, making materially false or misleading statements or omissions
regarding its financial condition, and engaging in a fraudulent schedule to inflate the value of its stock. This case, in addition to the legal actions alleging malpractice, product liability or related legal theories that are common in our
industry, have involved significant costs and a major drain on managements time and resources.

Although we maintain professional
malpractice liability insurance and general liability insurance coverage in amounts and with deductibles that we believe to be appropriate for our operations, our insurance coverage may not be sufficient or continue to be available at a cost
allowing us to maintain adequate levels of insurance. Our professional malpractice liability insurance has covered the majority of malpractice and related legal claims to date; however, the cost of defending the shareholder derivative suits and any
damages awarded as a result of those suits, are paid by the Company. In addition, the large monetary claims and significant defense costs involved in many of the malpractice claims may exceed the limits of our insurance coverage. If one or more
successful claims against us were not covered by or exceeded the coverage of our insurance, we could be adversely affected. We do not employ any of the physicians who conduct procedures at our hospitals, and the governing documents of each of our
hospitals require physicians who conduct procedures at our hospitals to maintain stated amounts of insurance.



16



---

##### Table of Contents

We indemnify our directors and officers against certain liabilities and do not presently carry director and officer
liability insurance.

As permitted under Nevada law and pursuant to our governing documents and indemnification agreements with
certain of our officers and directors, we indemnify our directors against monetary damages for breach of a directors fiduciary duty and advance expenses to the full extent permitted by Nevada law. As a result, shareholders rights to
recover against directors for breach of fiduciary duty are limited. We do not carry director and officer liability insurance, so our assets are at risk in the event of successful claims against us or our officers and directors. Our assets may not be
sufficient to satisfy judgments against us and our officers and directors in the event of such successful claims. In addition, our lack of director and officer liability insurance may adversely affect our ability to attract and retain highly
qualified directors and officers in the future.

We are dependent on certain key personnel.

The Company is dependent upon a limited number of key management, technical and professional personnel. The Companys future success will depend, in
part, upon its ability to attract and retain highly qualified personnel. The Company faces competition for such personnel from other companies and organizations, and there can be no assurance that the Company will be successful in hiring or
retaining qualified personnel. The Company does not have written employment agreements with any of its officers providing for specific terms of employment, and officers and other key personnel could leave the Companys employment with little or
no prior notice. The Companys loss of key personnel, especially if the loss is without advance notice, or the Companys inability to hire or retain key personnel, could have a material adverse effect on the Companys business,
financial condition or results of operations. The Company does not carry any key man life insurance.

Risks Associated with our Industry

If we fail to comply with the extensive laws and complex government regulations applicable to us, we could suffer penalties or be required to make significant
changes to our operations.

The healthcare industry is highly regulated and must comply with extensive government regulation at the
federal, state and local levels. Hospitals must meet requirements for licensure, certification to participate in government programs and accreditation. In addition, there are regulatory requirements related to areas such as adequacy and quality of
medical care, relationships with physicians and other referral sources (Anti-kickback Statute and Stark law, for example), qualifications of medical and support personnel, billing for services, confidentiality of medical records, emergency care and
compliance with building codes. While we believe that we are in substantial compliance with these extensive government laws and regulations, if we fail to comply with any of the laws or regulations we could be subject to criminal penalties and civil
sanctions, and our facilities could lose their licenses and their ability to participate in federal and state healthcare programs. In addition, government laws and regulations, or the interpretation of such laws and regulations, may change. In that
case, we may have to make changes in our facilities, equipment, personnel, services or business structures so that our facilities may remain licensed and qualified to participate in federal and state programs. If the rules governing reimbursement
are revised or interpreted in a different manner or if a determination is made that we did not comply with these requirements, we could be subject to denials of payment or recoupment of payments already received for services provided to patients.

Specifically, the federal Anti-kickback Statute and the Stark law are very broad in scope, and many of their provisions have not been
uniformly or definitively interpreted. See Business  Government Regulation for an in- depth description of those statutes. If the ownership distributions paid to physicians by our hospitals are found to constitute prohibited payments made to
physicians under the Anti-kickback Statute, physician self-referral or other fraud and abuse laws, our business may be adversely affected. Other companies within the healthcare industry continue to be the subject of federal and state investigations
that could increase the risk that we may become subject to similar investigations in the future.



17



---

##### Table of Contents

If laws governing the corporate practice of medicine change, we may be required to restructure some of our
relationships.

The laws of various states in which we operate or may operate in the future do not or may not permit business
corporations to practice medicine, exercise control over physicians who practice medicine or engage in various business practices, such as fee-splitting with physicians. The interpretation and enforcement of these laws vary significantly from state
to state. A government agency charged with enforcement of these laws, or a private party, might assert that our arrangements with physicians and physician group practices do not comply with applicable corporate practice of medicine laws. If our
arrangements with these physicians and physician group practices were deemed to violate state corporate practice of medicine, fee-splitting or similar laws, or if new laws were enacted rendering these arrangements illegal, we may be required to
restructure our relationships with physicians and physician groups, which may have a material adverse effect on our business.

Recent changes to the
Fee Guidelines for Texas workers compensation cases have resulted in lower reimbursement and may result in a decrease in the number of those type of procedures performed.

The Texas Workers Compensation 2008 Acute Care Hospital Outpatient and Inpatient Facility Fee Guidelines which became effective March 1, 2008
establish reimbursement amounts for workers compensation procedures performed at our facilities. Those amounts are determined by applying the most recently adopted and effective Medicare reimbursement formula and factors as published annually
in the Federal Register, including identifying the appropriate Ambulatory Payment Classification for outpatient services provided, or Diagnosis Related Group for inpatient services provided. The applicable classification or group is used to
determine the maximum allowable reimbursement for the procedures performed unless not calculable using Guidelines, in which case reimbursement will be determined on a fair and reasonable basis. Based on these new Guidelines, the reimbursement due
the Company for workers compensation cases is lower than we previously experienced. Our net patient service revenues attributable to Texas workers compensation cases as a percentage of gross billings have decreased and may continue to
decrease as a result of both the decreased number of procedures and the lower reimbursement rates for workers compensation procedures still being performed.

Our revenues may not increase due to a reduction in payments from third-party payers, a shift in the surgical mix and/or other circumstances over which we have no control.

We are dependent upon private and governmental third-party sources of payment for the services provided to patients in our healthcare facilities. The
amount of payment our facilities receive for their services may be adversely affected by market and cost factors as well as other factors over which we have no control, including federal and state regulations and the cost containment and utilization
decisions of third-party payers. The Companys decision to participate in certain managed care contracts may not result in an increase in patient revenues if we are unable to obtain favorable managed care contracts, we are excluded from
participation in a managed care contract, or the reimbursement rate for the procedure performed is too low.

Further, complicated
reimbursement rules that are subject to interpretation may subject us to denials of payment for services provided or to recoupments of payments already received. We have no control over the number of patients that are referred to our facilities
annually or whether such patients will be admitted as inpatients that typically have a higher reimbursement rate per procedure, or outpatients. Fixed fee schedules, capitation payment arrangements, exclusion from participation in managed care
programs or other factors affecting payments for healthcare services over which we do not have control could also cause a reduction in our revenues.

We are dependent upon the good reputation of our physicians.

The success of our business is dependent upon quality
medical services being rendered by our physicians. Any negative publicity, whether from civil litigation, allegations of criminal misconduct, or forfeiture of medical licenses, with respect to any of our physicians and/or our facilities could
adversely affect our results of operations. This could occur through the loss of a physician who provides significant revenue to the Company, or decisions by patients to use different physicians or facilities with respect to their healthcare needs.
In addition, Dynacq has been the subject of negative publicity in news reports focusing on its Pasadena facility, which has harmed its business and reputation. As the patient-physician relationship involves inherent trust and confidence, any
negative publicity



18



---

##### Table of Contents

adversely affecting the reputation of our physicians or our facilities would likely adversely affect our results of operations.

Our hospitals face competition for patients from other hospitals and healthcare providers.

The healthcare business is highly competitive, and competition among hospitals and other healthcare providers for patients has intensified in recent
years. Generally, other hospitals in the local communities served by most of our hospitals provide services similar to those offered by our hospitals. In addition, the number of freestanding specialty hospitals and surgery and diagnostic centers in
the geographic areas in which we operate has increased significantly. As a result, most of our hospitals operate in an increasingly competitive environment. Some of the hospitals that compete with our hospitals are owned by governmental agencies or
not-for-profit corporations supported by endowments and charitable contributions and can finance capital expenditures and operations on a tax-exempt basis. Increasingly, we are facing competition by physician-owned freestanding surgery centers that
compete for market share in high margin services and for quality physicians and personnel. If our competitors are better able to attract patients, recruit physicians, expand services or obtain favorable managed care contracts at their healthcare
facilities, we may experience a decline in patient volume.

Our hospitals face competition for staffing, which may increase our labor costs and
reduce profitability.

Our operations are dependent on the effort, abilities and experience of the management and medical support
personnel, such as nurses, pharmacists and lab technicians, as well as our physicians. We compete with other healthcare providers in recruiting and retaining qualified management and medical support personnel responsible for the day-to-day
operations of each of our hospitals. In some markets, the availability of nurses and other medical support personnel has become a significant operating issue to healthcare providers. This shortage may require us to continue to enhance wages and
benefits to recruit and retain nurses and other medical support personnel or to hire more expensive temporary personnel. We also depend on the available labor pool of semi-skilled and unskilled employees in each of the markets in which we operate.
If our labor costs increase, we may not be able to raise rates to offset these increased costs. Our failure to recruit and retain qualified management, nurses and other medical support personnel, or to control our labor costs could have a material
adverse effect on our results of operations.

Market Risks Related to Our Stock

A single stockholder controls a majority of our outstanding shares.

Our chairman and chief
executive officer beneficially owns an aggregate of approximately 54% of our issued and outstanding common stock as of August 31, 2008. As a majority stockholder, he is able to control all matters requiring stockholder approval, including the
election and removal of any directors and any merger, consolidation or sale of all or substantially all of our assets. In addition, he is in a position to control the management of our business and the appointment of executive officers as well as
all management personnel. This concentration of ownership could have the effect of delaying, deferring or preventing a change of control, or impeding a merger or consolidation, takeover or other business combination or sale of all or substantially
all of our assets. In the event that this stockholder elects to sell significant amounts of shares of common stock in the future, such sales could depress the market price of our common stock, further increasing the volatility of our trading market.

Our common stock has a limited trading market, which could affect your ability to sell shares of our common stock and the price you may receive for
our common stock.

Our common stock is currently quoted on the Nasdaq Global Markets. There is only limited trading activity in our
securities. We have a relatively small public float compared to our market capitalization. Accordingly, we cannot predict the extent to which investors interest in our common stock will provide an active and liquid trading market. Due to our
limited public float, we may be vulnerable to investors taking a short position in our common stock, which would likely have a depressing effect on the price of our common stock and add increased volatility to our trading market.
Furthermore, we have been, and in the future may be subject to, class action lawsuits that further increase market volatility. The volatility of the market for our common stock could have a materially adverse effect



19



---

##### Table of Contents

on our business, results of operations and financial condition. Accordingly, investors must be able to bear the financial risk of losing their entire
investment in our common stock.

Future issuance of additional shares of our stock could cause dilution of ownership interests and adversely affect
our stock price.

We issued 889,143 shares of the Companys common stock in a private placement in fiscal year 2006 at a price
per share equal to 70% of the current market price. We may in the future issue more of our authorized and unissued securities at less than market price, resulting in the dilution of the ownership interests of current shareholders. In
addition to approximately 84 million shares of common stock we have that are authorized to issue but are unissued, our board may issue up to 5 million shares of preferred stock which may have greater rights than our common stock, without
seeking approval from holders of our common stock. In addition, we are obligated to issue an aggregate of approximately 1.6 million shares of common stock upon the exercise of options outstanding under our 2000 Incentive Plan, and an
additional 1 million shares may be earned under a performance award agreement granted under that Plan. Of that aggregate number, options to purchase approximately 1.1 million shares have an exercise price which is lower than the market
price at August 31, 2008, and the 1 million share performance award is at a price which is lower than the market price at August 31, 2008. The shares subject to outstanding options and the performance award represent approximately 16%
of our currently outstanding shares of common stock. Additional shares are subject to options not yet granted under the plan, and we may grant additional options or warrants in the future to purchase shares of our common stock not under the
plan. The exercise price of each option granted under our option plan is equal to the fair market value of the shares on the date of grant, although that price may be substantially less than the value per share on the date of exercise.

We have not paid cash dividends on our common stock and do not expect to do so in the foreseeable future.

It has been our policy to use all available funds from operations to improve and expand our current facilities and to acquire new facilities. For that
reason, we have never paid cash dividends on our common stock and have no present intention to pay dividends in the foreseeable future. Therefore an investor in our common stock should not expect to obtain any economic benefit from owning our common
stock prior to a sale of those shares, if then.



|Item 1B. | Unresolved Staff Comments
|-------- | -------------------------

Not required.



|Item 2. | Properties.
|------- | -----------

The Company or its subsidiaries own
or lease the following properties:



| |  |  | The Pasadena facility, the office building adjacent to such facility and the land upon which the facilities are located, are owned by a wholly-owned subsidiary of
the Company. The hospital is approximately 45,000 square feet, and the office building is approximately 36,000 square feet.
| | - |  | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | The Garland facility, including an approximately 90,000 square foot hospital, an approximately 27,000 square foot medical office building and approximately 22.7
acres of land in Garland, Texas, are owned by a wholly-owned subsidiary of the Company.
| | - |  | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | The Company leases 7,250 square feet of office space for its executive offices through September 1, 2011 for $6,525 per month. The lessor of the office space
is Capital Bank, of which Mr. Earl Votaw, one of the Companys directors, is a director. Management believes that the lease rate being paid is consistent with comparable commercial rates available in the area.
| | - |  | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | The Company leases, on a short term 6-month renewable basis, an apartment for approximately $19,000 per month in Hong Kong for the Chief Executive Officer, who is
making efforts to develop the China Division operations.
| | - |  | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



20



---

##### Table of Contents

|Item 3. | Legal Proceedings.
|------- | ------------------

The Company is routinely
involved in litigation and administrative proceedings that are incidental to its business. Specifically, all judicial review of unsatisfactory determinations of reimbursement amounts due us for our facilitys fees must be made in the district
courts of Travis County, Texas in what can often be a lengthy procedure. Please refer to Managements Discussion and Analysis of Financial Condition and Results of Operations  Revenue Recognition for a detailed description of the MDR
process and our accounts receivable. The Company cannot predict whether any litigation or administrative proceeding to which it is currently a party will have a material adverse effect on the Companys results of operations, cash flows or
financial condition.



|Item 4. | Submission of Matters to a Vote of Security Holders.
|------- | ----------------------------------------------------

None.

PART II



|Item 5. | Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.
|------- | -------------------------------------------------------------------------------------------------------------

The Companys common stock was listed on the Nasdaq Capital Market System until February 28, 2008, when it began to be listed on the Nasdaq
Global Market. The trading symbol for the Companys common stock continues to be DYII.

The following table sets forth the
high and low bid prices of the common stock for the period from September 1, 2006 to August 31, 2008. These over-the-counter prices reflect inter-dealer prices, without retail mark-ups, mark-down or commissions, and may not necessarily
represent actual transactions.



|                 |  |       |      |      |   |     
|---------------- |  | ----- | ---- | ---- | - | ----
|                 |  | Highs |      | Lows
|FISCAL YEAR 2008 |  |       |      |      |   |     
|Fourth Quarter   |  | $     | 8.73 |      | $ | 3.56
|Third Quarter    |  |       | 6.27 |      |   | 3.32
|Second Quarter   |  |       | 6.70 |      |   | 4.21
|First Quarter    |  |       | 7.30 |      |   | 3.50
|                 |  |      
|FISCAL YEAR 2007 |  |       |      |      |   |     
|Fourth Quarter   |  | $     | 9.39 |      | $ | 1.73
|Third Quarter    |  |       | 2.09 |      |   | 1.13
|Second Quarter   |  |       | 1.94 |      |   | 1.30
|First Quarter    |  |       | 3.50 |      |   | 1.50

At October 31, 2008, there were approximately 341 record owners of the Companys common
stock. This number does not include stockholders who hold the Companys securities in nominee accounts with broker-dealer firms or depository institutions.

The Company has not declared any cash dividends on its common stock for the two most recent fiscal years. The Company intends to retain all earnings for operations and expansion of its business and does not anticipate
paying cash dividends in the foreseeable future. Any future determination as to the payment of cash dividends will depend upon the Companys results of operations, financial condition and capital requirements, as well as such other factors as
the Companys Board of Directors may consider.

Purchases of Equity Securities by the Company

Of the 500,000 shares authorized to be repurchased in January 2002, the Company purchased 10,000 shares in December 2007 at an average cost of $3.80 per
share. Prior to that the Company had bought back 450,676 shares of



21



---

##### Table of Contents

its common stock during in fiscal years 2002 - 2004 at an average cost of $14.08 per share, for a total purchase price of $6,345,680. The Company
is no longer purchasing its shares under this program.

On February 29, 2008 the Companys Board of Directors authorized a
program of repurchasing up to 2 million of its outstanding securities from time to time in open market transactions at prevailing prices on NASDAQ. The Company has repurchased 445,193 shares at an average cost of $5.10 per share during fiscal
year 2008. Shares repurchased during the fourth quarter of 2008 pursuant to our repurchase program are as follows:



|                    |  |                                                                               |  |                        |      |                                                                                               |          
|------------------- |  | ----------------------------------------------------------------------------- |  | ---------------------- | ---- | --------------------------------------------------------------------------------------------- | ---------
|Period              |  | Total Number of SharesPurchased as Part ofPublicly Announced Plansor Programs |  | Average Priceper Share |      | Maximum Number ofShares that May Yet bePurchased Under
thePublicly Announced Plansor Programs
|June 1 - 30, 2008   |  | 24,806                                                                        |  | $                      | 6.11 |                                                                                               | 1,731,729
|July 1 - 31, 2008   |  | 121,352                                                                       |  |                        | 4.32 |                                                                                               | 1,610,377
|August 1 - 31, 2008 |  | 55,570                                                                        |  |                        | 4.45 |                                                                                               | 1,554,807
|                    |  |                                                                               |  |                        |      |                                                                                               |          
|Total               |  | 201,728                                                                       |  | $                      | 4.58 |                                                                                               | 1,554,807
|                    |  |                                                                               |  |                        |      |                                                                                               |          



|Item 6. | Selected Financial Data.
|------- | ------------------------

Not required.



|Item 7. | Managements Discussion and Analysis of Financial Condition and Results of Operations.
|------- | --------------------------------------------------------------------------------------

Our Managements Discussion and Analysis includes forward-looking statements that are subject to risks and uncertainties. Actual results may differ
substantially from the statements we make in this section due to a number of factors that are discussed in Item 1A  Risk Factors.

Our operating results for all periods presented reflect our Baton Rouge and West Houston facilities as discontinued operations.

Critical
Accounting Policies and Estimates

The Consolidated Financial Statements and Notes to Consolidated Financial Statements contain
information that is pertinent to the managements discussion and analysis. The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and
assumptions that affect the reported amounts of assets and liabilities and disclosure of any contingent assets and liabilities. Management believes these accounting policies involve judgment due to the significant assumptions and estimates necessary
in determining the related asset and liability amounts. Management believes it has exercised proper judgment in determining these estimates based on the facts and circumstances available to its management at the time the estimates were made. The
significant accounting policies are described in the Companys financial statements (see Note 1 in Notes to the Consolidated Financial Statements). Of these policies, management believes the following ones may involve a comparatively higher
degree of judgment and complexity. We have discussed the development and selection of the critical accounting policies and related disclosures with the Audit Committee of the Board of Directors.

Revenue Recognition

Background

The Companys revenue recognition policy is significant because net patient service revenue is a primary component of its results of operations.
Revenue is recognized as services are delivered. The determination of the



22



---

##### Table of Contents

amount of revenue to recognize in connection with the Companys services is subject to significant judgments and estimates, which are discussed below.

Revenue Recognition Policy

The
Company has established billing rates for its medical services which it bills as gross revenue as services are delivered. Gross billed revenues are then reduced by the Companys estimate of the discount (contractual allowance) to arrive at net
patient service revenues. Net patient service revenues are based on estimated or historical cash collections as discussed below and may not represent amounts ultimately collected. At such time as the Company can determine that ultimate collections
have exceeded or have been less than the revenue recorded on a group of accounts, additional revenue or reduction in revenue is recorded as a change in estimate during the current period. The Company does adjust current period revenue for actual
differences in estimated revenue recorded in prior periods and actual cash collections. As the Company is able to identify specific closed blocks of business, the Company compares the actual cash collections on gross billed charges to the estimated
collections that were recorded in revenue. The Company records additional revenue or a reduction in revenue in the current period equal to the difference in the estimate recorded and the actual cash collected.

In the last two fiscal years, the Company has recorded additional revenue as follows:

1. The Company has recorded additional revenue of $8,217,000 during the fiscal year ended August 31, 2008 related to amounts collected on MDR accounts receivable. The Company settled various MDR claims for our
Pasadena and Garland facilities and collected a total of $26,713,000 for dates of service ranging from 2001 to 2005. This amount represents payments received initially at the time of filing of the claim, additional monies received upon filing the
MDR claim and the settlement amount. On these closed MDR accounts receivable, the Company had recognized approximately $18,496,000 as net revenue during the relevant fiscal years when the service was performed. Gross billings on this block of
receivables were $35,807,000. Since the Company actually collected $8,217,000 more on this block of receivables than was booked, additional revenue of $682,000, $3,835,000, $1,324,000 and $2,376,000 was recorded in the first, second, third and
fourth quarters of the fiscal year ended August 31, 2008, respectively. We do not believe that the amount of additional revenues from MDR settlements reached in this fiscal year is indicative of the amounts that will be obtained from
settlements reached in the next twelve months, since insurance companies who have not yet settled may be more likely to appeal their cases, which could delay settlement or a final judgment.

2. The Company collected $42,596,000 on a block of business generated at our Garland facility between September 2003 and February 2008. The accounts included in this
block of business were not related to workers compensation. Gross billings on this block of receivables were $78,781,000. The contractual allowance booked on this block of receivables was $41,485,000, or approximately 52.7%, generating net
revenue of $37,296,000. Since the Company actually collected $5,300,000 more than revenue booked on this block of receivables, additional revenue in the amount of $5,300,000 was recorded in the fourth quarter of the fiscal year ended August 31,
2008.

3. The Company collected $28,572,000 on a block of business generated at our Pasadena facility between September 2005 and February 2008. The
accounts included in this block of business were not related to workers compensation. Gross billings on this block of receivables were $60,715,000. The contractual allowance booked on this block of receivables was $36,643,000, or approximately
60.4%, generating net revenue of $24,072,000. Since the Company actually collected $4,500,000 more than revenue booked on this block of receivables, additional revenue in the amount of $4,500,000 was recorded in the fourth quarter of the fiscal year
ended August 31, 2008.

4. Due to the uncertainties regarding the accounts receivable in the MDR process, the recent Third Court of Appeals
opinion and outside counsels advice that settlements with insurance carriers have virtually stopped, the Company has fully reserved all accounts receivable related to the MDR process as of August 31, 2008, and written-off $8.7 million and
$9.8 million of MDR accounts receivable in the fourth quarter of the fiscal year ended August 31, 2008, at our Garland and Pasadena facilities, respectively.

The net write down in net patient service revenue was $6.3 million in the fourth quarter of the fiscal year ended August 31, 2008, or $4.1 million net of income tax expense, or $0.25 per diluted share.



23



---

##### Table of Contents

The table below sets forth the percentage of our gross patient service revenue by financial class for the
fiscal years 2008 and 2007:



|                      |  |      |  |     
|--------------------- |  | ---- |  | ----
|                      |  | 2008 |  | 2007
|Workers Compensation |  | 37%  |  | 47% 
|Commercial            |  | 41%  |  | 38% 
|Medicare              |  | 10%  |  | 9%  
|Medicaid              |  | %   |  | 1%  
|Self-Pay              |  | 10%  |  | 3%  
|Other                 |  | 2%   |  | 2%  

Contractual Allowance

Starting March 1, 2008, the Company computes its contractual allowance based on the estimated collections on its gross billed charges. The Company computes its estimate by taking into account collections received
for the services performed and also estimating amounts collectible within the next six months and after six months by considering historical collections ratio. Prior to March 1, 2008, the contractual allowance was calculated based on the ratio
of the Companys historical cash collections during the trailing twelve months on a case-by-case basis by operating facility. This ratio of cash collections to billed services was then applied to the gross billed services by operating facility.
The following table shows gross revenues and contractual allowances for fiscal years 2008 and 2007:



|                                 |  |      |             |      |   |           
|-------------------------------- |  | ---- | ----------- | ---- | - | ----------
|                                 |  | 2008 |             | 2007
|Gross billed charges             |  | $    | 145,763,332 |      | $ | 96,215,520
|Contractual allowance            |  |      | 85,489,385  |      |   | 53,369,699
|                                 |  |      |             |      |   |           
|Net revenue                      |  | $    | 60,273,947  |      | $ | 42,845,821
|                                 |  |      |             |      |   |           
|Contractual allowance percentage |  |      | 59%         |      |   | 55%       
|                                 |  |      |             |      |   |           

A significant amount of our net revenue results from Texas workers compensation claims,
which are governed by the rules and regulations of the TDWC and the workers compensation healthcare networks. If one of our hospitals chooses to participate in a network, the amount of revenue that will be generated from workers
compensation claims will be governed by the network contract.

For claims arising prior to the implementation of workers compensation
networks and out of network claims, inpatient and outpatient surgical services are either reimbursed pursuant to the Acute Care In-Patient Hospital Fee Guideline or at a fair and reasonable rate for services in which the fee guideline is
not applicable. Starting March 1, 2008, the Guidelines became effective. Under these Guidelines, the reimbursement amounts are determined by applying the most recently adopted and effective Medicare reimbursement formula and factors; however,
if the maximum allowable reimbursement for the procedure performed cannot be calculated using these Guidelines, then reimbursement is determined on a fair and reasonable basis.

Based on these new Guidelines, the reimbursement due the Company for workers compensation cases is lower than we previously experienced. The
Company has continued accepting Texas workers compensation cases, and has not made any substantial changes in its focus towards such cases. Our net patient service revenue for Texas workers compensation cases as a percentage of gross
billings has decreased primarily as a result of lower reimbursement rates for workers compensation procedures still being performed.

Should our facility disagree with the amount of reimbursement provided by a third-party payer, we are required to pursue the MDR process at the TDWC to request proper reimbursement for services. The Company has recently been successful in
its pursuit of collections regarding the stop-loss cases pending before SOAH, receiving positive rulings in over 90% of its claims presented for administrative determination. The 2007 district court decision upholding our interpretation of the
statute as applied to the stop-loss claims was recently appealed by certain insurance carriers, and the Third Court of Appeals determined that in order for a hospital to be reimbursed at 75% of its usual and customary audited charges for an
inpatient admission, the hospital must not only bill at least $40,000, but also show that the admission involved unusually costly and unusually extensive services. Procedurally, the



24



---

##### Table of Contents

decision means that each case where a carrier raised an issue regarding whether the services provided were unusually costly or unusually extensive would be
remanded to either SOAH or MDR for a case-by-case determination of whether the services provided meet these standards, once the definitions of those standards are determined. We plan to appeal the Third Court of Appeals decision and anticipate
further, lengthy litigation at the Travis County District Courts and the Texas Courts of Appeals to establish the legal definition for these standards. Because of this lengthy process and the uncertainty of recovery in these cases, collection of a
material amount of funds in these pending stop-loss cases is not anticipated during the 2009 fiscal year.

To date, insurance carriers have
voluntarily paid the awards in the decisions and orders issued by SOAH, plus interest, in approximately 180 cases, involving approximately $11 million. In most of these cases, the carriers have requested refunds of the payments made in the event
that the SOAH decisions and orders are reversed on appeal. We believe the Companys ultimate obligation to refund the payments is remote. Our request that the TDWC Commissioner enforce the awards which have not been voluntarily paid by the
carriers has been refused in approximately 130 cases.

Claims regarding payment for hospital outpatient services remain pending at the
TDWC. It is expected that these claims will be adjudicated at SOAH and ultimately in the Texas district and appellate courts. The basis for reimbursement for these services made the subject of these pending cases is the determination of fair
and reasonable charges. In 2007, we received unfavorable rulings from SOAH in all of our appeals of unfavorable decisions related to services provided in 2001 and 2002. The 179 cases which have been appealed to the Travis County district
courts challenge the constitutionality of the relevant statutory language. A lead case has been selected and is scheduled to be heard on January 14, 2009. Although we would appeal any negative ruling handed down in this lead case, such ruling
will impact cases in which a fee guideline was not applicable, specifically all pending cases involving ambulatory surgical services provided in 2001 and 2002 as well as all pending cases involving hospital outpatient services provided prior to
March 1, 2008. Successful collection of material amounts in these cases is unlikely.

We are currently pursuing claims against two
healthcare agents relating to contracts with certain of our facilities which set out reimbursement guidelines by several workers compensation carriers at a minimum of 70% of the facilitys charges. Discovery is continuing on these claims
to determine which carriers are involved and the amount of reimbursement due to us.

Due to the uncertainties regarding the accounts
receivable in the MDR process, the recent Third Court of Appeals opinion and our legal counsels advice that settlements with insurance carriers have virtually stopped, the Company has fully reserved all accounts receivable related to the
MDR process as of August 31, 2008. Any monies collected for these MDR accounts receivable will be recorded as current periods net patient service revenues.

Accounts Receivable

Accounts receivable represent net receivables for services provided by the
Company. Due to reasons discussed above for writing down all MDR accounts receivable, the Company does not have any long term receivables as at August 31, 2008, and expects to collect the net receivables within twelve months. At each balance
sheet date management reviews the accounts receivable for collectibility.

The contractual allowance stated as a percentage of gross
receivables at the balance sheet dates is larger than the contractual allowance percentage used to reduce gross billed charges due to the application of partial cash collections to the outstanding gross receivable balances, without any adjustment
being made to the contractual allowance. The contractual allowance amounts netted against gross receivables are not adjusted until such time as the final collections on an individual receivable are recognized.

Sources of Revenue and Reimbursement

The focal
point of our business is providing patient care services, including complex orthopedic and bariatric procedures. The Company pursues optimal reimbursement from third-party payers for these services. We do not normally participate in managed care or
other contractual reimbursement agreements, principally because they limit reimbursement for the medical services provided. This business model often results in increased amounts of



25



---

##### Table of Contents

reimbursement for the same or similar procedure, as compared to other healthcare providers. However, there are no contractual or administrative requirements
for prompt payment of claims by third-party payers within a specified time frame. As a result, the Company has tended to receive higher amounts of per-procedure reimbursement than that which may be received by other healthcare providers
performing similar services. Conversely, despite the increased reimbursement, we may take additional time to collect the expected reimbursement from third-party payers. The Company has been participating in managed care contracts since the first
quarter of fiscal 2006 and anticipates entering into additional contracts in the future. So far these contracts have not resulted in any meaningful patient revenues. Increased participation in managed care contracts and programs may decrease the
per-procedure reimbursement that the Company collects in the future for similar services.

In addition to the fact that our collection
process may be longer than other healthcare providers because of our focus on workers compensation and other commercial payers, the collection process can be extended due to our efforts to obtain all optimal reimbursement available to the
Company. Specifically, for medical services provided to injured workers, the Company may initially receive reimbursement that may not be within the fee guidelines or regulatory guidelines mandating reimbursement. For such cases in which third-party
payers did not provide appropriate reimbursement pursuant to these guidelines, the Company pursues further reimbursement. The Company reviews and pursues those particular claims that are determined to warrant additional reimbursement pursuant to the
fee or regulatory guidelines. The Companys pursuit of additional reimbursement amounts that it believes are due under fee or regulatory guidelines may be accomplished through established dispute resolution procedures with applicable regulatory
authorities.

Surgeries are typically not scheduled unless they are pre-authorized by the insurance carrier for medical necessity, with the
exception of Medicare, Medicaid and self-pay surgeries. After the surgery, the Companys automated computer system generates a statement of billed charges to the third-party payer. At that time, the Company also requests payment from patients
for any remaining amounts that are the responsibility of the patient. In cases where a commercial insurance payers pre-approval is not approved subsequently, those accounts receivable may be classified to self-pay. Historically, such
classifications have not been significant.

Income Taxes

SFAS 109, Accounting for Income Taxes, establishes financial accounting and reporting standards for the effect of income taxes. The objectives of accounting for income taxes are to recognize the amount of taxes
payable or refundable for the current year and deferred tax liabilities and assets for the future tax consequences of events that have been recognized in an entitys financial statements or tax returns. Judgment is required in assessing the
future tax consequences of events that have been recognized in our financial statements or tax returns.

Deferred income taxes are
determined based on the difference between the financial reporting and tax bases of assets and liabilities using enacted rates in effect during the year in which the differences are expected to reverse. Realization of deferred tax assets is
dependent upon generating sufficient taxable income. Valuation allowances are established for the deferred tax assets that we believe do not meet the more likely than not criteria established by SFAS No. 109. Judgments regarding
future taxable income may be revised due to changes in market conditions, tax laws, or other factors. If our assumptions and estimates change in the future, then the valuation allowances established may be increased, resulting in increased income
tax expense. Conversely, if we are ultimately able to use all or a portion of the deferred tax assets for which a valuation allowance has been established, then the related portion of the valuation allowance will be released to income as a credit to
income tax expense. Income tax expense is the tax payable for the period and the change during the period in deferred tax assets and liabilities.

Stock-Based Compensation

Effective at the beginning of our fiscal year 2006, we adopted the provisions of Statement of
Financial Accounting Standards No. 123 Share-Based Payment (SFAS No. 123(R)) to account for stock-based compensation. Under SFAS No. 123(R), we estimate the fair value of stock options granted using
the Black-Scholes option pricing model. The fair value for awards that are expected to vest is then amortized on a straight-line basis over the requisite service period of the award, which is generally the option vesting term. The amount of expense
attributed is based on an estimated forfeiture rate, which is updated as appropriate. This option pricing model requires the input of highly subjective assumptions, including the expected volatility of our common stock, pre-



26



---

##### Table of Contents

vesting forfeiture rate and an options expected life. The financial statements include amounts that are based on our best estimates and judgments.

Results of Operations



|                                                                               |  |                       |            |   |      |     |   |      |   |            |   |  |     |  
|------------------------------------------------------------------------------ |  | --------------------- | ---------- | - | ---- | --- | - | ---- | - | ---------- | - |  | --- | -
|                                                                               |  | Year Ended August 31, |           
|                                                                               |  | 2008                  |            |   | 2007 |    
|Net patient service revenue                                                    |  | $                     | 60,273,947 |   |      | 100 | % |      | $ | 42,845,821 |   |  | 100 | %
|                                                                               |  |                       |            |   |      |     |   |      |   |            |   |  |     |  
|Costs and expenses:                                                            |  |                       |            |   |      |     |   |      |   |            |   |  |     |  
|Compensation and benefits                                                      |  |                       | 16,983,322 |   |      | 28  |   |      |   | 12,061,185 |   |  | 28  |  
|Medical services and supplies                                                  |  |                       | 14,108,723 |   |      | 23  |   |      |   | 8,984,593  |   |  | 21  |  
|Other operating expenses                                                       |  |                       | 18,640,685 |   |      | 31  |   |      |   | 15,790,052 |   |  | 37  |  
|Depreciation and amortization                                                  |  |                       | 2,115,267  |   |      | 4   |   |      |   | 2,334,012  |   |  | 5   |  
|                                                                               |  |                       |            |   |      |     |   |      |   |            |   |  |     |  
|Total costs and expenses                                                       |  |                       | 51,847,997 |   |      | 86  |   |      |   | 39,169,842 |   |  | 91  |  
|                                                                               |  |                       |            |   |      |     |   |      |   |            |   |  |     |  
|Operating income                                                               |  |                       | 8,425,950  |   |      | 14  |   |      |   | 3,675,979  |   |  | 9   |  
|                                                                               |  |                       |            |   |      |     |   |      |   |            |   |  |     |  
|Other income (expense):                                                        |  |                       |            |   |      |     |   |      |   |            |   |  |     |  
|Rent and other income                                                          |  |                       | 889,178    |   |      | 1   |   |      |   | 257,022    |   |  | 1   |  
|Interest income                                                                |  |                       | 402,205    |   |      | 1   |   |      |   | 34,878     |   |  |    |  
|Interest expense                                                               |  |                       | (132,370   | ) |      |    |   |      |   | (455,008   | ) |  | (1  | )
|                                                                               |  |                       |            |   |      |     |   |      |   |            |   |  |     |  
|Total other income (expense), net                                              |  |                       | 1,159,013  |   |      | 2   |   |      |   | (163,108   | ) |  |    |  
|                                                                               |  |                       |            |   |      |     |   |      |   |            |   |  |     |  
|Minority interest in earnings                                                  |  |                       | (185,958   | ) |      |    |   |      |   | (121,563   | ) |  |    |  
|                                                                               |  |                       |            |   |      |     |   |      |   |            |   |  |     |  
|Income before income taxes                                                     |  |                       | 9,399,005  |   |      | 16  |   |      |   | 3,391,308  |   |  | 8   |  
|(Provision) benefit for income taxes                                           |  |                       | (4,056,653 | ) |      | (7  | ) |      |   | 445,490    |   |  | 1   |  
|                                                                               |  |                       |            |   |      |     |   |      |   |            |   |  |     |  
|Income from continuing operations                                              |  |                       | 5,342,352  |   |      | 9   |   |      |   | 3,836,798  |   |  | 9   |  
|Discontinued operations, net of income taxes                                   |  |                       | (26,763    | ) |      |    |   |      |   | 303,540    |   |  | 1   |  
|Gain (loss) on disposal of discontinued operations assets, net of income taxes |  |                       | 3,084,673  |   |      | 5   |   |      |   | (14,702    | ) |  |     |  
|                                                                               |  |                       |            |   |      |     |   |      |   |            |   |  |     |  
|Extraordinary gain, net of income taxes                                        |  |                       | 39,436     |   |      |    |   |      |   | 29,844     |   |  |    |  
|                                                                               |  |                       |            |   |      |     |   |      |   |            |   |  |     |  
|Net income                                                                     |  | $                     | 8,439,698  |   |      | 14  | % |      | $ | 4,155,480  |   |  | 10  | %
|                                                                               |  |                       |            |   |      |     |   |      |   |            |   |  |     |  
|                                                                               |  |                       |            |  
|Operational statistics (Number of procedures):                                 |  |                       |            |   |      |     |   |      |   |            |   |  |     |  
|Inpatient:                                                                     |  |                       |            |   |      |     |   |      |   |            |   |  |     |  
|Bariatrics                                                                     |  |                       | 847        |   |      |     |   |      |   | 334        |   |  |     |  
|Orthopedics                                                                    |  |                       | 279        |   |      |     |   |      |   | 279        |   |  |     |  
|Other                                                                          |  |                       | 242        |   |      |     |   |      |   | 65         |   |  |     |  
|                                                                               |  |                       |            |   |      |     |   |      |   |            |   |  |     |  
|Total inpatient procedures                                                     |  |                       | 1,368      |   |      |     |   |      |   | 678        |   |  |     |  
|                                                                               |  |                       |            |   |      |     |   |      |   |            |   |  |     |  
|Outpatient:                                                                    |  |                       |            |   |      |     |   |      |   |            |   |  |     |  
|Orthopedics                                                                    |  |                       | 620        |   |      |     |   |      |   | 411        |   |  |     |  
|Other                                                                          |  |                       | 1,300      |   |      |     |   |      |   | 1,553      |   |  |     |  
|                                                                               |  |                       |            |   |      |     |   |      |   |            |   |  |     |  
|Total outpatient procedures                                                    |  |                       | 1,920      |   |      |     |   |      |   | 1,964      |   |  |     |  
|                                                                               |  |                       |            |   |      |     |   |      |   |            |   |  |     |  
|Total procedures                                                               |  |                       | 3,288      |   |      |     |   |      |   | 2,642      |   |  |     |  
|                                                                               |  |                       |            |   |      |     |   |      |   |            |   |  |     |  
|                                                                               |  |                       |            |  
|                                                                               |  | 2008                  |            |   |      |     |   | 2007 |   |            |   | 
|Revenues                                                                       |  |                       |            |   |      |     |   |      |   |            |   |  |     |  
|U.S. Division                                                                  |  | $                     | 60,273,947 |   |      |     |   |      | $ | 42,845,821 |   |  |     |  
|China Division                                                                 |  |                       |           |   |      |     |   |      |   |           |   |  |     |  
|                                                                               |  |                       |            |  
|Operating income (loss)                                                        |  |                       |            |   |      |     |   |      |   |            |   |  |     |  
|U.S. Division                                                                  |  | $                     | 10,906,475 |   |      |     |   |      | $ | 4,424,664  |   |  |     |  
|China Division                                                                 |  |                       | (2,480,525 | ) |      |     |   |      |   | (748,685   | ) |  |     |  
|                                                                               |  |                       |            |  
|Income (loss) before taxes, discontinued operations and extraordinary gain     |  |                       |            |   |      |     |   |      |   |            |   |  |     |  
|U.S. Division                                                                  |  | $                     | 11,304,946 |   |      |     |   |      | $ | 4,136,103  |   |  |     |  
|China Division                                                                 |  |                       | (1,905,941 | ) |      |     |   |      |   | (744,795   | ) |  |     |  



27



---

##### Table of Contents

Comparison of the Fiscal Years Ended August 31, 2008 and August 31, 2007

Since the China Division has had no revenues in fiscal years ended August 31, 2008 and 2007, all net patient service revenue of the Company for
these years is from the U.S. Division. The China Division incurred costs and expenses during these years, which are discussed below.

Net
patient service revenue increased by $17,428,126, or 41%, from $42,845,821 to $60,273,947, and total surgical cases increased by 24% from 2,642 cases in fiscal year 2007 to 3,288 cases in fiscal year 2008. Following are the percentage changes in net
patient service revenues and number of cases at the hospital facilities:



|         |  |                                       |  |      
|-------- |  | ------------------------------------- |  | -----
|         |  | Percentage increase from 2007 to 2008
|Facility |  | Net patient revenue                   |  | Cases
|Pasadena |  | 44%                                   |  | 5%   
|Garland  |  | 39                                    |  | 42   
|Overall  |  | 41                                    |  | 24   

The increase in net patient service revenues is due to following reasons:

Increase in bariatric and orthopedic cases at Garland and Pasadena facilities

The Garland facility had an increase in both bariatric and orthopedic cases due to recruitment of additional physicians in previous
years. The increase in net patient service revenue is primarily due to an increase in overall number of cases and also due to a 113% increase in number of inpatient cases at our Garland facility, which typically have a higher average reimbursement
per case. Due to recruitment of additional physicians at our Pasadena facility, we had an increase primarily in bariatric cases, as well as in orthopedic cases.

The utilization rate of our hospitals varies widely among physicians on our medical staffs and among specializations, so an increase in
the number of physicians on our medical staffs does not, in itself, result in an increase in patient referrals or revenues. While we attempt to continue to attract and retain additional physicians, the potential loss of physicians who provide
significant net patient revenues for the Company may adversely affect our results of operations.

Increase in average net patient
service revenue per case

Even though the number of cases increased 24% overall in 2008 compared to 2007, the net
patient service revenue increased by 41%. Backing out the additional revenues booked discussed above, the net patient service revenue increased 42%, due to an increase of cases by 24% coupled with an increase of 14% in average net patient service
revenue per case. Excluding the above-mentioned additional revenues, net patient service revenue per case increased by $2,262 or 14%, from $16,217 in 2007 to $18,479 in 2008.

Starting March 1, 2008, the Company estimates the contractual allowance for Texas workers compensation cases based on the new
fee Guidelines, and for the other cases based on managements estimate of collection percentage of gross billed charges. The historical collection for non-Texas workers compensation cases is primarily used as a guideline to estimate
contractual allowance. Prior to March 1, 2008, the contractual allowance was calculated based on the ratio of the Companys historical cash collections during the trailing twelve months on a case-by-case basis by operating facility. In
compliance with this revenue recognition policy, the Companys contractual allowance as a percentage of gross patient revenue increased from 55% in 2007 to 59% in 2008.



28



---

##### Table of Contents

Net reduction in revenues due to closed books of business and write-off of MDR accounts receivable

In terms of the Companys revenue recognition policy, net patient service revenues are based on estimated or
historical cash collections and may not represent amounts ultimately collected. At such time as the Company determines that ultimate collections have exceeded the revenue recorded on a group of accounts, additional revenue or reduction in revenue is
recorded as a change in estimate during the current period. The Company analyzed various blocks of business for MDRs and commercial payers, for both the Garland and Pasadena facilities, and recognized additional revenues of approximately $6.5
million and $11.5 million, respectively, for amounts collected in excess of revenue recognized in prior years.

Due to the
uncertainties regarding the accounts receivable in the MDR process, the recent Third Court of Appeals opinion and our legal counsels advice that settlements with insurance carriers have virtually stopped, the Company has fully reserved
all accounts receivable related to the MDR process as of August 31, 2008, and written-off $8.7 million and $9.8 million of MDR accounts receivable in the fourth quarter of the fiscal year ended August 31, 2008, at our Garland and Pasadena
facilities, respectively.

Total costs and expenses increased by $12,678,155, or 32%, from $39,169,842 in fiscal 2007 to $51,847,997 in
fiscal 2008. The following describes the various changes in costs and expenses:



| |  | Compensation and benefits increased by $4,922,137, or 41%. During fiscal year 2008, the Company incurred a $373,435 non-cash pre-tax compensation expense primarily
related to employees incentive stock options granted in fiscal year 2007. Excluding this non-cash compensation expense, the increase in compensation and benefits in the current fiscal year is 38% compared to the prior fiscal year, primarily
due to an increase in number of cases, and also due to annual cash incentive bonuses paid to employees.
|- |  | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  | During 2008 and 2007, the China Division operations were handled by contract employees, and payments to them are included in Other operating expenses.
| |  | ------------------------------------------------------------------------------------------------------------------------------------------------------



| |  | Medical services and supplies expenses increased $5,124,130, or 57%, while the number of surgery cases increased 24%. The increase was primarily due to a 102%
increase in the number of inpatient procedures, which typically require more medical services and supplies. Medical services and supplies were consistent at 9.7% and 9.3% of gross billed charges for fiscal year 2008 and 2007, respectively.
|- |  | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  | Since the China Division had no revenues for fiscal years 2008 and 2007, there were no medical services and supplies expenses there.
| |  | ------------------------------------------------------------------------------------------------------------------------------------



| |  | Other operating expenses increased by $2,850,633, or 18%.
|- |  | ---------------------------------------------------------

U.S. Division

Other operating expenses for the U.S. Division increased by $1,046,677, or 7%, from $15,213,468 in 2007 to
$16,260,145 in 2008. Even though the net patient service revenue increased by 41%, the marginal increase in other operating expenses is due to continued efforts made by the Company to reduce costs and expenses.

China Division

Other operating expenses for the
China Division increased by $1,803,956, or 313%, from $576,584 in 2007 to $2,380,540 in 2008. In 2007 and part of 2008, development costs were incurred for the construction of a hospital in Shanghai. However, in 2008, the Company sold its interest
in the property owned by DeAn.

The increase in other operating expenses in 2008 is primarily for growth and development of the China
Division. The Company incurred expenses in its sale of the property owned by DeAn in July 2008, and in entering into the management agreement with the Rui An City Department of Health to oversee the construction of the Rui An Hospital in Rui An,
China, and then manage that hospital upon its completion in October 2009. Another Dynacq subsidiary has entered into a marketing agreement to market the services of Dynacq in China and Southeast Asia. Dynacq is seeking to expand its operations into
China to achieve



29



---

##### Table of Contents

geographic diversity and take advantage of a high growth market in the provision of healthcare services in that country. The management arrangement will
allow Dynacq to minimize its expenditure of capital to purchase assets, but still have the potential for an attractive return in its efficient management of the hospital facility.

Other income increased by $1,322,121 from $163,108 other expense, net, in 2007 to $1,159,013 other income, net, in 2008.

U.S. Division

Other income increased by $751,427
from $166,998 other expense, net, in 2007 to $584,429 other income, net, in 2008. Of this increase, interest income (expense), net, increased by $593,067, from net interest expense of $424,020 in 2007, to net interest income of $169,047 in 2008,
primarily due to cash from operations.

China Division

Other income increased by $570,694 from $3,890 in 2007 to $574,584 in 2008. In 2008 the Company sold its interest in the property owned by DeAn and realized a gain of $473,796. Interest income increased by $96,898,
from $3,890 in 2007 to $100,788 in 2008, primarily due to cash funding from U.S. Division.

The income (loss) from discontinued operations
represents the income (loss) primarily at our Baton Rouge facility for the fiscal year 2008 and at our Baton Rouge and West Houston facilities for the fiscal year 2007.

The gain on sale of discontinued operations during fiscal year 2008 was $4,745,650. Provision for income taxes on this gain was $1,660,977.

The extraordinary gain, net of income taxes, relates to gains on the purchase of minority interests from certain minority interest holders at an amount
less than the net book value of the minority interest liability on the date of purchase.

Liquidity and Capital Resources

The Company maintained sufficient liquidity to meet its business needs in fiscal 2008. As of August 31, 2008, its principal source of liquidity was
$63.1 million in cash and net accounts receivable. The Company has approximately $45.1 million in cash as of August 31, 2008, the majority of which is deposited in national and international banks. The amounts at these financial institutions
are substantially in excess of FDIC and Securities Investor Protection Corporation insurance limits; however, management believes that these financial institutions are of high quality and the risk of loss is minimal. Of the $45.1 million cash
balance, $17.7 million is in the China Division, and $27.4 million is in the U.S. Division. Subsequent to the fiscal year ended August 31, 2008, the Company transferred an additional $20 million to the China Division due to attractive interest
rates on time deposits. The cash balance in the China Division as of the date of this filing is $37 million. Of the $37 million in cash in the China Division, $23 million is deposited in banks in Hong Kong, where the government of Hong Kong has
guaranteed the repayment of all bank deposits until 2010.

Subsequent to the end of the fiscal year ended August 31, 2008, the Company
has engaged in negotiations to invest approximately $3.9 million in high yield bonds, which it expects to finalize in the first quarter of fiscal 2009.

Cash flows from operating activities

Total cash flow provided by operating activities was $27,712,623 (including $41,175
used in discontinued operations) during fiscal year 2008, primarily due to a net income before discontinued operations of $5,381,788, decreases in accounts receivable, restricted cash and inventories of $12,436,696, $4,388,857 and $717,711,
respectively, increases in income tax payable of $2,215,109, and depreciation and amortization of $2,115,267.

Cash flows from investing activities

Total cash flow provided by investing activities was $21,049,171 (including $16,175,259 provided by



30



---

##### Table of Contents

discontinued operations) primarily related to the sale proceeds of the assets of the Baton Rouge facility, land in The Woodlands, Texas and sale of the
Companys interest in DeAn, partially offset by purchases of property and equipment of $1,283,851.

Cash flows from financing activities

Total cash flow used in financing activities was $9,629,732 during the current period. During the fiscal year ended August 31,
2008, the Company paid down the entire outstanding balance of $7,073,813 under its Credit Agreement and also paid down $452,369 on the note payable for the class action lawsuit settlement. The Company repurchased 455,193 treasury shares for
$2,309,898, at an average cost of $5.07 per share. The Company received $721,398 from the exercise of employees stock options.

The
Company had working capital of $52,161,255 as of August 31, 2008, and maintained a liquid position by a current ratio of approximately 4.57 to 1.

Cancellation of line of credit

The Company and certain of its subsidiaries on May 27, 2005 entered into a Credit and
Security Agreement (the Credit Agreement) with Merrill Lynch Capital for a new five-year revolving credit facility for up to $10 million, subject to a borrowing base based on eligible accounts receivable and further subject to a $2
million reserve until satisfaction of certain conditions. As of August 31, 2008, the Company had not drawn any amounts under the Credit Agreement. Subsequent to the end of the fiscal year 2008, on October 10, 2008, the Credit Agreement was
terminated by the lenders due to technical defaults which related primarily to compliance in periodic reporting, as well as the Companys investment in China. The Company has sufficient cash on hand and cash flows from operations, and had not
used the credit facility since December 2007.

We believe we will be able to meet our ongoing liquidity and cash needs for fiscal year 2009
through the combination of available cash and cash flow from operations.

Off-Balance Sheet Arrangements

We are not a party to any off-balance sheet arrangements that have, or are reasonably likely to have, a material effect on us.

Contractual Obligations and Commitments

The Company
has operating leases primarily for medical and office equipment. The Company also incurs rental expense for office space and medical equipment. The Companys total minimum rental commitments under noncancellable operating leases are
approximately $2.1 million in the next four fiscal years.

The Company, through its subsidiary, also had agreements with outside
organizations that offer marketing, pre-authorization and follow up support services to prospective bariatric and orthopedic patients in areas serviced by the Pasadena and Garland facilities. These facilities received bariatric and orthopedic
referrals from other sources, and the organizations referred clients to other area hospitals. Payments made related to these agreements for the fiscal years 2008 and 2007 were $4,545,000 and $5,145,000, respectively. The Company has a total
commitment of approximately $6,750,000 to be incurred in the next two fiscal years related to these marketing agreements.

The Company is
currently overseeing the construction of a hospital in Rui An, China to be completed October 1, 2009, at which time it will manage the hospital for a term of 15 years. As part of this agreement, the Company will provide a construction loan of
approximately $2.1 million based on percentage of completion of construction of the hospital, and will also advance approximately $730,000 for equipment purchase. The Company also had a commitment to assume and discharge within ten years $883,000 of
existing liabilities, of which $736,000 has already been paid in the fiscal year ended August 31, 2008. The Company has subsequent to the year ended August 31, 2008, signed an agreement for marketing its services to hospitals in China, for
which the Company would incur at its discretion from $75,000 to $250,000 per month for the next three years.



31



---

##### Table of Contents

The Company has contracts with doctors to manage various areas of the Companys hospitals and other
service agreements. The Companys minimum commitments under these contracts are approximately $3.7 million to be incurred primarily in the next fiscal year.

Recent Accounting Pronouncements

See Note 1 to the Consolidated Financial StatementsRecent Accounting
Pronouncements, which is incorporated here by reference.

Inflation

Inflation has not significantly impacted the Companys financial position or operations.



|Item 7A. | Quantitative and Qualitative Disclosures About Market Risk
|-------- | ----------------------------------------------------------

Not
required.



|Item 8. | Financial Statements and Supplementary Data
|------- | -------------------------------------------

INDEX TO FINANCIAL STATEMENTS

Below is an index to the consolidated financial statements and notes thereto contained in
Item 8, Financial Statements and Supplementary Data.



|                                                        |  |     
|------------------------------------------------------- |  | ----
|                                                        |  | PAGE
|Report of Independent Registered Public Accounting Firm |  | 33  
|Consolidated Balance Sheets                             |  | 34  
|Consolidated Statements of Operations                   |  | 36  
|Consolidated Statements of Stockholders Equity         |  | 37  
|Consolidated Statements of Cash Flows                   |  | 38  
|Notes to Consolidated Financial Statements              |  | 40  



32



---

##### Table of Contents

Report of Independent Registered Public Accounting Firm

To the Stockholders and Board of Directors

Dynacq Healthcare, Inc.

Houston, Texas

We have audited the
accompanying consolidated balance sheets of Dynacq Healthcare, Inc. (the Company), as of August 31, 2008 and 2007, and the related consolidated statements of operations, stockholders equity, and cash flows for the years then
ended. These consolidated financial statements are the responsibility of the Companys management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that
we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control
over financial reporting. Our audit includes consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the
effectiveness of the Companys internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the consolidated financial
statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall consolidated financial statement presentation. We believe that our audits provide a reasonable basis for our
opinion.

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the
consolidated financial position of Dynacq Healthcare, Inc. at August 31, 2008 and 2007, and the consolidated results of its operations and its cash flows for the years then ended in conformity with accounting principles generally accepted in
the United States.

/s/ Killman, Murrell & Company, P. C.

Killman, Murrell & Company, P. C.

Houston, Texas

November 21, 2008



33



---

##### Table of Contents

Dynacq Healthcare, Inc.

Consolidated Balance Sheets



|                                                                                                                                            |  |            |            |      |   |           
|------------------------------------------------------------------------------------------------------------------------------------------- |  | ---------- | ---------- | ---- | - | ----------
|                                                                                                                                            |  | August 31,
|                                                                                                                                            |  | 2008       |            | 2007
|Assets                                                                                                                                      |  |            |            |      |   |           
|Current assets:                                                                                                                             |  |            |            |      |   |           
|Cash and cash equivalents                                                                                                                   |  | $          | 45,099,800 |      | $ | 5,436,787 
|Restricted cash                                                                                                                             |  |            |           |      |   | 4,388,857 
|Accounts receivable, net of contractual allowances of approximately $226,355,000 and $197,108,000 at August 31, 2008 and 2007,
respectively |  |            | 18,018,673 |      |   | 30,437,665
|Accounts receivable  other                                                                                                                 |  |            |           |      |   | 17,704    
|Inventories                                                                                                                                 |  |            | 1,469,775  |      |   | 2,187,486 
|Prepaid expenses                                                                                                                            |  |            | 475,251    |      |   | 430,391   
|Deferred tax assets                                                                                                                         |  |            | 859,255    |      |   | 1,057,931 
|Income taxes receivable                                                                                                                     |  |            | 868,249    |      |   | 1,519,138 
|                                                                                                                                            |  |            |            |      |   |           
|Total current assets                                                                                                                        |  |            | 66,791,003 |      |   | 45,475,959
|Assets held for sale                                                                                                                        |  |            |           |      |   | 13,187,738
|Property and equipment, net                                                                                                                 |  |            | 15,228,887 |      |   | 19,956,711
|Other assets                                                                                                                                |  |            | 228,672    |      |   | 274,553   
|                                                                                                                                            |  |            |            |      |   |           
|Total assets                                                                                                                                |  | $          | 82,248,562 |      | $ | 78,894,961
|                                                                                                                                            |  |            |            |      |   |           

The accompanying notes are an integral part of these consolidated financial statements.



34



---

##### Table of Contents

Dynacq Healthcare, Inc.

Consolidated Balance Sheets (continued)



|                                                                                                                                                |  |            |            |   |      |   |           
|----------------------------------------------------------------------------------------------------------------------------------------------- |  | ---------- | ---------- | - | ---- | - | ----------
|                                                                                                                                                |  | August 31,
|                                                                                                                                                |  | 2008       |            |   | 2007
|Liabilities and stockholders equity                                                                                                            |  |            |            |   |      |   |           
|Current liabilities:                                                                                                                            |  |            |            |   |      |   |           
|Accounts payable                                                                                                                                |  | $          | 3,816,585  |   |      | $ | 4,135,364 
|Accrued liabilities                                                                                                                             |  |            | 5,915,560  |   |      |   | 5,681,328 
|Notes payable                                                                                                                                   |  |            | 480,269    |   |      |   | 7,526,181 
|Current taxes payable                                                                                                                           |  |            | 4,417,334  |   |      |   | 534,425   
|                                                                                                                                                |  |            |            |   |      |   |           
|Total current liabilities                                                                                                                       |  |            | 14,629,748 |   |      |   | 17,877,298
|Non-current liabilities:                                                                                                                        |  |            |            |   |      |   |           
|Long-term portion of note payable                                                                                                               |  |            | 251,131    |   |      |   | 731,401   
|Deferred tax liabilities                                                                                                                        |  |            | 355,808    |   |      |   | 426,327   
|                                                                                                                                                |  |            |            |   |      |   |           
|Total liabilities                                                                                                                               |  |            | 15,236,687 |   |      |   | 19,035,026
|                                                                                                                                                |  |            |            |   |      |   |           
|Minority interests                                                                                                                              |  |            | 84,926     |   |      |   | 599,015   
|                                                                                                                                                |  |            |            |   |      |   |           
|Commitments and contingencies                                                                                                                   |  |            |           |   |      |   |          
|Stockholders equity:                                                                                                                           |  |            |            |   |      |   |           
|Preferred stock, $.01 par value; 5,000,000 shares authorized, none issued or outstanding                                                        |  |            |           |   |      |   |          
|Common stock, $.001 par value; 100,000,000 shares authorized, 16,010,924 and 15,843,557 shares issued at August 31, 2008 and 2007,
respectively |  |            | 16,011     |   |      |   | 15,844    
|Treasury stock, 455,193 at August 31, 2008, at cost                                                                                             |  |            | (2,309,898 | ) |      |   |          
|Additional paid-in capital                                                                                                                      |  |            | 15,023,927 |   |      |   | 13,829,616
|Accumulated other comprehensive income                                                                                                          |  |            | 561,271    |   |      |   | 219,520   
|Retained earnings                                                                                                                               |  |            | 53,635,638 |   |      |   | 45,195,940
|                                                                                                                                                |  |            |            |   |      |   |           
|Total stockholders equity                                                                                                                      |  |            | 66,926,949 |   |      |   | 59,260,920
|                                                                                                                                                |  |            |            |   |      |   |           
|Total liabilities and stockholders equity                                                                                                      |  | $          | 82,248,562 |   |      | $ | 78,894,961
|                                                                                                                                                |  |            |            |   |      |   |           

The accompanying notes are an integral part of these consolidated financial statements.



35



---

##### Table of Contents

Dynacq Healthcare, Inc.

Consolidated Statements of Operations



|                                                                                                 |  |                       |            |   |      |   |            |  
|------------------------------------------------------------------------------------------------ |  | --------------------- | ---------- | - | ---- | - | ---------- | -
|                                                                                                 |  | Year Ended August 31, |           
|                                                                                                 |  | 2008                  |            |   | 2007 |  
|Net patient service revenue                                                                      |  | $                     | 60,273,947 |   |      | $ | 42,845,821 |  
|                                                                                                 |  |                       |            |   |      |   |            |  
|Costs and expenses:                                                                              |  |                       |            |   |      |   |            |  
|Compensation and benefits                                                                        |  |                       | 16,983,322 |   |      |   | 12,061,185 |  
|Medical services and supplies                                                                    |  |                       | 14,108,723 |   |      |   | 8,984,593  |  
|Other operating expenses                                                                         |  |                       | 18,640,685 |   |      |   | 15,790,052 |  
|Depreciation and amortization                                                                    |  |                       | 2,115,267  |   |      |   | 2,334,012  |  
|                                                                                                 |  |                       |            |   |      |   |            |  
|Total costs and expenses                                                                         |  |                       | 51,847,997 |   |      |   | 39,169,842 |  
|                                                                                                 |  |                       |            |   |      |   |            |  
|Operating income                                                                                 |  |                       | 8,425,950  |   |      |   | 3,675,979  |  
|                                                                                                 |  |                       |            |   |      |   |            |  
|Other income (expense):                                                                          |  |                       |            |   |      |   |            |  
|Rent and other income                                                                            |  |                       | 889,178    |   |      |   | 257,022    |  
|Interest income                                                                                  |  |                       | 402,205    |   |      |   | 34,878     |  
|Interest expense                                                                                 |  |                       | (132,370   | ) |      |   | (455,008   | )
|                                                                                                 |  |                       |            |   |      |   |            |  
|Total other income (expense), net                                                                |  |                       | 1,159,013  |   |      |   | (163,108   | )
|                                                                                                 |  |                       |            |   |      |   |            |  
|Income before income taxes, minority interests and extraordinary gain                            |  |                       | 9,584,963  |   |      |   | 3,512,871  |  
|Minority interest in earnings                                                                    |  |                       | (185,958   | ) |      |   | (121,563   | )
|                                                                                                 |  |                       |            |   |      |   |            |  
|Income before income taxes                                                                       |  |                       | 9,399,005  |   |      |   | 3,391,308  |  
|(Provision) benefit for income taxes                                                             |  |                       | (4,056,653 | ) |      |   | 445,490    |  
|                                                                                                 |  |                       |            |   |      |   |            |  
|Income from continuing operations                                                                |  |                       | 5,342,352  |   |      |   | 3,836,798  |  
|Income (loss) from discontinued operations, net of income taxes                                  |  |                       | (26,763    | ) |      |   | 303,540    |  
|Gain (loss) on sale of assets of discontinued operations, net of income taxes                    |  |                       | 3,084,673  |   |      |   | (14,702    | )
|Extraordinary gain, net of $21,235 and $49,700 income tax expense in 2008 and 2007, respectively |  |                       | 39,436     |   |      |   | 29,844     |  
|                                                                                                 |  |                       |            |   |      |   |            |  
|Net income                                                                                       |  | $                     | 8,439,698  |   |      | $ | 4,155,480  |  
|                                                                                                 |  |                       |            |   |      |   |            |  
|Basic earnings per common share:                                                                 |  |                       |            |   |      |   |            |  
|Income from continuing operations                                                                |  | $                     | 0.34       |   |      | $ | 0.24       |  
|Income (loss) from discontinued operations, net of income taxes                                  |  |                       |           |   |      |   | 0.02       |  
|Gain (loss) on sale of assets of discontinued operations, net of income taxes                    |  |                       | 0.20       |   |      |   |           |  
|Extraordinary gain, net of income taxes                                                          |  |                       |           |   |      |   |           |  
|                                                                                                 |  |                       |            |   |      |   |            |  
|Net income                                                                                       |  | $                     | 0.53       |   |      | $ | 0.26       |  
|                                                                                                 |  |                       |            |   |      |   |            |  
|Diluted earnings per common share:                                                               |  |                       |            |   |      |   |            |  
|Income from continuing operations                                                                |  | $                     | 0.32       |   |      | $ | 0.24       |  
|Income (loss) from discontinued operations, net of income taxes                                  |  |                       |           |   |      |   | 0.02       |  
|Gain (loss) on sale of assets of discontinued operations, net of income taxes                    |  |                       | 0.19       |   |      |   |           |  
|Extraordinary gain, net of income taxes                                                          |  |                       |           |   |      |   |           |  
|                                                                                                 |  |                       |            |   |      |   |            |  
|Net income                                                                                       |  | $                     | 0.51       |   |      | $ | 0.26       |  
|                                                                                                 |  |                       |            |   |      |   |            |  
|Basic average common shares outstanding                                                          |  |                       | 15,793,660 |   |      |   | 15,749,891 |  
|                                                                                                 |  |                       |            |   |      |   |            |  
|Diluted average common shares outstanding                                                        |  |                       | 16,457,888 |   |      |   | 15,910,117 |  
|                                                                                                 |  |                       |            |   |      |   |            |  

The accompanying notes are an integral part of these consolidated financial statements.



36



---

##### Table of Contents

Dynacq Healthcare, Inc.

Consolidated Statements of Stockholders Equity



|                                                                      |  |              |  |                |        |        |                          |        |                                                      |            |                  |  |       |            |  |   |         |  |   |            |  |   |            |  
|--------------------------------------------------------------------- |  | ------------ |  | -------------- | ------ | ------ | ------------------------ | ------ | ---------------------------------------------------- | ---------- | ---------------- |  | ----- | ---------- |  | - | ------- |  | - | ---------- |  | - | ---------- | -
|                                                                      |  | Common Stock |  | Treasury Stock |        |        | AdditionalPaid-InCapital |        | OtherCompre-hensiveIncomeForeigncurrencytransla-tion |            | RetainedEarnings |  | Total |           
|                                                                      |  | Shares       |  | Amount         |        | Shares |                          | Amount |                                                      |            |                  |  |      
|Balance, August 31, 2006                                              |  | 15,740,711   |  | $              | 15,741 |        |                         |        | $                                                    |           |                  |  | $     | 13,056,974 |  | $ | 105,659 |  | $ | 41,040,460 |  | $ | 54,218,834 |  
|Stock issued on exercise of employees stock options                  |  | 102,846      |  |                | 103    |        |                         |        |                                                      |           |                  |  |       | 503,842    |  |   |        |  |   |           |  |   | 503,945    |  
|Proceeds from sale of stock                                           |  |             |  |                |       |        |                         |        |                                                      |           |                  |  |       | 67,375     |  |   |        |  |   |           |  |   | 67,375     |  
|Charge for granting stock options to employees                        |  |             |  |                |       |        |                         |        |                                                      |           |                  |  |       | 124,425    |  |   |        |  |   |           |  |   | 124,425    |  
|Income tax benefit for employees exercise of incentive stock options |  |             |  |                |       |        |                         |        |                                                      |           |                  |  |       | 77,000     |  |   |        |  |   |           |  |   | 77,000     |  
|Foreign currency translation adjustment, net of taxes of $113,000     |  |             |  |                |       |        |                         |        |                                                      |           |                  |  |       |           |  |   | 113,861 |  |   |           |  |   | 113,861    |  
|Net income                                                            |  |             |  |                |       |        |                         |        |                                                      |           |                  |  |       |           |  |   |        |  |   | 4,155,480  |  |   | 4,155,480  |  
|                                                                      |  |              |  |                |        |        |                          |        |                                                      |            |                  |  |       |            |  |   |         |  |   |            |  |   |            |  
|Balance, August 31, 2007                                              |  | 15,843,557   |  |                | 15,844 |        |                         |        |                                                      |           |                  |  |       | 13,829,616 |  |   | 219,520 |  |   | 45,195,940 |  |   | 59,260,920 |  
|Stock issued on exercise of employees stock options                  |  | 167,367      |  |                | 167    |        |                         |        |                                                      |           |                  |  |       | 721,231    |  |   |        |  |   |           |  |   | 721,398    |  
|Charge for granting stock options to employees                        |  |             |  |                |       |        |                         |        |                                                      |           |                  |  |       | 373,435    |  |   |        |  |   |           |  |   | 373,435    |  
|Income tax benefit for employees exercise of incentive stock options |  |             |  |                |       |        |                         |        |                                                      |           |                  |  |       | 99,645     |  |   |        |  |   |           |  |   | 99,645     |  
|Treasury shares acquired                                              |  |             |  |                |       |        | 455,193                  |        |                                                      | (2,309,898 | )                |  |       |           |  |   |        |  |   |           |  |   | (2,309,898 | )
|Foreign currency translation adjustment, net of taxes of $189,200     |  |             |  |                |       |        |                         |        |                                                      |           |                  |  |       |           |  |   | 341,751 |  |   |           |  |   | 341,751    |  
|Net income                                                            |  |             |  |                |       |        |                         |        |                                                      |           |                  |  |       |           |  |   |        |  |   | 8,439,698  |  |   | 8,439,698  |  
|                                                                      |  |              |  |                |        |        |                          |        |                                                      |            |                  |  |       |            |  |   |         |  |   |            |  |   |            |  
|Balance, August 31, 2008                                              |  | 16,010,924   |  | $              | 16,011 |        | 455,193                  |        | $                                                    | (2,309,898 | )                |  | $     | 15,023,927 |  | $ | 561,271 |  | $ | 53,635,638 |  | $ | 66,926,949 |  
|                                                                      |  |              |  |                |        |        |                          |        |                                                      |            |                  |  |       |            |  |   |         |  |   |            |  |   |            |  

The accompanying notes are an integral part of these consolidated financial statements.



37



---

##### Table of Contents

Dynacq Healthcare, Inc.

Consolidated Statements of Cash Flows



|                                                                                  |  |                       |            |   |      |   |            |  
|--------------------------------------------------------------------------------- |  | --------------------- | ---------- | - | ---- | - | ---------- | -
|                                                                                  |  | Year Ended August 31, |           
|                                                                                  |  | 2008                  |            |   | 2007 |  
|Cash flows from operating activities                                              |  |                       |            |   |      |   |            |  
|Net income                                                                        |  | $                     | 8,439,698  |   |      | $ | 4,155,480  |  
|                                                                                  |  |                      
|Less income from discontinued operations, net of income taxes                     |  |                       | (3,057,910 | ) |      |   | (288,838   | )
|                                                                                  |  |                       |            |   |      |   |            |  
|Net income before discontinued operations                                         |  |                       | 5,381,788  |   |      |   | 3,866,642  |  
|Adjustments to reconcile net income to net cash provided by operating activities: |  |                       |            |   |      |   |            |  
|Extraordinary gain, net of tax                                                    |  |                       | (39,436    | ) |      |   | (29,844    | )
|Depreciation and amortization                                                     |  |                       | 2,115,267  |   |      |   | 2,334,012  |  
|Gain on disposal of assets                                                        |  |                       | (503,226   | ) |      |   |           |  
|Deferred income taxes                                                             |  |                       | 197,106    |   |      |   | (744,604   | )
|Minority interests                                                                |  |                       | 185,958    |   |      |   | 121,563    |  
|Charge for granting stock options to employees                                    |  |                       | 373,435    |   |      |   | 124,425    |  
|Income tax benefit for employees exercise of incentive stock options             |  |                       | 99,645     |   |      |   | 77,000     |  
|Changes in operating assets and liabilities:                                      |  |                       |            |   |      |   |            |  
|Restricted cash                                                                   |  |                       | 4,388,857  |   |      |   | 469,000    |  
|Accounts receivable                                                               |  |                       | 12,436,696 |   |      |   | (2,415,113 | )
|Inventories                                                                       |  |                       | 717,711    |   |      |   | (435,726   | )
|Prepaid expenses                                                                  |  |                       | (44,860    | ) |      |   | 75,063     |  
|Income taxes receivable                                                           |  |                       | 392,740    |   |      |   | 212,054    |  
|Other assets                                                                      |  |                       | 45,881     |   |      |   | 131,871    |  
|Accounts payable                                                                  |  |                       | (318,779   | ) |      |   | (1,106,950 | )
|Accrued liabilities                                                               |  |                       | 109,906    |   |      |   | 2,440,086  |  
|Income taxes payable                                                              |  |                       | 2,215,109  |   |      |   | 462,395    |  
|                                                                                  |  |                       |            |   |      |   |            |  
|Cash provided by continuing activities                                            |  |                       | 27,753,798 |   |      |   | 5,581,874  |  
|                                                                                  |  |                      
|Cash provided by (used in) discontinued activities                                |  |                       | (41,175    | ) |      |   | 312,540    |  
|                                                                                  |  |                       |            |   |      |   |            |  
|                                                                                  |  |                      
|Net cash provided by operating activities                                         |  |                       | 27,712,623 |   |      |   | 5,894,414  |  
|                                                                                  |  |                       |            |   |      |   |            |  
|                                                                                  |  |                      
|Cash flows from investing activities                                              |  |                       |            |   |      |   |            |  
|Restricted cash for capital improvement                                           |  |                       |           |   |      |   | (4,049,149 | )
|Proceeds from sale of assets                                                      |  |                       | 6,157,763  |   |      |   |           |  
|Purchase of property and equipment                                                |  |                       | (1,283,851 | ) |      |   | (484,474   | )
|Purchase of accounts receivable-other                                             |  |                       |           |   |      |   | (312,449   | )
|                                                                                  |  |                      
|Collections of purchased accounts receivable-other                                |  |                       |           |   |      |   | 144,745    |  
|                                                                                  |  |                       |            |   |      |   |            |  
|Cash provided by (used in) continuing activities                                  |  |                       | 4,873,912  |   |      |   | (4,701,327 | )
|Cash provided by discontinued activities                                          |  |                       | 16,175,259 |   |      |   | 41,360     |  
|                                                                                  |  |                       |            |   |      |   |            |  
|                                                                                  |  |                      
|Net cash provided by (used in) investing activities                               |  |                       | 21,049,171 |   |      |   | (4,659,967 | )
|                                                                                  |  |                       |            |   |      |   |            |  

Continued.



38



---

##### Table of Contents

Dynacq Healthcare, Inc.

Consolidated Statements of Cash Flows (continued)



|                                                         |  |                       |            |   |      |   |            |  
|-------------------------------------------------------- |  | --------------------- | ---------- | - | ---- | - | ---------- | -
|                                                         |  | Year Ended August 31, |           
|                                                         |  | 2008                  |            |   | 2007 |  
|Cash flows from financing activities                     |  |                       |            |   |      |   |            |  
|Principal payments on notes payable                      |  | $                     | (7,526,182 | ) |      | $ | (216,231   | )
|Proceeds from note payable                               |  |                       |           |   |      |   | 734,601    |  
|Payments on capital lease                                |  |                       |           |   |      |   | (5,920     | )
|Proceeds from issuance of restricted stocks              |  |                       |           |   |      |   |           |  
|Proceeds from exercise of stock options                  |  |                       | 721,398    |   |      |   | 503,945    |  
|Proceeds from sale of stock                              |  |                       |           |   |      |   | 67,375     |  
|Treasury stock purchase                                  |  |                       | (2,309,898 | ) |      |   |           |  
|Distributions and purchases of minority interest holders |  |                       | (515,050   | ) |      |   | (179,245   | )
|                                                         |  |                       |            |   |      |   |            |  
|Cash provided by (used in) continuing activities         |  |                       | (9,629,732 | ) |      |   | 904,525    |  
|Cash used in discontinued activities                     |  |                       |           |   |      |   | (130,299   | )
|                                                         |  |                       |            |   |      |   |            |  
|Net cash provided by (used in) financing activities      |  |                       | (9,629,732 | ) |      |   | 774,226    |  
|                                                         |  |                       |            |   |      |   |            |  
|Effect of exchange rate changes on cash                  |  |                       | 530,951    |   |      |   | 45,782     |  
|                                                         |  |                       |            |   |      |   |            |  
|Net increase in cash and cash equivalents                |  |                       | 39,663,013 |   |      |   | 2,054,455  |  
|Cash and cash equivalents at beginning of year           |  |                       | 5,436,787  |   |      |   | 3,382,332  |  
|                                                         |  |                       |            |   |      |   |            |  
|Cash and cash equivalents at end of year                 |  | $                     | 45,099,800 |   |      | $ | 5,436,787  |  
|                                                         |  |                       |            |   |      |   |            |  
|                                                         |  |                      
|Supplemental cash flow disclosures                       |  |                       |            |   |      |   |            |  
|Cash paid during year for:                               |  |                       |            |   |      |   |            |  
|Interest                                                 |  | $                     | 132,370    |   |      | $ | 449,186    |  
|                                                         |  |                       |            |   |      |   |            |  
|Income taxes                                             |  | $                     | 1,543,634  |   |      | $ |           |  
|                                                         |  |                       |            |   |      |   |            |  
|                                                         |  |                      
|Non cash investing and financing activities:             |  |                       |            |   |      |   |            |  
|Accrued liabilities                                      |  | $                     | 124,326    |   |      | $ | (1,400,000 | )
|Minority interest                                        |  |                       | (124,326   | ) |      |   |           |  
|Note payable                                             |  |                       |           |   |      |   | 1,400,000  |  
|Equipment from capital lease                             |  |                       |           |   |      |   | (33,576    | )
|Capital lease obligation                                 |  |                       |           |   |      |   | 33,576     |  
|Deferred tax liabilities                                 |  |                       | (68,949    | ) |      |   |           |  
|Other comprehensive income                               |  |                       | (189,200   | ) |      |   |           |  
|Income tax receivable                                    |  |                       | 258,149    |   |      |   |           |  
|Land cost from foreign currency gains                    |  |                       |           |   |      |   | (203,490   | )
|Foreign currency gains                                   |  |                       |           |   |      |   | 203,490    |  
|                                                         |  |                       |            |   |      |   |            |  
|                                                         |  | $                     |           |   |      | $ |           |  
|                                                         |  |                       |            |   |      |   |            |  

The accompanying notes are an integral part of these consolidated financial statements.



39



---

##### Table of Contents

Dynacq Healthcare, Inc.

Notes to Consolidated Financial Statements

August 31, 2008



|1. | Significant Accounting Policies
|-- | -------------------------------

Business and Organization

Dynacq Healthcare, Inc. is a holding company that through its subsidiaries develops and manages general acute care hospitals which provide
specialized general surgeries, such as neuro-spine, bariatric and orthopedic surgeries. We are composed of two divisions, based on our geographic area of operations, U.S. and China. Hereinafter, the Company will refer to Dynacq
Healthcare, Inc. and its wholly or majority owned subsidiaries, unless the context dictates or requires otherwise.

The Company was
incorporated under the laws of the State of Nevada in 1992. The Company was reincorporated in Delaware in November 2003 and reincorporated back in Nevada in August 2007.

In May 1998, Vista Community Medical Center, L.L.C., a Texas limited liability company, was organized for the purpose of operating a hospital (the Pasadena facility). In June 2003, the Pasadena facility
was converted to a limited liability partnership. As of August 31, 2008 and 2007, the Company through its subsidiaries had a 99.9% and 98.5% ownership interest in the Pasadena facility, respectively.

In July 2003, Vista Hospital of Dallas, LLP was organized for the purposes of acquiring and operating a surgical hospital in Garland, Texas, (the
Garland facility). As of August 31, 2008 and 2007, the Company had a 100% and 99%, respectively, membership interest in the Garland facility.

In April 2008, the Company formed a wholly owned subsidiary, Dynacq Huai Bei Healthcare, Inc. (Dynacq-Huai Bei), a Chinese corporation, to provide healthcare management services in China. The Company has
also organized Sino Bond Inc. Limited, a Hong Kong corporation (Sino Bond), to hold investments in Hong Kong. Sino Bond has no operations to date but has entered into a marketing contract for the provision of healthcare services by
Dynacq subsidiaries in China and Southeast Asia.

The Company owned a 70% equity interest in Shanghai DeAn Hospital, a joint venture formed
under the laws of the Peoples Republic of China (the DeAn Joint Venture). The DeAn Joint Venture entered into land use agreements with the Chinese government for the purpose of constructing a hospital in Shanghai, China that was to
be owned and operated by the joint venture. In July 2008, the Company sold its interest in the property owned by DeAn.

The Company sold
its West Houston facility in the quarter ended February 28, 2007, its land in The Woodlands, Texas in the quarter ended November 30, 2007, its Baton Rouge facility in the quarter ended February 29, 2008, and its interest in the
property owned by DeAn in the quarter ended August 31, 2008.

Principles of Consolidation

The consolidated financial statements include the accounts of the Company and its wholly and majority owned subsidiaries. Intercompany accounts and
transactions have been eliminated in consolidation.



40



---

##### Table of Contents

Basis of Presentation

The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for annual financial information and with the instructions to Form
10-K and Article 3 and 3-A of Regulation S-X. The majority of the Companys expenses are cost of revenue items. Costs that could be classified as general and administrative by the Company would include the corporate office costs,
including advertising and marketing expenses, which were approximately $8.7 million and $8.8 million for the fiscal years 2008 and 2007, respectively.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in
the United States requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The most significant of the Companys estimates is the determination of
revenue to recognize for the services the Company provides and the determination of the contractual allowance. See Revenue Recognition below for further discussion. Actual results could differ materially from those estimates used in preparation of
these financial statements.

Reclassification

The assets related to the Baton Rouge and West Houston facilities, the land in The Woodlands, Texas, and the operating results for these facilities for all periods presented have been reclassified as Discontinued Operations. Certain balance
sheet amounts have been reclassified in the consolidated balance sheet as of August 31, 2007 to conform to the presentation as of August 31, 2008.

Cash and Cash Equivalents

The Company considers all highly liquid investments with maturities of three months or less on
the date of purchase to be cash equivalents. Cash equivalents are carried at cost, which approximates fair value.

Restricted Cash

Restricted cash includes $4.0 million as of August 31, 2007 for capital improvements in the DeAn Joint Venture. During the fiscal year ended
August 31, 2008, the interest in the DeAn Joint Venture was sold.

Inventories

Inventories, consisting primarily of medical supplies, are stated at the lower of cost or market, with cost determined by use of the average cost method.

Property and Equipment

Property and
equipment are stated at cost. Maintenance and repairs are charged to expense as incurred. Expenditures which extend the physical or economic life of the assets are capitalized and depreciated.

Depreciation is computed using the straight-line method over the estimated useful lives of the assets ranging from five to 39 years. The Company has
classified its assets into three categories. The categories are listed below, along with the useful life and the weighted average useful life for each category.



|                                  |  |             |  |                            
|--------------------------------- |  | ----------- |  | ---------------------------
|                                  |  | Useful Life |  | Weighted AverageUseful Life
|Land                              |  | N/A         |  | N/A                        
|Buildings and improvements        |  | 39 years    |  | 39 years                   
|Equipment, furniture and fixtures |  | 5-7 years   |  | 5.1 years                  



41



---

##### Table of Contents

The Company also leases equipment under capital leases. Such assets are amortized on a straight-line
basis over the lesser of the term of the lease or the remaining useful life of the assets.

Impairment of Long-lived Assets

The Company routinely evaluates the carrying value of its long-lived assets. The Company records an impairment loss when events or circumstances indicate
that a long-lived assets carrying value may not be recovered. These events may include changes in the manner in which we intend to use an asset or a decision to sell an asset.

Revenue Recognition

Background

The Companys revenue recognition policy is significant because net patient service revenue is a primary component of its results of operations.
Revenue is recognized as services are delivered. The determination of the amount of revenue to be recognized in connection with the Companys services is subject to significant judgments and estimates, which are discussed below.

Revenue Recognition Policy

The Company has
established billing rates for its medical services which it bills as gross revenue as services are delivered. Gross billed revenues are then reduced by the Companys estimate of the discount (contractual allowance) to arrive at net patient
service revenues. Net patient service revenues are based on estimated or historical cash collections as discussed below and may not represent amounts ultimately collected. At such time as the Company can determine that ultimate collections have
exceeded or have been less than the revenue recorded on a group of accounts, additional revenue or reduction in revenue is recorded as a change in estimate during the current period. The Company does adjust current period revenue for actual
differences in estimated revenue recorded in prior periods and actual cash collections. As the Company is able to identify specific closed blocks of business, the Company compares the actual cash collections on gross billed charges to the estimated
collections that were recorded in revenue. The Company records additional revenue or a reduction in revenue in the current period equal to the difference in the estimate recorded and the actual cash collected.

In the last two fiscal years, the Company has recorded additional revenue as follows:

1. The Company has recorded additional revenue of $8,217,000 during the fiscal year ended August 31, 2008 related to amounts collected on MDR accounts receivable. The Company settled various MDR claims for our
Pasadena and Garland facilities and collected a total of $26,713,000 for dates of service ranging from 2001 to 2005. This amount represents payments received initially at the time of filing of the claim, additional monies received upon filing the
MDR claim and the settlement amount. On these closed MDR accounts receivable, the Company had recognized approximately $18,496,000 as net revenue during the relevant fiscal years when the service was performed. Gross billings on this block of
receivables were $35,807,000. Since the Company actually collected $8,217,000 more on this block of receivables than was booked, additional revenue of $682,000, $3,835,000, $1,324,000 and $2,376,000 was recorded in the first, second, third and
fourth quarters of the fiscal year ended August 31, 2008, respectively. We do not believe that the amount of additional revenues from MDR settlements reached in this fiscal year is indicative of the amounts that will be obtained from
settlements reached in the next twelve months, since insurance companies who have not yet settled may be more likely to appeal their cases, which could delay settlement or a final judgment.

2. The Company collected $42,596,000 on a block of business generated at our Garland facility between September 2003 and February 2008. The accounts included in this
block of business were not related to workers compensation. Gross billings on this block of receivables were $78,781,000. The contractual allowance booked on this block of receivables was $41,485,000, or approximately 52.7%, generating net
revenue of $37,296,000. Since the Company actually collected $5,300,000 more than revenue booked on this block of receivables, additional revenue in the amount of $5,300,000 was recorded in the fourth quarter of the fiscal year ended August 31,
2008.



42



---

##### Table of Contents

3. The Company collected $28,572,000 on a block of business generated at our Pasadena facility between September 2005 and
February 2008. The accounts included in this block of business were not related to workers compensation. Gross billings on this block of receivables were $60,715,000. The contractual allowance booked on this block of receivables was
$36,643,000, or approximately 60.4%, generating net revenue of $24,072,000. Since the Company actually collected $4,500,000 more than revenue booked on this block of receivables, additional revenue in the amount of $4,500,000 was recorded in the
fourth quarter of the fiscal year ended August 31, 2008.

4. Due to the uncertainties regarding the accounts receivable in the MDR process, and the
recent Third Court of Appeals opinion and our legal counsels advice that settlements with insurance carriers have virtually stopped, the Company has fully reserved all accounts receivable related to the MDR process as of August 31,
2008, and written-off $8.7 million and $9.8 million of MDR accounts receivable in the fourth quarter of the fiscal year ended August 31, 2008, at our Garland and Pasadena facilities, respectively.

The net write down in net patient service revenue was $6.3 million in the fourth quarter of the fiscal year ended August 31, 2008, or $4.1 million net of
income tax expense, or $0.25 per diluted share.

The table below sets forth the percentage of our gross patient service revenue by
financial class for the fiscal years 2008 and 2007:



|                      |  |      |   |  |      |  
|--------------------- |  | ---- | - |  | ---- | -
|                      |  | 2008 |   |  | 2007 |  
|Workers Compensation |  | 37   | % |  | 47   | %
|Commercial            |  | 41   | % |  | 38   | %
|Medicare              |  | 10   | % |  | 9    | %
|Medicaid              |  |     | % |  | 1    | %
|Self-Pay              |  | 10   | % |  | 3    | %
|Other                 |  | 2    | % |  | 2    | %

Contractual Allowance

Starting March 1, 2008, the Company computes its contractual allowance based on the estimated collections on its gross billed charges. The Company computes its estimate by taking into account collections received
for the services performed and also estimating amounts collectible within the next six months and after six months by considering historical collections ratio. Prior to March 1, 2008, the contractual allowance was calculated based on the ratio
of the Companys historical cash collections during the trailing twelve months on a case-by-case basis by operating facility. This ratio of cash collections to billed services was then applied to the gross billed services by operating facility.
The following table shows gross revenues and contractual allowances for fiscal years 2008 and 2007:



|                                 |  |      |             |   |      |   |            |  
|-------------------------------- |  | ---- | ----------- | - | ---- | - | ---------- | -
|                                 |  | 2008 |             |   | 2007 |  
|Gross billed charges             |  | $    | 145,763,332 |   |      | $ | 96,215,520 |  
|Contractual allowance            |  |      | 85,489,385  |   |      |   | 53,369,699 |  
|                                 |  |      |             |   |      |   |            |  
|Net revenue                      |  | $    | 60,273,947  |   |      | $ | 42,845,821 |  
|                                 |  |      |             |   |      |   |            |  
|Contractual allowance percentage |  |      | 59          | % |      |   | 55         | %
|                                 |  |      |             |   |      |   |            |  

A significant amount of our net revenue results from Texas workers compensation claims,
which are governed by the rules and regulations of the Texas Department of Workers Compensation (TDWC) and the workers compensation healthcare networks. If one of our hospitals chooses to participate in a network, the amount
of revenue that will be generated from workers compensation claims will be governed by the network contract.

For claims arising
prior to the implementation of workers compensation networks and out of network claims, inpatient and outpatient surgical services are either reimbursed pursuant to the Acute Care In-Patient Hospital Fee Guideline or at a fair and
reasonable rate for services in which the fee guideline is not applicable. Starting March 1, 2008, the Texas Workers Compensation 2008 Acute Care Hospital Outpatient and Inpatient Facility Fee Guidelines (the Guidelines)
became effective. Under these Guidelines, the reimbursement amounts are determined by applying the most recently adopted and effective Medicare reimbursement formula and factors; however, if the maximum allowable reimbursement for the procedure
performed cannot be calculated using these Guidelines, then reimbursement is determined on a fair and reasonable basis.



43



---

##### Table of Contents

Based on these new Guidelines, the reimbursement due the Company for workers compensation cases is
lower than we previously experienced. The Company has continued accepting Texas workers compensation cases, and has not made any substantial changes in its focus towards such cases. Our net patient service revenue for Texas workers
compensation cases as a percentage of gross billings has decreased primarily as a result of lower reimbursement rates for workers compensation procedures still being performed.

Should our facility disagree with the amount of reimbursement provided by a third-party payer, we are required to pursue the MDR process at the TDWC to
request proper reimbursement for services. The Company has recently been successful in its pursuit of collections regarding the stop-loss cases pending before the State Office of Administrative Hearings (SOAH), receiving positive rulings
in over 90% of its claims presented for administrative determination. The 2007 district court decision upholding our interpretation of the statute as applied to the stop-loss claims was recently appealed by certain insurance carriers, and the Third
Court of Appeals determined that in order for a hospital to be reimbursed at 75% of its usual and customary audited charges for an inpatient admission, the hospital must not only bill at least $40,000, but also show that the admission involved
unusually costly and unusually extensive services. Procedurally, the decision means that each case where a carrier raised an issue regarding whether the services provided were unusually costly or unusually extensive would be remanded to either SOAH
or Medical Dispute Resolution (MDR) for a case-by-case determination of whether the services provided meet these standards, once the definitions of those standards are determined. We plan to appeal the Third Court of Appeals decision and
anticipate further, lengthy litigation at the Travis County District Courts and the Texas Courts of Appeals to establish the legal definition for these standards. Because of this lengthy process and the uncertainty of recovery in these cases,
collection of a material amount of funds in these pending stop-loss cases is not anticipated during the 2009 fiscal year.

To date,
insurance carriers have voluntarily paid the awards in the decisions and orders issued by SOAH, plus interest, in approximately 180 cases, involving approximately $11 million. In most of these cases, the carriers have requested refunds of the
payments made in the event that the SOAH decisions and orders are reversed on appeal. We believe the Companys ultimate obligation to refund the payments is remote. Our request that the TDWC Commissioner enforce the awards which have not been
voluntarily paid by the carriers has been refused in approximately 130 cases.

Claims regarding payment for hospital outpatient services
remain pending at the TDWC. It is expected that these claims will be adjudicated at SOAH and ultimately in the Texas district and appellate courts. The basis for reimbursement for these services made the subject of these pending cases is the
determination of fair and reasonable charges. In 2007, we received unfavorable rulings from SOAH in all of our appeals of unfavorable decisions related to services provided in 2001 and 2002. The 179 cases which have been appealed to the
Travis County district courts challenge the constitutionality of the relevant statutory language. A lead case has been selected and is scheduled to be heard on January 14, 2009. Although we would appeal any negative ruling handed down in this
lead case, such ruling will impact cases in which a fee guideline was not applicable, specifically all pending cases involving ambulatory surgical services provided in 2001 and 2002 as well as all pending cases involving hospital outpatient services
provided prior to March 1, 2008. Successful collection of material amounts in these cases is unlikely.

We are currently pursuing
claims against two healthcare agents relating to contracts with certain of our facilities which set out reimbursement guidelines by several workers compensation carriers at a minimum of 70% of the facilitys charges. Discovery is
continuing on these claims to determine which carriers are involved and the amount of reimbursement due to us.

Due to the uncertainties
regarding the accounts receivable in the MDR process, the recent Third Court of Appeals opinion and our legal counsels advice that settlements with insurance carriers have virtually stopped, the Company has fully reserved all accounts
receivable related to the MDR process as of August 31, 2008. Any monies collected for these MDR accounts receivable will be recorded as current periods net patient service revenues.

Accounts Receivable

Accounts receivable represent
net receivables for services provided by the Company. Due to reasons discussed above for writing down all MDR accounts receivable, the Company does not have any long term receivables as at



44



---

##### Table of Contents

August 31, 2008, and expects to collect the net receivables within twelve months. At each balance sheet date management reviews the accounts receivable
for collectibility.

The contractual allowance stated as a percentage of gross receivables at the balance sheet dates is larger than the
contractual allowance percentage used to reduce gross billed charges due to the application of partial cash collections to the outstanding gross receivable balances, without any adjustment being made to the contractual allowance. The contractual
allowance amounts netted against gross receivables are not adjusted until such time as the final collections on an individual receivable are recognized.

Stock Based Compensation

Effective at the beginning of fiscal year 2006, the Company adopted the provisions of Statement
of Financial Accounting Standards No. 123 Share-Based Payment (SFAS No. 123(R)) to account for stock-based compensation. Under SFAS No. 123(R), the Company estimates the fair value of stock options
granted using the Black-Scholes option pricing model. The fair value for awards that are expected to vest is then amortized on a straight-line basis over the requisite service period of the award, which is generally the option vesting term. The
amount of expense attributed is based on estimated forfeiture rate, which is updated based on actual forfeitures as appropriate. This option pricing model requires the input of highly subjective assumptions, including the expected volatility of our
common stock, pre-vesting forfeiture rate and an options expected life. The financial statements include amounts that are based on the Companys best estimates and judgments. Prior to fiscal year 2006, the Company accounted for
stock-based compensation plans using the intrinsic value method prescribed in Accounting Principles Board (APB) Opinion No. 25, Accounting for Stock Issued to Employees.

Advertising Costs

Advertising and marketing costs
in the amounts of $4,545,000 and $5,440,000 for the years ending August 31, 2008 and 2007, respectively, were expensed as incurred.

Income Taxes

The Company uses the liability method in accounting for income taxes. Under this method, deferred tax liabilities or assets are
determined based on differences between the income tax basis and the financial reporting basis of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse.

Minority Interests

The equity of
minority investors (minority investors are generally physician groups and other healthcare providers that perform surgeries at the Companys facilities) in certain subsidiaries of the Company is reported on the consolidated balance sheets as
minority interests. Minority interests reported in the consolidated income statements reflect the respective interests in the income or loss of the limited partnerships or limited liability companies attributable to the minority investors (equity
interests ranged from 0.1% to 7% during the fiscal year ended August 31, 2008, and was 0.1% at August 31, 2008 at the Pasadena facility). During 2008 and 2007, the Company purchased minority interests from certain minority interest holders
at an amount that was $60,671 and $45,244 less than the net book value of the minority interest liability on the date of purchase, respectively. These gains have been recorded as an extraordinary gain during the respective periods. In fiscal 2008
and 2007, the buy-out amounts were made in accordance with the provisions of the various partnership agreements.



45



---

##### Table of Contents

The following table sets forth the activity in the minority interest liability account for the fiscal
years ending August 31, 2008 and 2007:



|                                                |  |   |          |  
|----------------------------------------------- |  | - | -------- | -
|Balance August 31, 2006                         |  | $ | 656,697  |  
|Earnings allocated to minority interest holders |  |   | 121,563  |  
|Distribution to minority interest holders       |  |   | (15,000  | )
|Acquisition of various minority interests       |  |   | (164,245 | )
|                                                |  |   |          |  
|Balance August 31, 2007                         |  |   | 599,015  |  
|Earnings allocated to minority interest holders |  |   | 185,958  |  
|Distribution to minority interest holders       |  |   | (61,780  | )
|Acquisition of various minority interests       |  |   | (638,267 | )
|                                                |  |   |          |  
|Balance August 31, 2008                         |  | $ | 84,926   |  
|                                                |  |   |          |  

Net Income Per Share

Basic net income per share has been computed using the weighted average number of common shares outstanding during the period. Diluted net income per share has been calculated to give effect to the dilutive effect of
common stock equivalents consisting of stock options and warrants in years in which the Company has income.

Foreign Currency Translation

The Company has designated the Chinese Yuan Renminbi as the functional currency for the DeAn Joint Venture and Dynacq Huai Bei in China, and the Hong
Kong Dollar for Sino Bond Inc. Limited in Hong Kong. Assets and liabilities are translated into U.S. dollars using current exchange rates as of the balance sheet date. Income and expense are translated at average exchange rates prevailing during the
period. The effects of foreign currency translation adjustments are included as a component of Accumulated Other Comprehensive Income within stockholders equity.

Recent Accounting Pronouncements

In December 2007, the Financial Accounting Standards Board issued
SFAS No. 141 (revised 2007), Business Combinations (SFAS No. 141(R)) and SFAS No. 160, Noncontrolling Interest in Consolidated Financial Statements (SFAS No. 160). These new
standards represent the outcome of the FASBs joint project with the International Accounting Standards Board and are intended to improve, simplify and converge internationally the accounting for business combinations and the reporting of
noncontrolling interests in consolidated financial statements.

SFAS No. 141(R) replaces SFAS No. 141, Business
Combinations, however, it retains the fundamental requirements of the former Statement that the acquisition method of accounting (previously referred to as the purchase method) be used for all business combinations and for an acquirer to be
identified for each business. This Statement defines the acquirer as the entity that obtains control of one or more businesses in the business combination and establishes the acquisition date as the date that the acquirer achieves control. The new
standard requires the acquiring entity in a business combination to recognize all (and only) the assets acquired and liabilities assumed in the transaction; establishes the acquisition-date fair value as the measurement objective for all assets
acquired and liabilities assumed; and requires the acquirer to disclose to investors and other users all of the information they need to evaluate and understand the nature and financial effect of the business combination.

SFAS No. 160 amends Accounting Research Bulletin No. 51, Consolidated Financial Statements, to establish accounting and reporting
standards for the noncontrolling interest in a subsidiary and for the deconsolidation of a subsidiary. This Statement clarifies that a noncontrolling interest in a subsidiary is an ownership interest in the consolidated entity that should be
reported as equity in the consolidated financial statements. This Statement



46



---

##### Table of Contents

changes the way the consolidated income statement is presented by requiring net income to be reported at amounts that include the amounts attributable to
both the parent and the noncontrolling interest and to disclose those amounts on the face of the income statement. It also aligns the reporting of noncontrolling interest in subsidiaries with the requirements in International Accounting Standard 27.

Both SFAS No. 141(R) and SFAS No. 160 are effective beginning in our fiscal 2010. SFAS No. 141 (R) will be applied to
business combinations that are consummated beginning in fiscal 2010, and SFAS No. 160 will be applied prospectively to all noncontrolling interests, including any that arose before fiscal 2010. We are currently evaluating these Statements and
have not yet determined their effect on our consolidated financial statements.

In September 2006, the FASB issued SFAS No. 157,
Fair Value Measurements (SFAS 157) which addresses how companies should measure fair value when they are required to use a fair value measure for recognition or disclosure purposes under generally accepted accounting
principles (GAAP). As a result of SFAS 157 there is now a common definition of fair value to be used throughout GAAP. The FASB believes that the new standard will make the measurement of fair value more consistent and comparable and
improve disclosures about those measures. SFAS 157 will be effective for the Company for fiscal year 2009. Management is currently evaluating the impact of the statement on the Company. Management does not believe the adoption of SFAS 157
will have a material impact on its consolidated financial statements.

In March 2008, the FASB issued SFAS No. 161, Disclosures
about Derivative Instruments and Hedging Activities (SFAS 161). SFAS 161 requires entities to provide enhanced disclosures about derivative instruments and hedging activities. SFAS 161 is effective for financial statements issued
for fiscal years and interim periods beginning after November 15, 2008. The Company does not currently have any derivative instruments or hedging activities.



|2. | Property and Equipment
|-- | ----------------------

At August 31,
property and equipment consisted of the following:



|                                               |  |      |             |   |      |   |             |  
|---------------------------------------------- |  | ---- | ----------- | - | ---- | - | ----------- | -
|                                               |  | 2008 |             |   | 2007 |  
|Land                                           |  | $    | 2,452,110   |   |      | $ | 6,225,000   |  
|Buildings and improvements                     |  |      | 13,954,662  |   |      |   | 13,954,662  |  
|Equipment, furniture and fixtures              |  |      | 16,508,326  |   |      |   | 15,447,814  |  
|                                               |  |      |             |   |      |   |             |  
|                                               |  |      | 32,915,098  |   |      |   | 35,627,476  |  
|Less accumulated depreciation and amortization |  |      | (17,686,211 | ) |      |   | (15,821,032 | )
|Construction in progress                       |  |      |            |   |      |   | 150,267     |  
|                                               |  |      |             |   |      |   |             |  
|Net property and equipment                     |  | $    | 15,228,887  |   |      | $ | 19,956,711  |  
|                                               |  |      |             |   |      |   |             |  

For the years ended August 31, 2008 and 2007, depreciation expense was $2,106,100 and
$2,324,012, respectively.



|3. | Assets held for sale
|-- | --------------------

The Company sold its West
Houston facility in the quarter ended February 28, 2007, its land in The Woodlands, Texas in the quarter ended November 30, 2007 its Baton Rouge facility in the quarter ended February 29, 2008, and its interest in the property owned
by DeAn in the quarter ended August 31, 2008.



|4. | Discontinued operations
|-- | -----------------------

The Company has accounted
for its Baton Rouge and West Houston facilities as discontinued operations, and has reclassified prior period financial statements to exclude these businesses from continuing operations. A summary of financial information related to the
Companys discontinued operations for each of the past two years is as follows:



47



---

##### Table of Contents

|                                                                    |  |                       |            |   |      |   |             |  
|------------------------------------------------------------------- |  | --------------------- | ---------- | - | ---- | - | ----------- | -
|                                                                    |  | Year Ended August 31, |           
|                                                                    |  | 2008                  |            |   | 2007 |  
|Net patient service revenue                                         |  | $                     | 3,796,025  |   |      | $ | 12,389,320  |  
|Costs and expenses                                                  |  |                       | (3,949,998 | ) |      |   | (11,945,046 | )
|Other income                                                        |  |                       | 112,798    |   |      |   | 34,966      |  
|                                                                    |  |                       |            |   |      |   |             |  
|Income (loss) before income taxes                                   |  |                       | (41,175    | ) |      |   | 479,240     |  
|Benefit (provision) for income taxes                                |  |                       | 14,412     |   |      |   | (175,700    | )
|                                                                    |  |                       |            |   |      |   |             |  
|Income (loss) from discontinued operations, net of income taxes     |  |                       | (26,763    | ) |      |   | 303,540     |  
|                                                                    |  |                       |            |   |      |   |             |  
|Gain (loss) on sale of discontinued operations                      |  |                       | 4,745,650  |   |      |   | (23,702     | )
|(Provision) benefit for income taxes                                |  |                       | (1,660,977 | ) |      |   | 9,000       |  
|                                                                    |  |                       |            |   |      |   |             |  
|Gain (loss) on sale of discontinued operations, net of income taxes |  |                       | 3,084,673  |   |      |   | (14,702     | )
|                                                                    |  |                       |            |   |      |   |             |  
|Total income from discontinued operations, net of income taxes      |  | $                     | 3,057,910  |   |      | $ | 288,838     |  
|                                                                    |  |                       |            |   |      |   |             |  

Assets and liabilities of discontinued operations related to the Baton Rouge and West Houston
facilities and the land in The Woodlands, Texas, consist of the following as of August 31, 2007:



|                            |  |   |           
|--------------------------- |  | - | ----------
|Property and equipment, net |  | $ | 13,187,738
|                            |  |   |           
|Total assets                |  | $ | 13,187,738
|                            |  |   |           



|5. | Notes payable
|-- | -------------

At August 31, notes payable
consisted of the following:



|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |  |      |         |      |   |          
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |  | ---- | ------- | ---- | - | ---------
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |  | 2008 |         | 2007
|Current portion of $1.4 million note payable related to class action lawsuit settlement dated October 10, 2006. The note bears interest
at 6% per annum and is secured by a deed of trust on the Garland facility                                                                                                                                                                                                                                                                                                                                                                                                                                                     |  | $    | 480,269 |      | $ | 452,368  
|Five-year revolving credit facility with a financial institution subject to a borrowing base based on eligible accounts receivable, secured by
a first priority security interest in all existing and future accounts receivable and accounts receivable related items, other assets and deposit accounts of certain subsidiaries, a pledge of 75% of equity interest in the operating entities of the
Garland and Pasadena facilities and a negative pledge for the equity interests in the Company and other subsidiaries, variable interest payable of 2.85% plus LIBOR rate. Subsequent to fiscal year ended August 31, 2008, this credit facility was
terminated |  |      |        |      |   | 7,073,813
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |  |      |         |      |   |          
|Note payable  current portion                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |  |      | 480,269 |      |   | 7,526,181
|Long-term portion of $1.4 million note payable related to class action lawsuit settlement dated October 10, 2006. The note bears interest
at 6% per annum and is secured by a deed of trust on the Garland facility                                                                                                                                                                                                                                                                                                                                                                                                                                                   |  |      | 251,131 |      |   | 731,401  
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |  |      |         |      |   |          
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |  | $    | 731,400 |      | $ | 8,257,582
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |  |      |         |      |   |          



48



---

##### Table of Contents

|6. | Income Taxes
|-- | ------------

The provision (benefit) for income
taxes consisted of the following:



|                                   |  |                       |           |      |   |          |  
|---------------------------------- |  | --------------------- | --------- | ---- | - | -------- | -
|                                   |  | Year Ended August 31, |          
|                                   |  | 2008                  |           | 2007 |  
|Current tax expense (benefit):     |  |                       |           |      |   |          |  
|Federal                            |  | $                     | 3,684,270 |      | $ | 276,241  |  
|State                              |  |                       | 175,276   |      |   | 22,873   |  
|                                   |  |                       |           |      |   |          |  
|Total current                      |  |                       | 3,859,546 |      |   | 299,114  |  
|                                   |  |                       |           |      |   |          |  
|Deferred tax expense (benefit):    |  |                       |           |      |   |          |  
|Federal                            |  |                       | 197,107   |      |   | (687,666 | )
|State                              |  |                       |          |      |   | (56,938  | )
|                                   |  |                       |           |      |   |          |  
|Total deferred                     |  |                       | 197,107   |      |   | (744,604 | )
|                                   |  |                       |           |      |   |          |  
|Total income tax expense (benefit) |  | $                     | 4,056,653 |      | $ | (445,490 | )
|                                   |  |                       |           |      |   |          |  

As of August 31, 2008 and 2007, income tax benefits of $99,645 and $77,000, respectively,
resulting from deductions relating to nonqualified stock option exercises and disqualifying dispositions of certain employee incentive stock options were recorded as increases in stockholders equity.

The components of the provision for deferred income taxes at August 31 were as follows:



|                                                                                                             |  |      |          |   |      |   |            |  
|------------------------------------------------------------------------------------------------------------ |  | ---- | -------- | - | ---- | - | ---------- | -
|                                                                                                             |  | 2008 |          |   | 2007 |  
|Applicable to:                                                                                               |  |      |          |   |      |   |            |  
|Differences between revenues and expenses recognized for federal income tax and financial reporting purposes |  | $    | (258,079 | ) |      | $ | 333,827    |  
|Stock options and related employee compensation                                                              |  |      |         |   |      |   | (47,188    | )
|Allowance for uncollectible accounts                                                                         |  |      | (84,584  | ) |      |   | (85,448    | )
|Asset impairment                                                                                             |  |      | (455,000 | ) |      |   |           |  
|Difference in method of computing depreciation for tax and financial reporting purposes                      |  |      | 937,464  |   |      |   | (17,914    | )
|State tax rate change                                                                                        |  |      | 89,996   |   |      |   |           |  
|Net operating loss usage (carry forward)                                                                     |  |      |         |   |      |   | 835,899    |  
|Valuation allowance change                                                                                   |  |      |         |   |      |   | (1,763,780 | )
|Other                                                                                                        |  |      | (32,690  | ) |      |   |           |  
|                                                                                                             |  |      |          |   |      |   |            |  
|Deferred income tax expense (benefit)                                                                        |  | $    | 197,107  |   |      | $ | (744,604   | )
|                                                                                                             |  |      |          |   |      |   |            |  

Significant components of the Companys deferred tax liabilities and assets were as follows
at August 31, 2008:



|                                     |  |         |          |   |            |   |          |  
|------------------------------------ |  | ------- | -------- | - | ---------- | - | -------- | -
|                                     |  | Current |          |   | Noncurrent |  
|Deferred tax liabilities:            |  |         |          |   |            |   |          |  
|Depreciation                         |  | $       |         |   |            | $ | (93,983  | )
|Exchange gains provision             |  |         |         |   |            |   | (302,200 | )
|Deferred tax assets:                 |  |         |          |   |            |   |          |  
|Revenue and expense differences      |  |         | 290,990  |   |            |   |         |  
|Allowance for uncollectible accounts |  |         | 726,608  |   |            |   |         |  
|Other                                |  |         | (158,343 | ) |            |   | 40,375   |  
|                                     |  |         |          |   |            |   |          |  
|Net deferred tax asset (liability)   |  | $       | 859,255  |   |            | $ | (355,808 | )
|                                     |  |         |          |   |            |   |          |  



49



---

##### Table of Contents

Significant components of the Companys deferred tax liabilities and assets were as follows at
August 31, 2007:



|                                     |  |         |           |   |            |   |            |  
|------------------------------------ |  | ------- | --------- | - | ---------- | - | ---------- | -
|                                     |  | Current |           |   | Noncurrent |  
|Deferred tax liabilities:            |  |         |           |   |            |   |            |  
|Depreciation                         |  | $       |          |   |            | $ | (1,117,646 | )
|Exchange gains provision             |  |         |          |   |            |   | (113,000   | )
|Deferred tax assets:                 |  |         |           |   |            |   |            |  
|Revenue and expense differences      |  |         | 201,205   |   |            |   |           |  
|Allowance for uncollectible accounts |  |         | 878,986   |   |            |   |           |  
|Asset impairment                     |  |         |          |   |            |   | 493,026    |  
|Other                                |  |         | (22,260   | ) |            |   | 123,505    |  
|Minority interest                    |  |         |           |   |            |   | 187,788    |  
|                                     |  |         |           |   |            |   |            |  
|Net deferred tax asset (liability)   |  | $       | 1,057,931 |   |            | $ | (426,327   | )
|                                     |  |         |           |   |            |   |            |  

A reconciliation of the provision (benefit) for income taxes with amounts determined by applying
the statutory federal income tax rate to income before income taxes, minority interests and extraordinary gain is as follows:



|                                                                    |  |                       |           |   |      |   |            |  
|------------------------------------------------------------------- |  | --------------------- | --------- | - | ---- | - | ---------- | -
|                                                                    |  | Year Ended August 31, |          
|                                                                    |  | 2008                  |           |   | 2007 |  
|Provision for income taxes computed using the statutory rate of 35% |  | $                     | 3,354,737 |   |      | $ | 1,229,505  |  
|State income taxes, net of federal benefit                          |  |                       | 113,929   |   |      |   | 14,868     |  
|Minority interests in subsidiaries income                          |  |                       | (65,085   | ) |      |   | (46,103    | )
|Non-deductible expenses                                             |  |                       | 463,431   |   |      |   | 43,020     |  
|Change in valuation allowance                                       |  |                       |          |   |      |   | (1,763,780 | )
|State tax rate change                                               |  |                       | 89,996    |   |      |   |           |  
|Tax benefit of employees stock options exercise                     |  |                       | 99,645    |   |      |   | 77,000     |  
|                                                                    |  |                       |           |   |      |   |            |  
|Provision (benefit) for income taxes                                |  | $                     | 4,056,653 |   |      | $ | (445,490   | )
|                                                                    |  |                       |           |   |      |   |            |  



|7. | Related Party Transactions
|-- | --------------------------

The Company has
retained Redwood Health Corporation (Redwood), to furnish physicians to provide in-house emergency medical coverage for its Pasadena facility during the weekend hours and weekday nights at an hourly rate of $75. The son of the
Companys Chief Executive Officer is a physician and an affiliate of Redwood. The Company paid $437,100 and $433,500 for emergency room physician services to Redwood in fiscal 2008 and 2007, respectively. Management, as well as the Audit
Committee that approved the agreement, believes that the hourly rate being paid is consistent with comparable in-house emergency medical coverage rates available in the area.

The Company leases 7,250 square feet of office space for its executive offices through September 1, 2011 for $6,525 per month. The lessor of the
office space is Capital Bank, of which Mr. Earl Votaw, one of the Companys directors, is a director. Management believes that the lease rate being paid is consistent with comparable commercial rates available in the area.

Dr. Ping Chu, a director, has paid the Company $13,088 and $19,768 during fiscal years ended August 31, 2008 and 2007, respectively for rent
and management fees. As of August 31, 2008 and 2007, the Company had accounts receivable from Dr. Chu of $22,441 and $36,595, respectively. Included in the accounts receivable balance were amounts applicable to Dr. Chus
staffs payroll for which he reimburses the Company in the ordinary course of business.

Dr. Xiao Li, a director, was paid
$189,275 and $188,975 to provide in-house medical services to the emergency room patients at the Pasadena facility during the fiscal years ended August 31, 2008 and 2007, respectively. Management, as well as the Audit Committee that approved
the agreement, believes that the rate being paid is consistent with comparable in-house emergency medical services available in the area.



50



---

##### Table of Contents

|8. | Stockholders Equity and Stock Option Plan
|-- | ------------------------------------------

Preferred
Stock

In January 1992, the board of directors approved an amendment to the Companys Articles of Incorporation to authorize
5,000,000 shares of undesignated preferred stock, for which the board of directors is authorized to fix the designation, powers, preferences and rights. There are no shares of preferred stock issued or outstanding as of August 31, 2008.

Treasury Stock

Of the 500,000 shares
authorized to repurchase in January 2002, the Company purchased 10,000 shares in December 2007 at an average cost of $3.80 per share. Prior to that the Company had bought back 450,676 shares of its common stock during fiscal years
2002 - 2004, at an average cost of $14.08 per share, for a total purchase price of $6,345,680. The Company is no longer purchasing its shares under this program.

On February 29, 2008 the Companys Board of Directors authorized a program of repurchasing up to 2 million of its outstanding securities
from time to time in open market transactions at prevailing prices on NASDAQ. The Company has repurchased 445,193 shares at an average cost of $5.10 per share.

Stock Option Plan

The Companys 2000 Incentive Plan (the Plan) provides for options and other stock-based
awards that may be granted to eligible employees, officers, consultants and non-employee directors of the Company or its subsidiaries. The Company had reserved 5,000,000 shares of common stock for future issuance under the Plan. As of
August 31, 2008, there remain 1,219,854 shares which can be issued under the Plan, after giving effect to stock splits and shares issued under the Plan. The Plan permits stock awards, stock appreciation rights, performance units, and other
stock-based awards, all of which may or may not be subject to the achievement of one or more performance objectives.

The purposes of the
Plan generally are to retain and attract persons of training, experience and ability to serve as employees of the Company and its subsidiaries and to serve as non employee directors of the Company, to encourage the sense of proprietorship of such
persons and to stimulate the active interest of such persons in the development and financial success of the Company and its subsidiaries.

The Plan is administered by the Compensation Committee of the board of directors (the Committee). The Committee has the power to determine which eligible employees will receive awards, the timing and manner of the grant of such
awards, the exercise price of stock options (which may not be less than market value on the date of grant), the number of shares, and all of the terms of the awards. The Company may at any time amend or terminate the Plan. However, no amendment that
would impair the rights of any participant with respect to outstanding grants can be made without the participants prior consent. Stockholder approval of an amendment to the Plan is necessary only when required by applicable law or stock
exchange rules.

On June 22, 2007, the Compensation Committee granted stock options to purchase an aggregate of 1.3 million
shares, with a weighted average exercise price of $2.52 to all full time employees with a minimum of one year of employment with the Company. These stock options will vest in annual installments of 25 percent beginning on the first anniversary date,
and expire after six years. Generally, options granted become exercisable in annual installments of 25 percent beginning on the first anniversary date, and expire after five to ten years.

On July 25, 2008, the Compensation Committee granted a performance share award to an employee whereby the employee can earn up to 1 million
shares of the Companys common stock if certain operating performance criteria are met, beginning in fiscal 2010. The number of shares that are issuable each year is to be determined by quantifying the performance criteria and dividing the
quantified amount by $3.74, which was the market price of the Companys stock on the date of grant of the award. The performance period extends for ten years or until such time as the 1 million shares of common stock have been awarded.



51



---

##### Table of Contents

On August 19, 2008, the Compensation Committee granted stock options to purchase an aggregate of
100,000 shares, with an exercise price of $5.10 to an employee. These stock options will vest in annual installments of 25 percent beginning on the first anniversary date, and expire after six years.

Beginning in fiscal year 2006, the Company adopted SFAS No. 123(R) on a modified prospective transition method to account for its employee stock
options. Under the modified prospective transition method, fair value of new and previously granted but unvested equity awards is recognized as compensation expense in the income statement, and prior period results are not restated. Since all
of the outstanding stock options as of August 31, 2005 were vested, there was no impact on the consolidated financial statements of the Company as a result of the adoption.

SAB No. 107, which provided the Staffs views regarding valuation of share-based payments pursuant to SFAS No. 123(R), clarified that
there is not a particular method of estimating volatility. SAB No. 107 also provided certain simplified methods for determining expected life in valuing stock options. To the extent that an entity cannot rely on its
historical exercise data to determine the expected life, SAB No. 107 has prescribed a simplified plain-vanilla formula. The Company applied SAB No. 107 plain-vanilla method for determining the expected life.

The following table summarizes the stock option activities for the year ended August 31, 2008 (share amounts in thousands):



|                             |  |        |   |  |                                             |      |                                            |   |                            |  |   |          
|---------------------------- |  | ------ | - |  | ------------------------------------------- | ---- | ------------------------------------------ | - | -------------------------- |  | - | ---------
|                             |  | Shares |   |  | WeightedAverageOptionExercisePrice PerShare |      | WeightedAverageGrantDateFairValue PerShare |   | AggregateIntrinsicValue(1)
|Outstanding, August 31, 2007 |  | 2,151  |   |  | $                                           | 3.77 |                                            | $ |                           |  | $ | 6,053,359
|Granted                      |  | 100    |   |  |                                             | 5.10 |                                            |   | 3.62                       |  |   |         
|Exercised                    |  | (167   | ) |  |                                             | 4.31 |                                            |   |                           |  |   | 512,794  
|Expired or canceled          |  | (513   | ) |  |                                             | 4.59 |                                            |   |                           |  |   |         
|                             |  |        |   |  |                                             |      |                                            |   |                            |  |   |          
|Outstanding, August 31, 2008 |  | 1,571  |   |  | $                                           | 3.52 |                                            |   |                           |  | $ | 2,139,450
|                             |  |        |   |  |                                             |      |                                            |   |                            |  |   |          





(1)These amounts represent the difference between the exercise price and $4.85, the closing price of Dynacq common stock on August 31, 2008 as reported on the NASDAQ stock market, for all in-the-money options outstanding. For exercised
options, intrinsic value represents the difference between the exercise price and the closing price of Dynacq common stock on the date of exercise.

For the years ended August 31, 2008 and 2007, the Company received $721,398 and $503,945, respectively, for stock options exercised. Total tax benefit realized for the tax deductions from stock options exercised was $99,645 and $77,000
for the years ended August 31, 2008 and 2007, respectively.

The following summarizes information related to stock options outstanding
at August 31, 2008:



|                         |  |                              |  |                                                 |  |                              |      |        |     |                              |  |  |   |     
|------------------------ |  | ---------------------------- |  | ----------------------------------------------- |  | ---------------------------- | ---- | ------ | --- | ---------------------------- |  |  | - | ----
|                         |  | Options Outstanding          |  | OptionsExercisable                             
|Range of Exercise Prices |  | Shares                       |  | WeightedAverageRemainingContractualLife (Years) |  | WeightedAverageExercisePrice |      | Shares |     | WeightedAverageExercisePrice
|                         |  | (Share Amounts In Thousands)
|$ 2.50  2.75            |  | 886                          |  | 4.8                                             |  | $                            | 2.53 |        | 253 |                              |  |  | $ | 2.52
|$ 4.44  5.10            |  | 685                          |  | 5.0                                             |  |                              | 4.81 |        | 585 |                              |  |  |   | 4.76
|                         |  |                              |  |                                                 |  |                              |      |        |     |                              |  |  |   |     
|Total                    |  | 1,571                        |  | 4.9                                             |  | $                            | 3.52 |        | 838 |                              |  |  | $ | 4.09
|                         |  |                              |  |                                                 |  |                              |      |        |     |                              |  |  |   |     



52



---

##### Table of Contents

The fair value of the stock-based awards was estimated using the Black-Scholes model with the following
weighted average assumptions for two fiscal years ended August 31, 2008:



|                        |  |                       |       |      |   |      
|----------------------- |  | --------------------- | ----- | ---- | - | -----
|                        |  | Year Ended August 31,
|                        |  | 2008                  |       | 2007
|Estimated fair value    |  | $                     | 3.62  |      | $ | 1.70 
|Expected life (years)   |  |                       | 4.04  |      |   | 4.32 
|Risk free interest rate |  |                       | 3.07% |      |   | 5.00%
|Volatility              |  |                       | 204%  |      |   | 89%  
|Dividend yield          |  |                       |      |      |   |     



|9. | Employee Benefit Plan
|-- | ---------------------

The Company sponsors a
401(k) defined contribution plan covering substantially all employees of the Company and provides for voluntary contributions by these employees, subject to certain limits. The plan was effective June 1, 2001. The Company makes discretionary
contributions to the plan. The Companys contributions for fiscal years 2008 and 2007 were $81,111 and $50,901, respectively.



|10. | Net Income Per Share
|--- | --------------------

The numerator used in the
calculations of both basic and diluted net income per share for all periods presented was net income. The shares outstanding for basic and diluted are the same, as an increase in the number of shares for dilution purposes would be anti-dilutive. The
denominator for each period presented was determined as follows:



|                                                                 |  |                       |  |           
|---------------------------------------------------------------- |  | --------------------- |  | ----------
|                                                                 |  | Year Ended August 31,
|                                                                 |  | 2008                  |  | 2007      
|Denominator:                                                     |  |                       |  |           
|Basic net income per shareweighted average shares outstanding   |  | 15,793,660            |  | 15,749,891
|Effect of dilutive securities:                                   |  |                       |  |           
|Common stock optionstreasury stock method                       |  | 664,228               |  | 160,226   
|                                                                 |  |                       |  |           
|Diluted net income per shareweighted average shares outstanding |  | 16,457,888            |  | 15,910,117
|                                                                 |  |                       |  |           



|11. | Comprehensive Income
|--- | --------------------

Comprehensive income at
August 31 is as follows:



|                                                                                                                                       |  |      |           |      |   |          
|-------------------------------------------------------------------------------------------------------------------------------------- |  | ---- | --------- | ---- | - | ---------
|                                                                                                                                       |  | 2008 |           | 2007
|Net income                                                                                                                             |  | $    | 8,439,698 |      | $ | 4,155,480
|Foreign currency translation adjustment, net of income tax expenseof $189,200 and $113,000, in fiscal years 2008 and 2007,respectively |  |      | 341,751   |      |   | 113,951  
|                                                                                                                                       |  |      |           |      |   |          
|Comprehensive income                                                                                                                   |  | $    | 8,781,449 |      | $ | 4,269,431
|                                                                                                                                       |  |      |           |      |   |          



53



---

##### Table of Contents

|12. | Accrued Liabilities
|--- | -------------------

Accrued liabilities at
August 31 is as follows:



|                                               |  |      |           |      |   |          
|---------------------------------------------- |  | ---- | --------- | ---- | - | ---------
|                                               |  | 2008 |           | 2007
|Marketing fees liability                       |  | $    | 639,224   |      | $ | 1,951,100
|Payroll, bonus and related taxes               |  |      | 2,657,086 |      |   | 961,209  
|Minority interest buy-out liability            |  |      | 383,068   |      |   |         
|Property taxes                                 |  |      | 321,969   |      |   | 441,014  
|Medicare liability                             |  |      | 400,000   |      |   | 400,000  
|Lawsuit settlements and other related expenses |  |      | 100,000   |      |   | 385,000  
|Sales tax liability                            |  |      | 357,216   |      |   | 325,216  
|Insurance premium payable                      |  |      | 95,715    |      |   | 157,383  
|Rui An management fee payable                  |  |      | 146,088   |      |   |         
|Accrued interest                               |  |      | 4,048     |      |   | 50,329   
|Year-end accruals of expenses and other        |  |      | 811,146   |      |   | 1,010,077
|                                               |  |      |           |      |   |          
|Total accrued liabilities                      |  | $    | 5,915,560 |      | $ | 5,681,328
|                                               |  |      |           |      |   |          



|13. | Commitments and Contingencies
|--- | -----------------------------

Total rent and
lease expenses paid by the Company for the fiscal years 2008 and 2007 were approximately $1,240,000 and $1,056,000, respectively. The Companys total minimum rental commitments under noncancellable operating leases are approximately $2.1
million in the next four fiscal years.

The Company, through its subsidiary, also had agreements with outside organizations that offer
marketing, pre-authorization and follow up support services to prospective bariatric and orthopedic patients in areas serviced by the Pasadena and Garland facilities. These facilities received bariatric and orthopedic referrals from other sources,
and the organizations referred clients to other area hospitals. Payments made related to these agreements for the fiscal years 2008 and 2007 were $4,545,000 and $5,145,000, respectively. The Company has a total commitment of approximately $6,750,000
to be incurred in the next two fiscal years related to these marketing agreements.

The Company is currently overseeing the construction of
a hospital in Rui An, China to be completed October 1, 2009, at which time it will manage the hospital for a term of 15 years. As part of this agreement, the Company will provide a construction loan of approximately $2.1 million based on
percentage of completion of construction of the hospital, and will also advance approximately $730,000 for equipment purchase. The Company also has a commitment to assume and discharge within 10 years $883,000 of existing liabilities, of which
$736,000 has already been paid in fiscal year ended August 31, 2008. The Company has subsequent to the year ended August 31, 2008, signed an agreement for marketing its services to hospitals in China, for which the Company would incur at
its discretion from $75,000 to $250,000 per month for the next three years.

The Company has contracts with doctors to manage various areas
of the Companys hospitals and other service agreements. Payments made under these agreements for the fiscal years ending August 31, 2008 and 2007 were $3,276,000 and $2,888,000, respectively. The Companys minimum commitments under
these contracts are approximately $3.7 million to be incurred primarily in the next fiscal year.

Risks and Uncertainties

The Company maintains various insurance policies that cover each of its facilities. Specifically, the Company has occurrence medical malpractice coverage
for its Pasadena and Garland facilities. In addition, all physicians granted privileges at the Companys facilities are required to maintain medical malpractice insurance coverage. The Company also maintains general liability and property
insurance coverage for each facility, including flood coverage. The Company does not currently maintain workers compensation coverage in Texas. In regard to the Employee Health Insurance Plan, the Company is self-insured with specific and
aggregate re-insurance with stop-



54



---

##### Table of Contents

loss levels appropriate for the Companys group size. Coverage is maintained in amounts management deems adequate.

The Company is routinely involved in litigation and administrative proceedings that are incidental to its business. Specifically, all judicial review of
unsatisfactory determinations of reimbursement amounts due us for our facilitys fees must be made in the district courts of Travis County, Texas in what can often be a lengthy procedure.



|14. | Concentrations of Credit Risk and Fair Value of Financial Instruments
|--- | ---------------------------------------------------------------------

The Company has financial instruments that are exposed to concentrations of credit risk and consist primarily of cash investments and trade accounts receivable. The Company routinely maintains cash and temporary cash
investments at certain financial institutions in amounts substantially in excess of FDIC and Securities Investor Protection Corporation (SIPC) insurance limits; however, management believes that these financial institutions are of high
quality and the risk of loss is minimal. At August 31, 2008, the Company had cash balances in excess of the FDIC and SIPC limits of $45.1 million.

As is customary in the healthcare business, the Company has accounts receivable from various third-party payers. The Company does not request collateral from its customers and continually monitors its exposure for
credit losses and maintains allowances for anticipated losses. Receivables from third -party payers are normally in excess of 90% of the total receivables at any point in time. The mix of gross receivables from self-pay patients and third-party
payers at August 31, 2008 and 2007 is as follows:



|                                                                    |  |      |   |  |      |  
|------------------------------------------------------------------- |  | ---- | - |  | ---- | -
|                                                                    |  | 2008 |   |  | 2007 |  
|Workers compensation                                               |  | 10   | % |  | 3    | %
|Workers compensation subject to Medical Dispute Resolution process |  | 69   | % |  | 79   | %
|Commercial                                                          |  | 9    | % |  | 9    | %
|Medicare                                                            |  | 3    | % |  | 5    | %
|Medicaid                                                            |  |     | % |  |     | %
|Self-pay                                                            |  | 5    | % |  | 2    | %
|Other                                                               |  | 4    | % |  | 2    | %
|                                                                    |  |      |   |  |      |  
|                                                                    |  | 100  | % |  | 100  | %
|                                                                    |  |      |   |  |      |  

We had two third-party payers (customers) representing 11% and 10% of the Companys gross
revenue for the year ended August 31, 2008. We had one third-party payer (customer) representing 12% of the Companys gross revenue for the year ended August 31, 2007. We did not have a single third-party payer (customer) who
represented 10% of our gross receivables as of August 31, 2008. We had one third-party payer (customer) who represented 14% of our gross receivables as of August 31, 2007.

The carrying amounts of cash and cash equivalents, current receivables, accounts payable and accrued liabilities approximate fair value due to the
short-term nature of these instruments. The carrying amounts of the Companys short-term borrowings at August 31, 2008 and 2007 approximate their fair value.



|15. | Industry Segments and Geographic Information
|--- | --------------------------------------------

We
manage our operations through two operating segments, based on our geographic areas: U.S. and China.

U.S. Division

Our U.S. Division develops and operates general acute care hospitals designed to handle specialized surgeries such as bariatric, orthopedic and
neuro-spine surgeries. Certain of the Companys facilities also provide sleep laboratory and pain management services, as well as minor emergency treatment services. The U.S. Division owns two hospitals, which are the Pasadena facility and the
Garland facility.



55



---

##### Table of Contents

China Division

Our China Division is set up to provide healthcare management services in China. In the fiscal year ended August 31, 2008 and 2007, there have been no revenues in China.

DeAn, which was formed for the purpose of constructing, owning and operating a hospital in Shanghai, China, had entered into land use agreements with the
Chinese government under which it leased, for a term of 50 years, approximately 28.88 acres of government-owned land on which the hospital would be constructed. After protracted negotiations with the Chinese government for, among other matters, the
payment by the government of the amounts due by it under the Joint Venture Agreement which it had not funded, the sale by the government of its interest in DeAn to a third party, and the extension of the dates for completion of construction of the
hospital, the Company, in July 2008, sold its interest in the property owned by DeAn for the construction of the hospital for approximately $4.3 million U.S., net of commissions.

In April 2008, the Company formed Dynacq-Huai Bei, to provide healthcare management services to hospitals in China. Dynacq Huai Bei has entered into an
Agreement to Assign Management (Management Agreement) with Rui An City Department of Health assigning to Dynacq Huai Bei the right to manage the operations, human resources and financials of the Rui An Hospital beginning October 2009,
when the new hospital currently under construction is completed and operational. Dynacq-Huai-Bei is currently overseeing the construction of the hospital until it is completed.

The Company has also organized Sino Bond to hold investments in Hong Kong. Sino Bond has no operations to date but has entered into a three-year
marketing contract effective October 1, 2008 for the provision of healthcare services by Dynacq subsidiaries in China and Southeast Asia.

We generally evaluate performance based on profit or loss from operations before income taxes and non-recurring charges and other criteria. The accounting policies of the reportable segments are the same as those described in the summary of
significant accounting policies. There are no transfers between segments.

Summarized financial information concerning the business
segments from continuing operations is as follows:



|                                                                           |  |                       |            |   |      |   |            |  
|-------------------------------------------------------------------------- |  | --------------------- | ---------- | - | ---- | - | ---------- | -
|                                                                           |  | Year Ended August 31, |           
|                                                                           |  | 2008                  |            |   | 2007 |  
|Revenues from external customers                                           |  |                       |            |   |      |   |            |  
|Net patient service revenues                                               |  |                       |            |   |      |   |            |  
|U.S. Division                                                              |  | $                     | 60,273,947 |   |      | $ | 42,845,821 |  
|China Division                                                             |  |                       |           |   |      |   |           |  
|                                                                           |  |                       |            |   |      |   |            |  
|Consolidated                                                               |  | $                     | 60,273,947 |   |      | $ | 42,845,821 |  
|                                                                           |  |                       |            |   |      |   |            |  
|                                                                           |  |                      
|Income (loss) before taxes, discontinued operations and extraordinary gain |  |                       |            |   |      |   |            |  
|U.S. Division                                                              |  | $                     | 11,304,946 |   |      | $ | 4,136,103  |  
|China Division                                                             |  |                       | (1,905,941 | ) |      |   | (744,795   | )
|                                                                           |  |                       |            |   |      |   |            |  
|Consolidated                                                               |  | $                     | 9,399,005  |   |      | $ | 3,391,308  |  
|                                                                           |  |                       |            |   |      |   |            |  
|Total Assets                                                               |  |                       |            |   |      |   |            |  
|U.S. Division                                                              |  | $                     | 64,083,652 |   |      | $ | 70,219,802 |  
|China Division                                                             |  |                       | 18,164,910 |   |      |   | 8,675,159  |  
|                                                                           |  |                       |            |   |      |   |            |  
|Consolidated                                                               |  | $                     | 82,248,562 |   |      | $ | 78,894,961 |  
|                                                                           |  |                       |            |   |      |   |            |  

Many hospitals in China are owned and operated by the local governments subject to the oversight
by the central government. The Companys strategy is to minimize its capital investment by entering into long term mutually beneficial relationships by utilizing space from existing government hospitals and providing specialty medical treatment
therapies that the government owned hospitals are lacking and are in high demand. There currently exist joint venture arrangements between foreign healthcare providers and government owned hospitals, principally in major cities, such as Shanghai and
Beijing. Some of these competitors have greater financial and



56



---

##### Table of Contents

other resources than the Company in China. The Company has no prior experience of operating hospitals and can provide no assurance that it will be able to
compete successfully in China.

The above financial data are not reflective of the future trends, since revenue from China Division has not
started as yet. Subsequent to the fiscal year ended August 31, 2008, the cash balance at the China Division has increased from $17.7 million to $37 million. The U.S. Division has transferred an additional $20 million in October 2008 to the
China Division due to attractive interest rates on time deposits. Of the $37 million in cash in the China Division, $23 million is deposited in banks in Hong Kong, where the government of Hong Kong has guaranteed the repayment of all bank deposits
until 2010.

Subsequent to the end of the fiscal year ended August 31, 2008, the Company has engaged in negotiations to invest
approximately $3.9 million in high yield bonds, which it expects to finalize in the first quarter of fiscal 2009.



|16. | Subsequent Events
|--- | -----------------

Subsequent to the fiscal year
ended August 31, 2008, the cash balance at the China Division has increased from $17.7 million to $37 million. The U.S. Division has transferred additional $20 million in October 2008 to the China Division due to attractive interest rates on
time deposits. Of the $37 million cash in the China Division, $23 million is deposited in banks in Hong Kong, where the government of Hong Kong has guaranteed the repayment of all bank deposits until 2010.

A three-year management support and marketing agreement was executed effective October 1, 2008 between Sino Bond, Inc. Ltd., the Companys Hong
Kong subsidiary and Otto Regent Ltd., a Hong Kong marketing company to develop strategies to lead the Companys marketing activities in China including but not limited to recruitment of physicians, multi-media advertising and enhancing the
reputation of the Companys healthcare services, for which the Company would incur at its discretion from $75,000 to $250,000 per month for the next three years.

Subsequent to the end of the fiscal year ended August 31, 2008, the Company has engaged in negotiations to invest approximately $3.9 million in high yield bonds, which it expects to finalize in the first quarter
of fiscal 2009.



57



---

##### Table of Contents

|Item 9. | Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.
|------- | -------------------------------------------------------------------------------------

None.



|Item 9A(T). | Controls and Procedures.
|----------- | ------------------------

Conclusion Regarding the
Effectiveness of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our
chief executive officer and chief financial officer, we conducted an evaluation to assess the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report, pursuant to Exchange Act Rule 13a-15(e). Based
on that evaluation, our chief executive officer and chief financial officer concluded that, as of August 31, 2008, our internal disclosure controls and procedures were effective except for the filing of our Current Report on Form 8-K on
June 25, 2008. That report disclosed that a subsidiary of the Company had entered into a hospital management agreement in China on April 28, 2008; however, the management agreement had been amended on May 30, 2008 in several respects.
Those amendments were described in a Current Report on Form 8-K of the Company subsequently filed on November 6, 2008. The reason for this deficiency was a lack of effective communication between the executive officers and legal counsel of the
Company. The executive officers of the Company have recognized this deficiency and resolved to communicate more effectively and timely with their legal counsel regarding events requiring public disclosure.

Managements Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal controls over financial reporting, as such term is defined in Exchange Act Rule 13a-15(f). Under the supervision and with the
participation of management, including our chief executive officer and chief financial officer, an evaluation of the effectiveness of our internal controls over financial reporting was conducted based on the framework in Internal Controls 
Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Based on that evaluation under the framework in Internal Controls  Integrated Framework issued by the COSO, our management concluded
that our internal control over financial reporting were not effective as a result of a material weakness in internal controls as of August 31, 2008. That weakness was that the Company created a new entity in China during the first fiscal
quarter of 2008 and had activity in its cash accounts early in the second fiscal quarter of 2008 but lacked general ledgers for its China operations. After the Companys auditors pointed out this deficiency in the course of their audit during
October 2008, the Company prepared general ledgers for its three separate China entities, which were completed prior to the completion of the audit.

An internal control material weakness is a significant deficiency, or combination of significant deficiencies, that results in more than a remote likelihood that a material misstatement of the financial statements
would not be prevented or detected on a timely basis by employees in the normal course of their work. Our internal control system was designed to provide reasonable assurance to the Companys management and Board of Directors regarding the
preparation and fair presentation of published financial statements. All internal control systems, no matter how well designed, have inherent limitations, and therefore can only provide reasonable assurance with respect to financial statement
preparation and presentation. In order to address the material weaknesses identified, management has initiated corrective measures that will continue through 2009. The Company will continue to monitor the effectiveness of its internal controls and
procedures on an ongoing basis and will take further actions, as appropriate.

Changes in Internal Control over Financial Reporting

There have been no significant changes in our internal control over financial reporting during the most recently completed fiscal quarter or in other
factors that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.



58



---

##### Table of Contents

No Attestation Report

This annual report does not include an attestation report of the Companys registered public accounting firm regarding internal control over financial reporting. Managements report was not subject to
attestation by the Companys registered public accounting firm pursuant to temporary rules of the SEC that permit the Company to provide only managements report in this annual report.



|Item 9B. | Other Information
|-------- | -----------------

None.

PART III



|Item 10. | Directors, Executive Officers and Corporate Governance.
|-------- | -------------------------------------------------------

The information required by this Item 10 is incorporated by reference from the Companys Definitive Proxy Statement for our 2009 annual meeting to be filed on or before December 29, 2008.



|Item 11. | Executive Compensation.
|-------- | -----------------------

The information required
by this Item 11 is incorporated by reference from the Companys Definitive Proxy Statement for our 2009 annual meeting to be filed on or before December 29, 2008.



|Item 12. | Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.
|-------- | -----------------------------------------------------------------------------------------------

The information required by this Item 12 is incorporated by reference from the Companys Definitive Proxy Statement for our 2009 annual meeting
to be filed on or before December 29, 2008.



|Item 13. | Certain Relationships and Related Transactions, and Director Independence.
|-------- | --------------------------------------------------------------------------

The information required by this Item 13 is incorporated by reference from the Companys Definitive Proxy Statement for our 2009 annual meeting to be filed on or before December 29, 2008.



|Item 14. | Principal Accounting Fees and Services.
|-------- | ---------------------------------------

The
information required by this Item 14 is incorporated by reference from the Companys Definitive Proxy Statement for our 2009 annual meeting to be filed on or before December 29, 2008.

PART IV



|Item 15. | Exhibits, Financial Statement Schedules.
|-------- | ----------------------------------------

(a)(1) Financial Statements: See Index to Consolidated Financial Statements under Item 8 on Page 32 of this Report.

(a)(2) Financial Statement Schedule: Not required.

(b) Exhibits. The following exhibits are to be filed as part of the
annual report:



59



---

##### Table of Contents

|              |  |                                                                                                                                                                                                                                                            
|------------- |  | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|EXHIBIT NO.   |  | IDENTIFICATION OF EXHIBIT                                                                                                                                                                                                                                  
|              | 
|Exhibit 3.1   |  | Certificate of Incorporation incorporated by reference to Exhibit 3.1 to the Form 10-K filed November 13, 2007.                                                                                                                                            
|              | 
|Exhibit 3.2   |  | Bylaws incorporated by reference to Exhibit 3.2 to the Form 10-K filed November 13, 2007.                                                                                                                                                                  
|              | 
|+Exhibit 10.1 |  | The Companys Year 2000 Incentive Plan adopted on August 29, 2000, and incorporated by reference as Appendix B from the Companys Definitive Proxy Statement on Schedule 14A filed
August 9, 2000.                                                         
|              | 
|Exhibit 10.2  |  | Amended Management Support and Marketing Agreement between Otto Regent Limited and Sino Bond Inc. Limited dated October 1, 2008.                                                                                                                           
|              | 
|Exhibit 10.3  |  | Agreement selling real estate owned by DeAn Joint Venture dated July 11, 2008.                                                                                                                                                                             
|              | 
|+Exhibit 10.4 |  | Performance Award Agreement dated July 25, 2008.                                                                                                                                                                                                           
|              | 
|Exhibit 10.5  |  | Form of Indemnification Agreement with various officers and directors of the Company, incorporated by reference to Exhibit 10.11 to the Form 10-K for the fiscal year ended August 31,
2004.                                                               
|              | 
|Exhibit 10.6  |  | Purchase and Sale Agreement between Vista Holdings, LLC and the State of Louisiana dated November 8, 2007 incorporated by reference to Exhibit 10.7 to the Form 10-K filed November 13,
2007.                                                              
|              | 
|Exhibit 10.7  |  | Management Support and Marketing Agreement dated October 15, 2003 between the Company and Medical Multimedia Advertising, Inc. and Addendum thereto, incorporated by reference to Exhibit 10.12 to
the Form 10-K for the fiscal year ended August 31, 2003.
|              | 
|Exhibit 14.1  |  | Code of Ethics for Principal Executive and Senior Financial Officers, incorporated by reference to Exhibit 14.1 to the Companys Annual Report on Form 10-K for the fiscal year ended August
31, 2003.                                                     
|              | 
|Exhibit 21.1  |  | Listing of subsidiaries.                                                                                                                                                                                                                                   
|              | 
|Exhibit 23.1  |  | Consent of Killman, Murrell and Company, P.C.                                                                                                                                                                                                              
|              | 
|Exhibit 31.1  |  | Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.                                                                                                                                                        
|              | 
|Exhibit 31.2  |  | Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.                                                                                                                                                        
|              | 
|Exhibit 32.1  |  | Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.                                                                                                         
|              | 
|Exhibit 32.2  |  | Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.                                                                                                         



|+ | Management contract or compensatory plan or arrangement.
|- | --------------------------------------------------------



60



---

##### Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.



|                        |  |  |  |                         |  |                                      
|----------------------- |  |  |  | ----------------------- |  | -------------------------------------
|                        |  |  |  | Dynacq Healthcare, Inc.
|                        |  |  | 
|Date: November 26, 2008 |  |  |  | By:                     |  | /s/ Chiu M. Chan                     
|                        |  |  |  |                         |  | Chiu M. Chan, Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed
below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.



|                                                                               |  |                                                        |  |                  
|------------------------------------------------------------------------------ |  | ------------------------------------------------------ |  | -----------------
|Signature                                                                      |  | Title                                                  |  | Date             
|                                                                               |  |                                                       
|/s/ Chiu M. Chan Chiu
M. Chan (Principal Executive Officer)                    |  | Chairman of the Board, CEO and President               |  | November 26, 2008
|                                                                               |  |                                                       
|/s/ Philip S. Chan Philip S. Chan (Principal Financial and Accounting Officer) |  | Director, Vice President - Finance, CFO, and Treasurer |  | November 26, 2008
|                                                                               |  |                                                       
|Stephen L.
Huber                                                               |  | Director                                               |  | November 26, 2008
|                                                                               |  |                                                       
|/s/ Ping S. Chu Ping
S. Chu                                                    |  | Director                                               |  | November 26, 2008
|                                                                               |  |                                                       
|/s/ James G. Gerace James G. Gerace                                            |  | Director                                               |  | November 26, 2008
|                                                                               |  |                                                       
|/s/ Earl R. Votaw Earl R. Votaw                                                |  | Director                                               |  | November 26, 2008
|                                                                               |  |                                                       
|/s/ Xiao H. Li Xiao H. Li                                                      |  | Director                                               |  | November 26, 2008



61



---

##### Table of Contents

EXHIBIT INDEX



|              |  |                                                                                                                                                                                                                                                            
|------------- |  | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|EXHIBIT NO.   |  | IDENTIFICATION OF EXHIBIT                                                                                                                                                                                                                                  
|              | 
|Exhibit 3.1   |  | Certificate of Incorporation incorporated by reference to Exhibit 3.1 to the Form 10-K filed November 13, 2007.                                                                                                                                            
|              | 
|Exhibit 3.2   |  | Bylaws incorporated by reference to Exhibit 3.2 to the Form 10-K filed November 13, 2007.                                                                                                                                                                  
|              | 
|+Exhibit 10.1 |  | The Companys Year 2000 Incentive Plan adopted on August 29, 2000, and incorporated by reference as Appendix B from the Companys Definitive Proxy Statement on Schedule 14A filed
August 9, 2000.                                                         
|              | 
|Exhibit 10.2  |  | Amended Management Support and Marketing Agreement between Otto Regent Limited and Sino Bond Inc. Limited dated October 1, 2008.                                                                                                                           
|              | 
|Exhibit 10.3  |  | Agreement selling real estate owned by DeAn Joint Venture dated July 11, 2008.                                                                                                                                                                             
|              | 
|+Exhibit 10.4 |  | Performance Award Agreement dated July 25, 2008.                                                                                                                                                                                                           
|              | 
|Exhibit 10.5  |  | Form of Indemnification Agreement with various officers and directors of the Company, incorporated by reference to Exhibit 10.11 to the Form 10-K for the fiscal year ended August 31,
2004.                                                               
|              | 
|Exhibit 10.6  |  | Purchase and Sale Agreement between Vista Holdings, LLC and the State of Louisiana dated November 8, 2007 incorporated by reference to Exhibit 10.7 to the Form 10-K filed November 13,
2007.                                                              
|              | 
|Exhibit 10.7  |  | Management Support and Marketing Agreement dated October 15, 2003 between the Company and Medical Multimedia Advertising, Inc. and Addendum thereto, incorporated by reference to Exhibit 10.12 to
the Form 10-K for the fiscal year ended August 31, 2003.
|              | 
|Exhibit 14.1  |  | Code of Ethics for Principal Executive and Senior Financial Officers, incorporated by reference to Exhibit 14.1 to the Companys Annual Report on Form 10-K for the fiscal year ended August
31, 2003.                                                     
|              | 
|Exhibit 21.1  |  | Listing of subsidiaries.                                                                                                                                                                                                                                   
|              | 
|Exhibit 23.1  |  | Consent of Killman, Murrell and Company, P.C.                                                                                                                                                                                                              
|              | 
|Exhibit 31.1  |  | Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.                                                                                                                                                        
|              | 
|Exhibit 31.2  |  | Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.                                                                                                                                                        
|              | 
|Exhibit 32.1  |  | Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.                                                                                                         
|              | 
|Exhibit 32.2  |  | Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.                                                                                                         



|+ | Management contract or compensatory plan or arrangement.
|- | --------------------------------------------------------



62